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Title: 
 
Evaluation of Syringe Markers Distributed Through Community Pharmacy 
Needle Exchanges.  
 
Abstract 
 
The aim of this study is to evaluate the supply of markers for the identification of 
syringes distributed by pharmacy needle exchanges and to determine if this product 
and service delivery offers a feasible method of marking syringes to promote the 
reduction of accidental sharing of syringes and needles amongst injecting drug users 
(IDU) and thereby reduce the risk of transmission of blood borne viruses (BBVs) and 
other related infections. This study involves the assessment, implementation and 
evaluation of syringe markers as a pilot study within three community pharmacy sites 
in Glasgow. The secondary aims of the study were to identify whether the supply of 
syringe markers from community pharmacy needle exchanges was acceptable to IDU 
and if it enabled them to mark their syringes. The literature review demonstrates that 
providing a means of identification of personal injecting equipment has been proposed 
as a viable option that should be promoted to prevent the inadvertent accidental 
sharing of syringes within a group setting.    
 
Needle exchanges (NEX) are important component parts of the harm reduction 
responses designed to reduce the physical health harms caused to individuals through 
injecting drug use. The literature is reviewed on BBV transmission and the historical, 
legal and policy context associated with the development of NEXs. Community 
 vii 
 
pharmacies act as a source of health advice and can help to facilitate access to 
treatment services for those attending the NEX. However the specific aim of this 
study is not to investigate the totality of the benefits of a NEX but to examine the 
supply of a potential means of reducing accidental and unintentional sharing of all 
injecting equipment and thereby contribute to minimising some of the health harms 
linked to injecting drug use.  
 
Three established community pharmacies were identified as suitable sites to pilot the 
supply of syringe markers. A number of criteria were used to select the sites. These 
included an assessment of the geographic locations, staffing arrangements, NEX 
attendances and transactional activity and the availability of private consultation 
facilities. The health board central database which holds records on a range of factors 
including, the characteristics of those who attend NEX and detailed information on all 
transactions, was used to identify the most suitable sites to pilot the new intervention. 
This indicated that the characteristics of those who attended the three chosen sites 
were broadly similar to the wider NEX attending population.  
 
The evaluation was conducted in two separate periods. The first 4 week period was 
the supply phase where markers were distributed over this period to all patients 
receiving NEX packs from the 3 pharmacies. The second data collection phase was 
undertaken in the following 4 week period. Data was collected by means of a 
structured questionnaire. In order to reduce the potential interviewer bias it was 
decided to incorporate the use of peer researchers in the administration of the 
questionnaire. The Scottish Drugs Forum (SDF) was approached and agreement was 
reached to use members of the Service User Involvement Group (SUIG) to assist with 
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the design and administration of the questionnaire. A submission was made to the 
health board Research Ethics Committee (REC) and approval was given to enable the 
study and the research evaluation to proceed. Before the start of the study, joint 
briefing and training sessions were held for pharmacy staff from the 3 sites and the 6 
participating SUIG members. 
 
A total of 177 questionnaires were completed during the second data collection phase 
of the evaluation. Information was collected on personal details and injecting 
behaviours (including deliberate and accidental sharing), any current means of syringe 
identification, use of the markers and on the usefulness of the instruction card. Most 
individuals (75%, n=132) had been supplied with the markers to trial during the first 
supply phase of the study with 63% of the 132 (n=83) of those individuals reporting 
use of the markers. The results of the evaluation and subsequent analysis of the 
findings indicated that the syringe marker supply could be successfully implemented 
using pharmacy NEXs. The product and the supply method were acceptable to both 
staff and service users. Initial bivariate analysis was conducted using a number of 
dependent and independent variables identified within the questionnaire. These 
findings highlighted a number of areas worthy of further exploration, including 
emerging differences between male and female respondents, and indicated specific 
target groups for future developments in syringe identification.  
 
The contribution of the peer researchers was found to be a significant factor in 
successfully completing the evaluation. However it is not possible to make any 
definitive statements on how effective the intervention is in terms of reducing the 
transmission of BBVs and other related infections. The findings of the evaluation 
 ix 
 
indicated a number of potential areas of work that could be usefully explored to 
investigate the effectiveness of the markers in reducing the transmission of infections. 
The limitations of the evaluation became apparent during the course of the study and 
the implications of these limitations are discussed.       
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Chapter 1 
 
Literature Review. 
 
1.1 Introduction. 
 
The supply of syringe markers is a proposed harm reduction intervention that was 
based on the emerging evidence on the identified risks associated with deliberate or 
accidental sharing of injecting equipment (Speed, 1998; Hunter, Stimson, Judd et al, 
2000; Taylor, Fleming, Rutherford et al, 2004). This evaluation is aimed at 
investigating the practical application of one proposed solution to reducing accidental 
sharing and thereby promoting safer injecting practices. The intervention and 
evaluation was conducted in community pharmacy needle exchanges (NEXs).   
 
In 1656, Sir Christopher Wren was the first person in Britain reported to use a form of 
intravenous injecting when he conducted experiments administering opium and other 
substances to dogs using this new method (Derricott, Preston and Hunt, 1999:8). The 
syringe attributed to Wren was described as a crude device which consisted of “a quill 
attached to a small bladder” (Derricott et al, 1999:8). According to Berridge, in the 
19
th
 Century, developments into finding an injectable means of drug delivery were 
associated with developments in the medical profession which, at the time, was 
attempting to differentiate itself from the “quacks, herbalists, patent-medicine vendors 
and manufacturers” who had predominated in providing medical remedies and advice 
(1999:140). Part of this search for a distinct scientific medical identity involved using 
injecting equipment as a new means of administering drugs and according to Berridge 
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this enabled the medical profession to use the injection of drugs as a “more scientific 
and exact” way of treating symptoms (1999:140). In an 1868 article, Dr Francis 
Anstie had promoted the hypodermic injection of remedies and claimed that the 
advantages of treating the patient by injecting morphine when compared with oral 
administration of the drug were substantial (Berridge, 1999:141).  
 
Despite this historical background, widespread problematic injecting drug use is a 
relatively recent phenomenon. Early indications of illicit intravenous drug use were 
first reported in the UK in the 1920s (Derricott et al, 1999:25). It was recorded that 
this became established as a cultural phenomenon during the 1970s and 80s when 
illicit drug injecting drug established itself in Western societies and rapidly spread 
globally (Rhodes, Greenwood and Robertson, 2001:6).  
 
Addiction, including drug injecting, has evolved into a global phenomenon and 
according to Alexander has become “endemic in western free-market society” 
(2000:501). Alexander’s premise is that social dislocation caused by free markets is 
the “precursor of addiction” (2000:504). This is only one of a number of theories of 
the origin and causes of addiction. While a full review of the range of theories is out 
with the scope of this study, there is no doubt that whatever the cause(s) of addiction, 
the problems associated with injecting drugs are not solely local but have national and 
international dimensions.  It is therefore inevitable that injecting equipment supply 
schemes are now found world wide in response to widespread addiction and the health 
problems related to injecting drug use. Different models of delivery have developed 
that are dependent on the existence of national differences in both legal and policy 
contexts.  
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Two of the current major problems related to increasing injecting drug use, both in the 
UK and world wide, are the continuing health problems associated with the Human 
Immunodeficiency Virus (HIV) and with the transmission of Hepatitis C (HCV).  
 
1.2 HIV /AIDS. 
 
Acquired immunodeficiency syndrome (AIDS) is defined as a cluster of related 
medical conditions resulting from infection by the human immunodeficiency virus 
(HIV), which results in severe weakening of the immune system and HIV is spread 
through contamination of paraphernalia used to inject drugs and through a variety of 
other means including sexual transmission, blood transfusions, and from mother to 
child (Piot and Cherney, 2001). The major problem for those who inject illicit drugs is 
that AIDS can be transmitted through the injecting drug using population mainly by 
sharing of any of the items of paraphernalia used to prepare and inject illicit drugs 
(Battjes and Pickens, 1988:1).   
 
The syndrome was first identified in Los Angeles in 1981 and a description of the  
HIV responsible for causing AIDS was first recorded in 1983 (Oxford Medical 
Dictionary, 2007). Due to the development of new treatment therapies the progression 
of the disease from infection with the HIV to AIDS has dramatically changed and it is 
now possible to delay the onset, improve survival rates and at the same time improve 
the overall quality of life of sufferers by treatment with new drug therapies including 
combinations of protease inhibitors and reverse transcriptase inhibitors (Piot and 
Cherney, 2001). However, although the progression of the disease can be slowed, 
there is still no cure for HIV infection. The primary means of prevention of the 
transmission of HIV in IDU remains rooted in the health services along with a 
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combination of educational and harm reduction methods including the increased 
provision of sterile injection equipment (Piot and Cherney 2001). As a result of the 
global scale of the problem a major monitoring programme entitled, “The Joint United 
Nations Programme (JUNP) on HIV/AIDS”, has been initiated under the direct 
control of the United Nations (UN) Secretary General (Last, 2007, Oxford Ref 
Online). This UN body is responsible for collection, analysis and production of 
reports from data on AIDS and HIV infection and for the international co-ordination 
and advocacy for improved public health programmes to prevent and control the 
spread of AIDS. In January 2006 the JUNP reported that HIV/AIDS was responsible 
for infecting in excess of 42 million people and that this had resulted in an estimated 
12 million deaths (Last, 2007). 
 
The recent 2009 “Shooting Up” report from the UK Health Protection Agencies 
(HPA) claims that, apart from the outbreak in Edinburgh in the 1980s, HIV infection 
is relatively uncommon in injecting drug users (IDUs) and proposed that this low 
incidence is due in part to effective community based interventions (HPA(s), 2009:7). 
Despite the obvious dangers and risks of HIV transmission through injecting drug use 
the “Shooting Up” report claims that there has been no recorded episode of a specific 
outbreak in the United Kingdom similar to outbreaks that have happened in other 
parts of the world (HPS(s), 2009:7). 
In Britain the levels of HIV infection amongst the IDU population remains low by 
international standards (Stimson, 1995:700). Whilst acknowledging the difficulties 
inherent in linking social interventions and the prevention of an epidemic Stimson 
argues that there is prima facie evidence to demonstrate the success of syringe 
exchanges and that the range of different interventions introduced in the UK has 
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affected the behaviour of IDU to an extent that an epidemic of HIV infection in this 
group has been prevented (Stimson, 1995:699). The UK experience is only one 
example that illustrates the prime importance of introducing interventions quickly to 
encourage the changes in behaviour that are required to reduce the spread of HIV 
infection (Stimson, 1995:699).  
The first major report on the relationship between HIV / AIDS and injecting drug 
misuse was published by the Advisory Council on the Misuse of Drugs (ACMD) in 
1988. The report concluded that “HIV is a greater threat to public health and 
individual health than drug misuse” (ACMD, 1988:75). As a result, the fear generated 
by the concerns relating to the spread of HIV was a major contributory factor that 
resulted in the early development of needle and syringe exchange programmes (NSP) 
in the UK.  
 
Scotland was at the forefront in identifying the relationship between injecting drug 
use and HIV infection. In 1985, Dr Roy Robertson and his colleagues in a general 
practice in Edinburgh had identified, within one GP practice, that 51% of the injecting 
drug users were HIV positive (Robertson, Bucknall, Welsby et al, 1986:528). 
Robertson and his colleagues advocated that a “rapid and aggressive intervention” 
was required to limit the spread of infection (1986: 527). The authors were unable to 
identify the origin of the virus within the local population. However, they claimed that 
the rapid spread of infection had resulted from a combination of a number of 
interrelated factors including injection of heroin and sharing of injecting equipment 
due to lack of access to sterile equipment. They concluded that this combination of 
factors resulted in an increased risk of contracting HIV (1986:529). This effectively 
resulted in the establishment of a service that was a precursor to the subsequent 
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development of NEX schemes where the two GPs within the practice introduced an 
exchange policy for needles and syringes to those patients they had identified as being 
most at risk  (Robertson et al, 1986:529).      
 
A 1986 report published by the Scottish Home and Health Department (SHHD) was 
the first United Kingdom Government paper to recognise the existence of HIV 
infection within the population of IDUs. This report stated that,  
 
“There is a need to contain the spread of HIV infection among drug users, not 
only to limit the harm caused to drug misusers themselves but also to protect 
the health of the general public. The gravity of the problem is such that on 
balance the containment of the spread of the virus is a higher priority in 
management than the prevention of drug misuse” (SHHD, 1986:5).  
 
This mirrored the later conclusions of the 1988 ACMD report where prevention of 
harm by minimising the spread of HIV became the primary priority for intervention. It 
has been reported that the changes which took place at this time were effectively a 
“paradigm shift” which had radically changed the focus of attention away from the 
addiction itself onto the impact that injecting behaviours were having on the physical 
health of drug users (Jones, Pickering , Sumnall et al, 2008:11).   
 
It is clear from this brief summary that the introduction of NSPs and related policy 
developments in the United Kingdom have had a major impact in reducing injecting 
associated risks resulting in, what Stimson described as, the UK’s “low and stable 
prevalence of HIV infection” (Stimson, 1995:712). Australia adopted an approach 
similar to that of the UK which incorporated harm reduction interventions including 
drug treatment programmes, prescription of substitution therapies and education about 
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safer injecting practices that became a core part of their early national HIV/AIDS 
policies (Loxley, 2000:407). In Europe by 1987 NSPs had been adopted by Denmark, 
the Netherlands, Malta, Spain and the UK as public health measures and by 2001, 26 
of the European Union countries had NSPs in place (Hedrich, Pirona and Wiessing, 
2008:508).   
 
This picture is not replicated in other parts of the world where different policy 
approaches to the risks of intravenous drug use have been adopted. Despite the fact 
that the HIV was first identified in the USA there was no parallel introduction of NSP 
similar to those established in Europe and Australia.  Lurie and Drucker claimed that 
this was a major public health failure and that the USA federal government’s lack of 
support and funding for any national NEX schemes, contrary to a number of 
government funded reports that had supported the introduction of NEXs, could have 
been responsible for high levels of HIV infection among “thousands of IDUs, their 
sexual partners and their children” (1997:604). As a result of this ban, Lurie and 
Drucker claim that the absence of a national NEX in the USA has contributed to an 
estimated “4,000-10,000 preventable HIV infections” and that the associated social 
costs attached to providing treatment for these infections are estimated at between “a 
quarter and half a billion dollars” (1997:600). These estimates were arrived at by 
comparison with the Australian schemes where the estimated figures were based on 
the assumption of the position that would have existed if, in 1987, the USA had 
implemented and developed a NEX programme following the Australian model 
(Laurie and Drucker, 1997:606).  
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1.3 Hepatitis C Virus (HCV)   
 
HCV is described as a “blood-borne virus that can seriously damage the liver and 
affect its ability to function” (Scottish Executive, 2006:1). This virus was first 
identified in 1989 (Health Protection Scotland (HPS), 2010).  HPS reported on the 
differences in routes of transmission of HCV in countries that are termed either 
resource-rich or resource-poor. In resource-rich countries, including the UK, sharing 
of injecting drug equipment has been identified as the main route of transmission and 
in resource-poor areas the main cause of infection is deficiencies in the healthcare 
system including use of infected blood products and of non-sterile equipment (HPS, 
2010). It has been estimated that approximately 70 to 75% of people infected with 
HCV will progress to developing chronic hepatitis infections with a high risk of the 
infection leading to serious liver disease including liver cancer (HPS, 2010). If these 
estimates are accurate then this will inevitably lead to increased demands on the 
resources of both health and social care services in Scotland, throughout the UK and 
in other countries. 
 
HCV has been declared a global health problem and the World Health Organisation 
(WHO) estimates that 3% of the world’s population is infected (Wright, Millson and 
Tompkins, 2005:5). The evidence from a review of the worldwide HCV prevalence 
among IDU recorded reported data from 57 countries and that for 49 of those 
countries the HCV prevalence rates among IDU was reported to be more than 50% 
(Aceijas and Rhodes, 2007:352). The authors also identified evidence to show that in 
16 countries, IDUs were infected with both HCV and HIV. At the end of 2008 it was 
estimated that 1% of the population in Scotland, which equates to approximately 
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50,000 people, had been infected with HCV (HPA, 2009:10). The majority of these 
infections were as the result of injecting drug use (Hutchison, Roy, Wadd et al, 
2006:8). As testing for HCV is ongoing, not all of the estimated numbers of those 
infected have yet been diagnosed as HCV positive. By the end of 2008 the total 
number of diagnosed HCV positive people in Scotland was 25,355 (HPA, 2009:11). 
 
Scotland’s Health Minister in 2004 stated that the HCV “is one of the most serious 
and significant public health risks of our generation” (Hutchison, Roy et al, 2006:8).  
As already described this is a worldwide problem and in a review of the global 
epidemiology of HCV infection, Shepard and colleagues estimated that approximately 
123 million people may be infected with HCV (Shepard, Finelli and Alter, 2005:558). 
They concluded that for the developed world, injecting drug use is the main causative 
factor responsible for the high rates of HCV infection (Shepard et al, 2005:559).  
 
In an examination of the trends in HCV prevalence in Glasgow and Edinburgh 
amongst IDUs, at a time when needle and syringe exchange schemes were expanding, 
it was found that amongst young injectors in the 1990s there was a decrease in the  
incidence of HCV that coincided with the introduction of NEX schemes and related 
treatment  interventions, however the authors claimed that the number of those 
infected were still at unacceptably high levels (Goldberg, Burns, Taylor  et al, 
2001:457).  This indicated that the basic NEX schemes had only been partially 
successful in controlling the spread of HCV and the authors recommended the need 
for expanded prevention work and further research (Goldberg et al, 2001:457).  
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A review of the epidemiological evidence in Scotland has demonstrated that in 
Glasgow, from the period 1990 to 1996, there had been a reduction in HCV 
prevalence from 79% to 66% (Hutchison, Roy et al, 2006:11). The authors suggested 
that this decline was due to the fact that in the period from the late 1980’s and 
throughout the 1990’s a number of interventions had been implemented. These 
interventions, aimed at reducing the transmission of BBVs among IDUs, included 
schemes to provide sterile injecting equipment and prescribing opioid substitution 
treatment programmes (Hutchison, Roy at al, 2006:11).  As no further significant 
reductions in HCV prevalence after 1997 were noted the authors concluded that the 
findings demonstrated that although it was accepted that the current harm reduction 
measures were recognised as reducing the spread of HCV among IDUs, in isolation 
these strategies were not sufficient to fully control the epidemic (Hutchison, Roy at al, 
2006:11). One of the aims of the study described here includes the evaluation of a 
novel method of syringe identification that may have the potential to contribute to the 
reduction of HCV transmission in the drug using population through providing a 
method to promote a reduction in accidental sharing. 
 
Inevitably, due to the interrelated physical, social and cultural factors linked to 
intravenous drug use, it is difficult to definitively isolate the effects of NEXs from 
other harm reduction, treatment, education and other preventative initiatives. 
According to Ashton the argument relating to the critical role that NEX plays in 
containing the spread of HCV when compared with HIV is less apparent. He claims 
that the evidence to support the effectiveness of NEXs in reducing the incidence of 
HCV in IDUs is far less convincing and “rests partly on eliminating the alternatives” 
(Ashton, 2003:4). However the inherent difficulties should not deter the search for 
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alternative prevention strategies to reduce the spread of HCV. This is particularly 
important when the scale and urgency of the current and potential future problems 
outlined above have been identified as a major issue that can no longer be ignored 
(Scottish Executive, 2006:3).    
 
There appears to be evidence to show that the effects of NEX have not had the same 
impact on HCV as with HIV. Despite this, results from a modelling study assessing 
the impact of existing and of “hypothesised” prevention initiatives on HCV 
transmission among IDUs in Glasgow concluded that during the period 1988-2000 an 
estimated 45,000 HCV infections had potentially been prevented as a result of these 
harm reduction strategies (Hutchison, Bird, Taylor et al, 2006:211). The authors claim 
that, in terms of public health, this model has the potential to indicate strategies that 
are effective in reducing the incidence of HCV infection (Hutchison, Bird, et al, 
2006:219). These conclusions have been supported elsewhere and a previous 
Australian study had concluded that control of an HCV epidemic required different 
approaches with a greater emphasis on reducing needle and syringe sharing from 
those employed to reduce the impact of HIV transmission and that “more intense 
concentration” was required to develop effective HCV harm reduction strategies 
(Crofts, Aitken and Kalder 1999:221).      
 
In 2002 the Effective Interventions Unit (EIU) in Scotland reviewed the current 
research evidence on the HCV risks and prevention strategies in IDUs. This review 
concluded that no single strategy was likely to be effective and that any new strategy 
should incorporate a range of different interventions (Morrison, Duff, Taylor et al, 
2002:5). Phase 1 of Scotland’s Hepatitis C Action Plan (HCAP) was published in 
 12 
 
2006. In a foreword to the document the Chief Medical Officer (CMO) noted that 
“Prevention is as important and necessary as treatment and care” and that “in order to 
meet the needs of people who have been infected with Hepatitis C, existing services 
may need to change the way they do things” (Scottish Executive, 2006:v). In 
Scotland, and internationally, existing strategies have not yet controlled the epidemic 
and reducing HCV and Hepatitis B incidence  in the IDU population continues to be a 
“major challenge” (Loxley, 2000:407). For this reason the prevention aims of 
Scotland’s national Hepatitis C Action Plan incorporate specific actions where the 
anticipated outcomes include reducing sharing of injecting paraphernalia and reducing 
HCV transmission among IDUs (Scottish Government, 2008:19).  
 
1.4 Harm Reduction and the Development of Needle Exchanges. 
 
Harm reduction has been defined as,  
 
“Policies, programmes and practices that aim primarily to reduce the adverse 
health, social and economic consequences of the use of legal and illegal 
psychoactive drugs without necessarily reducing drug consumption. Harm 
reduction benefits people who use drugs, their families and the community” 
(IHRA, 2009:1).   
 
The supply of syringe markers through community pharmacy NEXs is a harm 
reduction initiative that focuses solely on reducing the adverse health consequences 
caused by continued injection of illegal drugs. Essentially the aim of any NEX is to 
reduce the harms caused by injecting drug use. The harm reduction term is wider than 
NEXs and covers a wide range of programmes and policies including: 
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1. Advocacy for changes in drug policies, including legalisation 
and changes in drug paraphernalia laws.  
2. HIV/AIDS-related interventions, including needle/syringe 
exchange programmes. 
3. Broader drug treatment options, including methadone 
maintenance prescribing. 
4. Drug abuse management for those who wish to continue using 
drugs, including promoting safer and more responsible drug use. 
5. Ancillary interventions, including housing and advocacy 
groups.” 
(Extract from Inciardi and Harrison, 2000:viii). 
 
According to Inciardi and Harrison, although the term harm reduction covers a range 
of areas described above, there is no single universally accepted definition (2000:vii). 
It appears obvious that the ultimate harm reduction initiative would be a total 
cessation of injecting drug use. Despite there being a number of different perceptions 
as to the exact definition of harm reduction they claimed that the essential feature of 
harm reduction is the “attempt to ameliorate the adverse health, social or economic 
consequences associated with the mood altering substances without necessarily 
requiring a reduction in the consumption of these substances” (Inciardi and Harrison, 
2000:viii). As mentioned above this evaluation is confined to the one specific health 
aspect of harm reduction within the NEX context and that is to evaluate the supply of 
markers and acceptability of this method of syringe identification as  a potential 
means of minimising the harms caused by sharing of injecting equipment. Whilst the 
complete cessation of drug use inevitably remains the ultimate goal for patients and 
treatment services, the evaluation that has been undertaken into the distribution of 
syringe markers from community pharmacies attempts to investigate a potential 
method of ameliorating harms within the context of the period of a patient’s life 
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where they are continuing to participate in potentially dangerous injecting drug use 
practices.  
 
Early harm reduction initiatives originated in the Netherlands where the first NEX 
programme was established in 1984 (van Haastrecht, 1997:57). This programme was 
established in an attempt to reduce the spread of hepatitis in the injecting population. 
As these programmes predated the identification and understanding of the 
transmission mechanism of HIV/AIDS it is postulated that this is the reason why the 
incidence and prevalence of HIV infection in the Netherlands remained at a relatively 
low level when compared with the “epidemic levels” that emerged in other countries. 
(van Haastrecht, 1997: 59). In the UK, NEX schemes were initiated as a policy 
response to the emergence of HIV/AIDS. According to Stimson, there is evidence 
from a review of this policy change and its subsequent implementation that IDU can 
alter their behaviour and that this, in turn, led to improved health by reducing risks of 
HIV infection  (1995:699).   
 
The policy of providing drug users with sterile injecting equipment did not have 
universal acceptance in the early stages of development. For example, in 1987, 
Ghodse and colleagues commented in the debate that due to the fact that there was 
minimum information available on existing injecting practices it was not possible to 
assess whether equipment supply schemes and increased knowledge of AIDS and 
HIV transmission had caused any behaviour changes (Ghodse, Treganza and Li, 
1987:698).  Farid pointed out that those in treatment represented only a small fraction 
of the population at risk. Despite this observation he questioned the emerging policy 
on NEX schemes and claimed that screening facilities from drug treatment services 
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offered a more effective way of “combating the spread of AIDS” (1988:376). 
However, this appears to have been a logical argument for extending the schemes to 
those in the target population who are outside the treatment services rather than a 
sound reason for restricting the supply of clean injecting equipment.    
 
Similar harm reduction initiatives were also adopted in others areas outside Western 
Europe. The prevalence of HIV infection among injecting drug users in Australia is 
approximately 2% (Loxley, 2000:407). According to Loxley harm reduction has been 
the major response to reducing the spread of HIV in Australia and she claims that 
there is evidence to show that this approach has led to a decrease in needle sharing 
(2000:407). An Australian report published in 2002 claims that NSP, established in 
1988, have been responsible for reducing the rates of HIV infection (Commonwealth 
of Australia, 2002:10). The report claims that by the year 2000, approximately 25,000 
HIV infections had been prevented and estimated that by 2010 approximately 4,500 
deaths would have been prevented as a result of the implementation of these 
programmes (2002:10).  
 
The situation in the United States is different as the government there has remained 
opposed to the widespread introduction of NEX. It has been claimed that no other 
country has reported a similar ban on funding into NEX programs or related research 
on effectiveness (Vlahov, Des Jarlais, Goosby et al, 2001:S72). In 1998, although the 
federal ban remained, the USA government finally concluded that, despite evidence to 
support the fact that NEX programs did not promote injecting drug use and were 
effective in reducing HIV infection, federal funds would still not be made available. 
However, they allowed local communities to make unilateral decisions on establishing 
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NSPs within their existing resources (Vlahovy et al, 2001:S72). By 2007 it was 
reported that local funds had been made available to establish approximately 200 
NEX programs across 36 states (Johnson, 2008/09:1).  
 
NEX schemes that distribute sterile injecting equipment to IDUs and provide safe 
storage facilities have become an accepted component of the harm reduction strategy   
in the UK (Strang and Gossop, 2005:145). NEXs operate from a variety of different 
sites and can adopt varying methods of supply. These have been reported to include 
“drug agencies, drug treatment clinics, accident and emergency departments, mobile 
units, voluntary agencies, outreach services” (Strang and Gossop, 2005: 146). The 
range of services available offers access to sterile injecting equipment to a wide range 
of IDU including those who are not in contact with the mainstream drug treatment 
services. Having injecting equipment supplied from various locations means that there 
is increased access in terms of geography and in the hours that the service is 
accessible. 
 
The 1987 the UK Government sponsored experimental schemes that were designed to 
provide 
“a) injecting equipment on an exchange basis to drug abusers who were  
     already injecting and unable or unwilling to stop;  
 b) assessment of and counselling for clients’ drug problems;  
 c) advice on safer sex and counselling on HIV testing”  
    (Stimson, Allritt, Dolan et al, 1988:1717).  
 
The findings from the initial monitoring of the schemes in England and Scotland 
showed that the schemes had been successful in attracting clients who had no other 
access to treatment services. The schemes were found to have been “reasonably 
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successful” and provided evidence that this was an effective means of supplying 
equipment using exchanges (Stimson et al, 1988:1717). This means that clean 
injecting equipment was supplied free of charge when used, and therefore potentially 
contaminated equipment was returned for safe disposal.   
  
In the European context, Hedrich and colleagues examined the developments and 
shifts in policy and attitudes and claim that there is data to support a European trend 
of recognising harm reduction as an essential and widespread element in public health 
and social policies designed to deal with problem drug use (Hedrich, Pirona and 
Weissing, 2008:512). These authors maintain that despite the reported differential 
approaches to the extent and existence of both abstinence based, and harm reduction 
strategies that have been reported across Europe, the reality is that both coexist 
(Hedrich et al, 2008:512). It is clear that NEXs have become a core element of any 
harm reduction strategy.  
 
Referring to the initial starting point of the 1988 ACMD report Yates has outlined that 
the underlying theme of the report of remains one where “the goal is abstinence” 
(2002:119). He describes two sets of circumstances where the goal of abstinence can 
be legitimately delayed; these are “where circumstances dictate that it cannot be 
immediately achieved and where to attempt an abstinence intervention may 
undermine risk reduction initiatives already underway” (Yates, 2002: 119).  Initially 
the goal of abstinence and any harm reduction strategies may appear to be mutually 
incompatible. However it is possible to implement strategies to maximise protection 
of the health of an individual where circumstances exist that have resulted in a delay 
in attaining the goal of abstinence. 
 18 
 
1.5 Sharing and the Re-Use of Injecting Equipment.  
 
An early review of needle sharing among intravenous drug users in 1987 had shown 
that those involved in injecting illicit drugs shared a range of equipment paraphernalia 
in addition to needles and syringes including “cookers” and cotton filters (Battjes and 
Pickens, 1988:2). This review of the international situation in 1987 concluded that the 
term “needle sharing” should be used in a wider context to refer to the sharing of all 
equipment used in the preparation and administration of drugs for injection (Battjes 
and Pickens, 1988:2). In Scotland the “McClelland Report” had indicated that the 
shortage of needles and syringes in Edinburgh, due to active local police enforcement 
policies, had resulted in injection equipment being widely shared (Scottish Home and 
Health Department (SHHD), 1986:7).  
 
An early ethnographic study of drug users in Scotland by McKeganey and Barnard 
was undertaken to investigate the interrelationship between the behaviours of IDUs 
and the transmission of HIV infection (1992:xvii). This work was conducted as there 
was minimal existing knowledge of the reasons for sharing and the practical aspects 
of the drug injecting situations that resulted in sharing and also the extent and 
relationships amongst those who shared injecting equipment (McKeganey and 
Barnard, 1992:25). The results of this study showed that sharing was not merely due 
to lack of availability, information or access to injecting equipment, but that there was 
a complex interplay of social factors directly affecting levels of sharing. This was 
particularly evident in the sharing that was identified amongst “sexual partners, close 
friends and family members” (1992:51). Whilst acknowledging the need for the 
provision of clean injecting equipment and for continued health education messages, 
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the authors claimed that it was probable that some level of sharing would be likely to 
remain despite the implementation of campaigns to promote safer injecting and 
highlighting risk related behaviours (McKeganey and Barnard, 1992:52). There is 
evidence from other countries to demonstrate that the social element influencing 
sharing amongst drug injectors also occurs outside the UK. Field studies in Rotterdam 
and New York had shown that despite differences in the types of equipment used, 
injecting practices and the drugs injected, “syringe-mediated drug sharing (SMDS)” 
was affected by an IDU’s social network and by the injection setting (Grund, Kaplan, 
Adriaans et al, 1991:701).   
  
One of the early studies in Australia by Crofts et al had pointed out the emerging 
evidence on how blood contact was possible outside the recognised sharing of needles 
and syringes but could also occur through injecting practices and sharing of related 
paraphernalia (Crofts, Aitken and Kalder, 1999:220). This study involved 
ethnographic work videotaping groups of drug users and revealed that there were 
many varied instances where the individuals could become exposed to the 
transmission of a range of infections through blood contaminated equipment other 
than the needles and syringes. This work showed the possibilities for transmission 
through a range of items including “swabs, spoons, water vials and tourniquets, as 
well as fingers, other body parts and surfaces in the immediate environment” (Crofts 
et al, 1999:220). On the basis of this evidence the authors concluded that for any 
measures to be effective in controlling the spread of HCV, greater efforts would have 
to be targeted towards reducing needle and syringe sharing and the other identified 
risk related behaviours (Crofts et al, 1999:221). In addition to the sharing of needles 
and syringes, the indirect sharing of other paraphernalia, including filters, spoons, 
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water and drug division processes were illustrated in a number of later studies that 
highlighted that even when needles and syringes were not being shared it was possible 
for transmission of HIV and Hepatitis B and C to occur through other means (Gossop, 
Griffiths, Powis et al, 1997, Hunter, Stimson, Jones et al 1998). According to Hunter 
and colleagues, HIV rates in the UK have remained comparatively low due to the 
existence of NEXs and other HIV harm reduction work, however they cautioned 
against complacency as there was evidence to show that despite these actions the 
potential remains for BBV transmission to continue (1998:46).  
 
The Hunter et al study in 1998 measured the level of sharing of syringes and other 
injecting equipment among IDUs. This work was carried out on a population of drug 
users in England who were not in current contact with treatment services (Hunter et 
al, 1998:5). This showed that when asked detailed questions about injecting behaviour 
and sharing practices in the previous four weeks 78 % reported some form of sharing 
behaviour (Hunter et al: 1998: 24).  
 
Some of the early work by Grund and colleagues in Rotterdam and Koester and 
colleagues in Denver was based on a series of observations of how IDUs actually mix, 
divide and distribute the prepared drug solutions for injecting (Grund, Kaplan, 
Adriians et al, 1991, Koester, Booth and Wiebel 1990). Koester outlines 9 distinct 
means of injection equipment sharing, shown in Table 1.1. These are in addition to 
directly sharing a previously used needle or syringe and can be summarised as, shared 
use of water, cookers, mixers, cotton filters, “front loading”, and “back loading” 
(Koester, 1996:1350). 
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Table 1.1  
Indirect Sharing.  
“INDIRECT SHARING”: AN ETHNOGRAPHIC TYPOLOGY. 
1. Rinsing previously used syringes(s) in a shared water container prior to drug          
preparation and injection. 
2. Using one participant’s syringe to draw up water for dissolving the drug. 
3. Using the rubber internal end of a participant’s syringe plunger to mix water with 
the drug. 
4. Using one participant’s syringe to measure and distribute a share of the drug 
solution to each participant (distribution then occurs through “back-loading” or 
“front-loading”). 
5. Drawing each share of the drug through a common cotton filter. 
6. Returning the drug solution to the common cooker, or directly to another injector’s 
syringe when an injector inadvertently draws up more than his/her share. 
7. Returning the drug solution to the cooker or directly into another’s syringe to “kick 
them out a taste” 
8. “Beating a cotton” that others have placed their needles in to draw up their dose. 
9. Rinsing a used syringe in water in which others have previously used for mixing 
and rinsing. 
Source:  Koester, 1996: 135.  
 
The terms “front loading “and “back loading” included in the typology are 
sociological terms that were first used to describe the practices observed by Grund in 
in 1993 (Derricott et al, 1999: 48). These terms are used to describe practices where a 
single syringe is used as a measuring device in the preparation of a batch of drugs. 
The prepared solution is then redistributed to other syringes either by “frontloading” 
where the “recipient” syringe has no needle attached or by “backloading” where the 
drug solution is inserted to the recipient syringe through the plunger end as the needle 
is non detachable (Derricott et al, 1999:48). These are inherently unsafe injecting 
practices and according to Smythe et al there is a clear and demonstrable association 
between these practices and the transmission of HCV infection (Smythe, Barry and 
Keenan, 2005:167). 
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Smythe and colleagues conducted a cross-sectional study of IDUs in Dublin in 2004 
using structured interviews. HCV tests were also performed on participants and 61% 
were found to be antibody positive (Smythe et al, 2005:166). This study was aimed at 
exploring the social context of drug injecting and the results suggested that unplanned 
sharing through accident and inadvertent sharing of equipment was potentially an 
important contributory factor in the spread of HCV infection and of increasing an 
individual’s risk of contracting this virus over time (Smythe et al, 2005:167). In 
Scotland a direct observational study of the practices of injecting drug users was 
published in 2004 (Taylor, Fleming, Rutherford et al, 2004). This research 
incorporated the use of video taping of actual injecting events supplemented by 
detailed field notes and the aim was to examine in detail the practicalities of the 
injecting processes to an extent that had not previously been done in the UK (2004). 
This work provided definitive evidence from direct observations that there were a 
number of points in the preparation process where deliberate or accidental sharing of 
equipment occurred. In observations where groups of injectors were involved it was 
found that in 44 out of 47 observed episodes, a range of injecting paraphernalia was 
shared by those observed (Taylor et al, 2004:2). This illustrates the high level of 
sharing that existed and the observations demonstrated how the social aspects of the 
situation often led to unsafe and “sub-optimal practices” (2004:3).  
 
In Scotland, the NHS Information Services Division (ISD) publishes an annual report 
that provides information on a range of drug misuse statistics (Drug Misuse Statistics 
Scotland (DMSS). This publication incorporates data from a wide range of relevant 
sources. These sources include services and agencies from primary, secondary, 
paediatric and mental health agencies and incorporate prescription related and hospital 
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discharge information.  An illustration of the existing data available on sharing from 
individuals who have reported to have injected in the past month has been extracted 
and summarised below in Table 1.2.  
 
Table 1.2. Extracted Injecting Sharing Data 2003-07 (DMSS).  
Scotland Current Sharing of 
needles/syringes 
(%) 
Current sharing of 
spoons/water/filters/solutions 
(%) 
2003/4 34 50 
2004/5 31 47 
2005/6 27 42 
2006/7 29 36 
(source: Drug Misuse Statistics Scotland, ISD publications)  
 
Table 1.2 gives a summary of figures on sharing behaviours from 2003 to 2007 for 
Scotland. This data is also collected on a health board and local authority basis and it 
is therefore possible to use this data for local monitoring purposes. The use of the data 
as a monitoring tool and how to incorporate this into an assessment of the impact of 
any intervention on sharing practices is discussed further in Chapter 5. Although there 
may appear to be an indication of reduced levels of sharing, the figures illustrate that 
sharing remains at an unacceptably high level. It is important to note that the figures 
in Table 1.2 are likely to be an underestimate of the full extent of sharing behaviours 
as they only record information from patients already in contact with treatment 
services. For example, there is no record of any information from those attending 
NEXs and therefore the information will not capture sharing data from the IDUs who 
are most likely to be involved in unsafe and risk taking injecting practices. This group 
contains some of the most hard to reach injecting drug users who may have no other 
formal contact with any health or social service and are likely to be a group that will 
have a significant effect on the levels of sharing of injecting equipment and the 
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resultant transmission of BBVs, related bacterial and other infections. Work by Scott 
in 2008 explored the risks attached to the use of injecting paraphernalia other than 
needles and syringes. This study included a qualitative element in addition to 
laboratory investigations of injecting equipment and methods of drug preparation 
(Scott, 2008:2). The results of the Scott study showed evidence of bacterial and fungal 
infections and vascular damage that was attributable to the circumstances surrounding 
injection preparation and to the re-use and sharing of equipment.  
 
The evidence demonstrated by existing research that utilised a variety of different 
methods and from the Scottish Government annual drug misuse statistics all indicate 
that sharing and re-use of injecting equipment is a real and significant health problem 
for IDUs that requires further investigation. 
 
1.6 Syringe Identification 
 
Following from the work described in section 1.5 that had successfully shown the 
existence, and some of the characteristics, of both planned and accidental sharing, 
proposals emerged for the introduction of a method of syringe identification. One of 
the recommendations from the observational work carried out in Scotland was that 
injecting equipment should be produced in a range of colours so that drug users who 
lived together would be able to easily recognise their own equipment when it was 
stored in a central shared space (Taylor et al, 2004:38). The subsequent practical 
development of different methods of syringe identification and their relevance to the 
syringe marker supply evaluation are discussed in Chapter 2.  
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The National Institute for Health and Clinical Excellence (NICE) has promoted the 
introduction of syringe identification schemes (NICE, 2009:8).  The 2009 NICE 
public health report also highlighted that there was an ongoing need for more 
extensive research to assess the most effective and cost effective types of injecting 
equipment that could be used to minimise harms and also recommended that drug 
users should be involved with this type of research and development (2009:22). The 
syringe marker evaluation study described here is designed to address some of the 
practical aspects associated with the introduction of a supply of one type of injecting 
equipment identification and its acceptability to services and service users.   
 
The study of the distribution and use of syringe markers in community pharmacies 
was conducted against a background policy context that included the emerging 
development of the National Hepatitis C Plans for Scotland. Phase 1 of Scotland’s 
National Hepatitis C Action Plan was published in 2006. Following extensive 
consultation the Action Plan concluded that this needed to be tackled on several fronts 
and that the actions should be “focussed and co-ordinated” (Scottish Executive, 
2006:3). The plan was divided into 6 main sections. These covered “Co-ordination, 
Prevention, Testing, Treatment, Care and Support, Education, Training and 
Awareness-raising and Surveillance and Monitoring” (Scottish Executive, 2006:3). 
This evaluation is confined to the action points detailed in Section 2: Prevention. The 
Action Plan highlighted that the main means of transmission of HCV in Scottish IDUs 
was through sharing and reusing of equipment (Scottish Executive, 2006:7). 
Recommendations from the Action Plan included advice to Health Boards that 
consideration should be given to using a proportion of the funds allocated to them to 
improve prevention services for HCV with particular reference to enhancing NEX 
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services (Scottish Executive, 2006:10).  More specifically, NHS Boards were asked to 
assess if the extent and nature of the interventions they currently offered were 
sufficient to promote safer injecting within this group (Scottish Executive, 2006). The 
Action Plan was explicit that in order to assist IDUs to identify their own equipment, 
these interventions should include “labelling or colour-coding” of injecting equipment 
(Scottish Executive, 2006:10).  
 
The aim of Phase 1 of the Hepatitis C Action Plan was to generate the evidence base 
for the actions detailed in Phase 2 (Scottish Government, 2008: 8). The main action 
relevant to the syringe marker evaluation is Action 15 which states that: 
 
“Services providing injecting equipment (needles/syringes and 
other injection paraphernalia) will be improved in accordance with 
the Guidelines referred to in Action 14 above. Improvements will 
be made in terms of the i) quantity (increasing access and uptake 
of equipment through innovative, including outreach, approaches). 
ii) quality (e.g. the colour coding of equipment to avoid sharing) 
and, iii) nature (e.g. the provision of equipment other than 
needles/syringes), of provision (Action 15)” 
(Scottish Government, 2008: 19).  
 
 
It is clear that the service development and evaluation that is the subject of this study 
has direct relevance to the evolving Scottish HCV policy initiatives and 
recommendations.  
 
The ACMD produced an extensive report for the UK Government on the “Primary 
Prevention of Hepatitis C among Injecting Drug Users” (ACMD, 2009). This report 
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made a number of policy recommendations with major implications for HCV 
prevention and other harm reduction services. This report noted the innovative nature 
of a number of UK prevention initiatives including reference to “coloured syringes” 
(ACMD, 2009:29). The report, however, recorded a note of caution as it 
recommended that innovation in this field should be supported but that  more attention 
needs to be given to evaluating innovative interventions and that this should include 
attempts to model the “potential impact and cost-effectiveness” of any innovation 
(ACMD, 2009:29). Section 1.7 below discusses the potential cost effectiveness of the 
intervention described in this evaluation and the likely financial impact for the health 
board of expansion of the supply.    
 
NEXs, including pharmacy based exchanges, have been extensively developed over 
the last 25 years and are now an integral part of UK and international prevention 
policies. There has been long established involvement in Glasgow and it has been 
claimed that the development of the Glasgow pharmacy based services has had a 
major impact on service developments in other parts of the United Kingdom (Roberts 
and Hunter, 2004:6). In 1996, Greater Glasgow Health Board (GGHB) published a 
joint planning strategy for HIV and AIDS (GGHB, 1996). This strategy recognised 
that an essential element in tackling the health harms associated with drug misuse was 
to prevent the spread of HIV within the population and that the developing role of 
community pharmacists was becoming an increasingly important element in this 
strategy (Roberts, Gilchrist, Cameron et al, 2002:4).   
 
The Scottish and the UK policy strategies are broadly similar in relation to reducing 
the sharing of injecting equipment by using syringe identification methods. The 2009 
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NICE public health report promotes the optimal provision of needle and syringe 
programmes for injecting drug users. One of the actions recommended to providers of 
this type of service is that they should “encourage people who inject drugs to mark 
their syringes and other injecting equipment or to use easily identifiable equipment to 
prevent mix-ups” (2009:18).   
 
1.7 Cost Effectiveness 
 
Although a full cost benefit analysis was outside the scope of this evaluation, the 
findings described in Chapter 4 and 5 would indicate that this is an area worthy of 
further examination. Intuitively the supply of syringe markers appears to be a 
relatively inexpensive intervention. A full cost benefit analysis would ideally include 
the costs of the intervention and the wider benefits shown to be associated with 
reduced transmission of BBVs and other related infections. For an intervention 
designed to reduce the harms to IDUs any potential cost benefit is a difficult factor to 
isolate and to quantify. This difficulty was acknowledged in the Scottish Hepatitis C 
Action Plan. The Action Plan recommends the supply of colour coded injecting 
equipment to reduce sharing and transmission of HCV but notes that even if these 
benefits were achieved, attributing the benefits with any degree of certainty to specific 
interventions would be problematic (Scottish Government, 2008:19). This is largely 
due to the fact that the influences on drug users are multifactorial and include the 
interplay of biological, social, psychological, cultural and practical influences. 
 
In an English study into the factors and the costs that could be attributed to injection 
site infections caused by illicit drug injecting it was found that were significant costs 
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for the health services (Hope, Kimber, Vickerman et al, 2008:1). In this study in 
England over 75% of those who attended hospital for treatment of injecting infections 
required hospital admission and the authors estimated that the associated costs were in 
the region of £19.2 to £30.5 million annually (Hope et al, 2008:3). The authors 
claimed that a large proportion of these infections were caused by the reuse of 
syringes (Hope et al, 2008:6). Therefore any intervention, such as the supply of 
syringe markers, which has the potential to reduce the level of deliberate or accidental 
sharing, is likely to have a consequential positive impact on the associated health 
costs. It should be noted that the Hope et al study refers only to injection site 
infections which were defined as “abscess (pus filled swelling) or open wound/sore” 
and excludes any costs attributed to the contraction of HIV or HCV through injecting 
drug use (2008:2). The annual individual patient costs associated with HIV and HCV 
treatment range from £14,000 to £20,000 annually (Y Gourlay, 2008: personal 
communication). Therefore the estimated costs quoted by Hope et al only reflect a 
fraction of the potential costs associated with the totality of the BBVs and associated 
infections that can be acquired through the use, re-use and sharing of contaminated 
injecting equipment. A full analysis would require further work to include all 
associated costs and ideally the incorporation of a statistical model that could 
definitively establish an association between the supply of markers and reduced levels 
of equipment sharing leading to a subsequent reduction in the transmission of BBVs 
and other related infections.  
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1.8 Development of Community Pharmacy Based Needle Exchanges. 
 
It has been reported that the first recorded provision of sterile injecting equipment 
worldwide was made by a pharmacist in the early 1980’s in Edinburgh (Wodak and 
Cooney, 2005: S31). As mentioned previously there are many different types of 
exchanges. The variety of service delivery locations and staffing complements 
determines the range and type of service available. These are provided from different 
settings and in addition to community pharmacies include specialist drug treatment 
services, outreach and mobile services, supplies from police custody suites and 
hospital based accident and emergency units (National Treatment Agency (NTA), 
2007). This evaluation is concerned exclusively with one aspect of the NEX service 
provided from community pharmacies. In 1982 the Royal Pharmaceutical Society of 
Great Britain (RPSGB) issued a directive, which prohibited pharmacists from selling 
needles and syringes (RPSGB, 1982). In 1986, due to the emerging concerns around 
the transmission of HIV, this was reversed and pharmacists were then allowed by 
their professional body to supply injecting equipment to IDUs (RPSGB, 1986). This 
referred to the sale of injecting equipment and not to the free provision of injecting 
equipment through a NEX service. According to Sheridan the reversal of the 1982 
advice in 1986 “paved the way for pharmacists to become major players” in the 
supply of injecting equipment and enabled the profession to be included in exchange 
schemes (in Strang and Gossop, 2005:147).   
 
Of the first British schemes established in 1986, only Sheffield had any pharmacy 
involvement. Unlike the current situation where injecting equipment is supplied free 
of charge, this was a scheme that allowed clients to purchase equipment and provided 
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a safe disposal facility. Based on the results from the initial monitoring of the early 
pilot schemes different models of service began to evolve. In addition to offering 
supplies of clean injecting equipment and providing safe disposal facilities there was 
an expansion of the range and type of services offered by NEXs. The evolution 
increased the diversity and accessibility of services available from different sites and 
increased the range of interventions offered to include “condoms, referrals, hepatitis B 
vaccination, HIV and hepatitis testing” (Jones, Pickering, Sumnall et al, 2008:12). A 
survey conducted in 2005 in Scotland identified that NEXs existed across the full 
range of different services (Greisbach, Abdulrahim, Gordon et al, 2006). The services 
and types of intervention that can be provided were, and still are, largely dependent on 
the premises and the type of staff involved. Vaccinations, for example, can only be 
provided by appropriately qualified professional staff. The pharmacy based NEX 
schemes also changed to the type of free exchange with additional health advice that 
is familiar today. The aim of pharmacy-based schemes was described by Shorrock and 
services included providing, free of charge, a range of injecting equipment, condoms 
and related health information materials aimed at reducing the transmission of HIV 
(2003:114). Important aspects of this local community service are to provide easy 
access to safe disposal facilities, to maintain patient confidentiality and for staff to 
have a “non-judgemental attitude” (Shorrock, 2003:114).  
 
The ACMD report in 1993 recommended an increased role for pharmacists in 
providing injecting equipment to intravenous drug users. This report advised that 
there was untapped potential within the pharmacy network that could be used to 
expand the existing needle and syringe provision (ACMD, 1993:34). This early report 
identified the training and support needs of pharmacists that required to be addressed 
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in order to provide this type of enhanced service. The training and support service run 
by a pharmacist employed by the Leicestershire Community Drug Service was 
commended as an example of good practice that could be reproduced in other areas 
(1993:34).  An independent review by the Department of Health (DOH) of drug 
treatment services in England in 1996, recommended an extension of the role of the 
pharmacy based NEXs. In this review community pharmacies were viewed as sites 
where there was the opportunity to incorporate health promotion advice and other 
services alongside supplies of injecting equipment in a setting that could be described 
as a “neutral space” (DOH, 1996:32). Despite being impressed by the existing 
commitment demonstrated by pharmacists the review noted that there was scope to 
realise untapped potential that existed due to unique accessibility of pharmacies for 
IDUs who were not currently in contact with treatment services. The review continued 
to advise that not only should geographic coverage via community pharmacies be 
extended but that there should be an expansion of the range of services available 
(1996:33).      
 
According to Shorrock, pharmacy-based schemes have a number of advantages that 
should be utilised. There is a network of approximately 12,000 community 
pharmacies in the UK. For IDUs these provide relatively easy local accessibility with 
associated longer opening hours and she also claims that there is reduced stigma 
associated with entering a community pharmacy as opposed to a dedicated drug 
treatment service (Shorrock, 2003:115). Many of these perceived advantages are due 
to the presence of the pharmacist who is a health care professional who can provide 
health information, interventions and advice and where consultations can occur on an 
opportunistic basis with no need for pre-planned appointments (Shorrock, 2003: 115).     
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Research indicated that more effort should be made to maximise the potential 
contribution of locally based community pharmacists in providing this type of 
intervention as it had been demonstrated that there were high levels of contact with 
“hard to reach” drug misusers (Sheridan, Strang, Barbour et al, 1996:272). This was 
confirmed later in an investigation into the profile of service users in community 
pharmacies and other settings where it was found that pharmacy NEXs could attract  
large numbers of injectors and that this was associated with high return rates of the 
needles and syringes that had been supplied (Cameron, Gilchrist and Roberts, 
2004:211). 
 
In 1988, 3% of community pharmacies in England and Wales provided a NEX service 
and by 1995 this had risen to 19% (Sheridan et al, 1996: 272). This situation was not 
mirrored in Scotland where only 9% provided the service in 1995. It has been 
suggested that this discrepancy may possibly be due to the fact that the first pharmacy 
based NEXs were not established in Scotland until four years later in 1992 and that 
participation was therefore inevitably slower to increase than in England (Cameron et 
al,  2004:211). It is also possible to speculate that the relatively slower involvement of 
Scottish pharmacists may also have been due, in part, to the existence in Scotland of 
the criminal offence of “reckless conduct”. Unlike England and Wales, in Scotland 
common law crimes, including reckless conduct, are relevant when considering 
injecting equipment supply and this may possibly have acted as a deterrent to the 
parallel expansion of the schemes in Scotland. In Scotland, unlike England, it is 
technically possible for pharmacists to be prosecuted using the law of reckless 
conduct and there is anecdotal evidence from NEX co-ordinators that this may have 
deterred some pharmacists from participating in exchange programmes despite 
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reassurances that prosecution under this statute would be an extremely unlikely action 
if supplies were made as part of a health board approved exchange scheme (Roberts 
K, 2004: personal communication).  
 
It should be noted that between 1988 and 1992 in Scotland pharmacies only supplied 
injecting equipment on a sale and not an exchange basis. In 1988, the office of the 
Lord Advocate had issued a statement that said. 
 
“The existence of the common law crime of reckless conduct 
makes it impossible to say that the supply of needles and 
syringes to be used for injecting controlled drugs could never 
amount to the commission of a criminal offence. The Lord 
Advocate’s view is that the crime of reckless conduct would 
only arise very exceptionally as regards the supply of needles 
and syringes by doctors and pharmacists and he would wish to 
retain discretion to prosecute only in such exceptional cases. 
While the Lord Advocate will not give any general and 
unqualified undertaking of immunity, he would not authorise the 
prosecution of any pharmacist in respect of the sale by the 
pharmacist of needles and syringes to drug misusers, provided 
they acted in accordance with the conditions and procedures set 
out in Annex 1”  
(SHHD, 1988). 
 
The Scottish Department of the Royal Pharmaceutical Society (RPS) was instructed to 
make arrangements for the guidance to be communicated to pharmacists in Scotland 
(SHHD, 1988). Despite the fact that this common law offence was not used to 
prosecute any pharmacists, Stimson claimed that “ it is clear that police in some parts 
of Scotland have been active in dissuading pharmacists from selling syringes” (1988: 
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91). It is reasonable to assume that this could have had an adverse effect on the sale of 
syringes and the development of pharmacy based NEXs in Scotland. This was not an 
issue that had to be addressed by pharmacists involved in the sale or supply of 
injecting equipment to drug users in England. For this reason it is possible to 
speculate that the cross border legal differences may have been a contributory factor 
in the identified slower increase in pharmacies willing to participate in exchange 
schemes in Scotland.   
 
By 1995 the participation of community pharmacies in Glasgow was below the 
English, Welsh and Scottish averages at only 5% of the eligible pharmacies within the 
Health Board area participating (Cameron et al, 2004:211). Recognition of this fact 
and the need for a full scale examination of the existing ad hoc arrangements for 
injecting equipment provision across the Health Board led in 2001 to a full scale 
review (Gruer, 2001).  
  
Despite the fact that there is evidence to indicate that pharmacy NEXs have positively 
contributed to promoting safer injecting behaviours and reducing sharing of used 
equipment, the number of pharmacies involved in providing this service in Glasgow 
remained low (Cameron et al, 2004:212). The 2001 comprehensive review concluded 
that local drug injectors were at “high risk of infection with HIV, hepatitis B and C 
viruses and other micro-organisms through sharing and other unhygienic uses of 
injection equipment” (Roberts, Gilchrist, Cameron et al, 2002:6).  The review 
recommended that more community pharmacies should participate in the NEX 
scheme with a target of increasing participating sites from 15 to 30 by 2005 (Gruer, 
2001:2). This recommendation was accepted and implemented and the target of 30 
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participating pharmacies was eventually reached in 2005. Since then there has been a 
continued increase in the number of sites, improvements in service delivery and staff 
training in response to the Action Points contained in Phases 1 and 2 of Scotland’s 
National Hepatitis C Action Plan (Scottish Government, 2006, 2008). By 2009 the 
numbers had risen and there are now 62 community pharmacies providing NEX 
services across the Greater Glasgow and Clyde health board. This constitutes 20% of 
the total of 312 pharmacies and has now reached a par with service provision in 
England. 
 
1.9 Legal Issues  
 
The discussion above has focussed on the supply of needles and syringes through the 
development of community pharmacy based services. Before 1986 it was not an 
offence to supply other pieces of equipment that could potentially be used in 
preparing illicit drugs for injection. According to Bucknell and Ghodse changes in 
legislation relating to the types of equipment that could be supplied  were in response 
to the fact that some shops in Soho, London, were selling articles “which in 
themselves appeared innocent, but when put together they formed cocaine sniffing 
kits” (1989:2).  In 1986 the Dug Trafficking Offences Act (DTOA) inserted Section 
9A into the Misuse of Drugs Act. The Drug Trafficking Offences Act introduced the 
term “drug administration kits”. This resulted in the “prohibition of supply etc of 
articles for administering or preparing controlled drugs”. Section 34 of the DTOA 
reinforced that “it is not an offence to supply or offer to supply a hypodermic syringe 
or any part of one”. Section 9A of the Misuse of Drugs Act created a new summary 
offence, with a maximum penalty of six months imprisonment, for the supply of any 
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articles that could be used or adapted for the administration of controlled drugs.  This 
meant that any supplier, including pharmacists, was committing an offence if they 
knowingly supplied any article where “the supplier believes it may be used by the 
recipient to administer an unlawful drug or prepare an unlawful drug for 
administration”. The insertion of Section 9A into the MDA was as a direct result of a 
visit, in 1985, by the UK Home Affairs Select Committee Office to the United States. 
Following this visit the committee described problematic drug use as the “most 
serious peacetime threat to our national well being” (Roberts, 2009:2). At this time 
there was an acknowledgement of the health benefits to be gained from the supply of 
sterile needles and syringes, in terms of reducing the transmission of HIV.  
 
This remained the situation with the supply of injecting equipment until 2003 when 
the Misuse of Drugs Act was amended (Statutory Instrument (SI), 2003, 1653). This 
followed a Home Office consultation in 2002 into the proposed amendments to 
Section 9A of the MDA. These amendments made legal the supply to drug users of 
five specific items, by practitioners, pharmacists and persons employed or engaged in 
lawful provision of drug treatment services. The five items which could now be 
legally supplied under the Section 9A amendment were ampoules of water for 
injection (subject to the requirements of the Medicines Act), swabs, utensils for the 
preparation of a controlled drug (spoons, bowls, cups, and dishes), citric acid and 
filters. 
 
Before embarking on the syringe marker study, an assessment had to be made of the 
legal aspects of this supply with reference to Section 9A of the MDA and the Scottish 
common law crime of reckless conduct. As outlined above, Section 9A permits the 
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supply of specific items of injecting paraphernalia by pharmacists and other 
professionals as part of NEX services. Syringe markers are not mentioned as an 
exempted item in this section, however Section 9A relates to items used in the 
“preparation” and “administration” of illicit drugs. It can be seen that all of the current 
5 exempted items are intimately involved in the preparation and administration and 
have direct contact with illicit controlled drugs. Syringe markers appear to be one step 
removed from involvement in direct preparation and administration and therefore not 
affected by the restrictions of Section 9A. Further advice was sought from the NHS 
legal department who supported this interpretation. As noted above, blanket immunity 
for NEXs from prosecution under the common law crime of reckless conduct is not 
possible. This power is retained for use in exceptional circumstances only, and would 
not apply to NHS or other approved services. Confirmation was received from the 
Scottish Crime and Drug Enforcement Agency (SCDEA) who supported the view that 
any prosecution was “highly unlikely” in the settings and circumstances described.      
 
In England there were no restrictions on the quantities of needles, syringes and 
associated paraphernalia that could be supplied. However in Scotland the Lord 
Advocate set restrictions on the quantities that could be supplied. This was limited to 
only 5 sets of equipment to be supplied on a first visit and up to a maximum of 15 sets 
thereafter. As a direct response to the growing problem of HCV transmission these 
limits were revised in 2002 to a maximum of 20 needles and syringes on a first visit 
with a limit of 60 for subsequent visits and an exceptional upper limit to account for 
holiday or other similar periods of 120 sets (NHSHDL No.(2002)90). As a direct 
response to the accepted public health benefits of NEXs these restrictions were finally 
eliminated in 2010. To coincide with the introduction of the national Injecting 
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Equipment Providers (IEP) guidelines the Lord Advocate lifted restrictions on the 
maximum number of sets of needles and syringes that could be supplied and removed 
the return of used equipment as a prerequisite for increased supplies (Scottish 
Government, 2010: 31)  
 
1.10 Public Attitudes and Needle Exchanges 
  
It is clear from the review of the evidence on the development of needle and syringe 
exchange programmes that there is almost universal agreement on their effectiveness 
in reducing the spread of BBVs and other related infections and on the associated 
potential cost savings. However it should not be assumed that there is also universal 
acceptance of the principle of making such schemes freely available. There is often a 
tension between the proponents of the evidence based research and a media fuelled 
“moral panic” response. In 1971, Young first introduced the term “moral panic” in an 
examination of statistics that appeared to indicate an alarming increase in the levels of 
drug abuse and the public concern that this generated (Young, 1971). He noted that 
the “moral panic over drug-taking results in the setting up of drug squads” (Young, 
1971:10). According to Thompson this observation by Young highlights the effect 
produced by the interaction of the media, public opinion, interest groups and the 
authorities and a combination of these influences and effects results in the 
phenomenon described as  moral panic (Thompson, 1998:7). Thompson identifies five 
key elements or stages that describe the development of moral panic. These are: 
 
“1. Something or someone is defined as a threat to values or interests. 
  2. This threat is depicted in an easily recognisable form by the media. 
 3. There is a rapid build up of public concern. 
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 4. There is a response from authorities or opinion-makers. 
 5. The panic recedes or results in social changes”  
 (Thompson, 1998: 8).     
 
There are numerous current local examples where the media and public reaction to 
new NEXs and advances in the type and range of equipment supplied appear to have 
evoked a reaction which follows precisely the stages identified above and could be 
legitimately labelled as  examples of moral panic. Appendix 1 illustrates some local 
examples of this type of media reporting. Similarly, Cohen’s “Model of Deviancy 
Amplification” can be summarised as a process that exhibits a number of stepwise 
stages.  These are:  
         “Initial problem  
           Initial Solution 
           Societal Reaction 
           Operation of Control Culture, Exploitation and Creation of Stereotypes           
          Increased Deviance, Polarisation 
          Confirmation of Stereotypes”  
          (Cohen, 1980: 199). 
 
This can be related to the subject under discussion here where, the “initial problem” is 
the emergence of HIV/AIDs and the recognition that this virus can be spread through 
the IDU population by the sharing of injecting equipment. The “initial solution” is the 
development and the introduction of NEXs. The involvement of the media is essential 
in the evolution of stereotypes of deviancy in relation to those who use NEXs.  It is 
rare to find any media recognition that the use of NEXs can be a positive health step 
for an individual and that the existence of NEXs protects both the health of the 
individual and promotes public health benefits for the wider community. This type of 
adverse media reporting has inevitably shaped “societal reaction”. In turn this has led 
to “polarisation” and further “confirmation of stereotypes” resulting in public 
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opposition to establishment of NEXs and the “dramatisation” of reports of single 
discarded needles (Illustrated in Appendix 2).    
 
It has been claimed that concentrated media attention confers the status of high public 
concern on issues which are highlighted; these generally become understood by 
everyone as the “pressing issues of the day” (Hall, Critcher, Jefferson et al 1978:62). 
When the media acts in this way it effectively sets an agenda and by the act of further 
reporting it then establishes what has been termed a “reality-confirming effect” (Hall, 
Critcher, Jefferson et al 1978:62). Thomson explains how this can lead to a state 
where the media assumes a campaigning role claiming that their reports articulate 
what the ‘moral majority think” (1998:61). When this set of circumstances exists with 
controversial issues, including NEXs, where a single dominant viewpoint is 
consistently presented, it becomes very difficult to discuss the wider context and to 
propose alternative opposing viewpoints (Thomson 1998:61). This partly explains 
some of the inherent underlying difficulties for professional treatment services of 
promoting evidence to support both the health and the cost effective benefits of NEXs 
to the wider community.  
 
An analysis of the politics of NEXs demonstrated that there is compelling evidence to 
support the public health benefits of syringe exchange programmes (Buchanan, Shaw, 
Ford et al, 2003:427). These authors highlighted the existence of evidence in support 
of NEXs as part of the public health interventions to prevent the spread of HIV and 
also noted that supplying injecting equipment in this way did not promote or increase 
the use if illegal drugs (Buchanan et al, 2003:427).  This view is supported by the first 
comprehensive international review of the evidence for needle syringe programmes 
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where it was shown that the findings demonstrated that  needle syringe programmes 
were able to reduce HIV transmission “effectively, safely and cost effectively” and 
that these are benefits are significant (Wodak and Cooney 2005:31).  
 
Despite the existence of a large body of empirical scientific evidence to support the 
benefits of NEXs, these programmes do not always benefit from full public and 
professional support (Buchanan et al, 2003:427). Attempts were made to analyse why 
this situation existed and the authors highlighted the problems associated with 
resorting solely to the scientific evidence in NEX policy development (Buchanan et 
al, 2003:431). They advise the proponents of NEX that scientific evidence on it’s own 
will never be sufficient to gain public support for  public policies but that the 
underlying “moral values” need to be used to counter the opponents expressed ethical 
concerns (Buchanan et al, 2003:432). Rather than promoting the use of scientific 
evidence alone on the transmission of BBVs, it should be claimed that these schemes 
are best viewed from a wider social and fiscal viewpoint as they help to prevent the 
most disadvantaged groups in society from suffering further preventable harms 
(Buchanan  et al 2003:439). These authors claimed that in any public debate the most 
effective position to adopt to gain acceptance of the NEX was to remove the debate 
away from the benefits to individual IDUs and to demonstrate the security that the 
exchange affords to protect, those they termed, “innocent” victims as the risk of HIV 
affecting the wider non-drug using population is reduced by IDUs having access to 
sterile injecting equipment (Buchanan et al, 2003: 440). The authors concluded that in 
order to build greater public support the “interpretive framework” of the policy is the 
aspect that needs to change. (2003:440). Although the work by Buchanan and 
colleagues outlined above is centred in an American analysis of NEX policies, there 
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are general parallels with the existing situation in the UK and in Scotland as shown by 
the examples in Appendix 1 and 2 of similar distorted reporting that inevitably serves 
to inflame local communities and debates. According to Stone, when communities 
and officials debate policy issues the decisions are rarely based exclusively on matters 
of “fact and science” but are based on the meanings attributed to the subject (2001: 
232). She further claims that the disputes in relation to NEX become disputes about 
“core values” and this is the reason why reference to the scientific evidence is never 
solely sufficient (Stone, 2001:233). This clearly identifies the problem as one that 
cannot be resolved purely by reference to the existing body of scientific evidence or 
by the promotion of the proven public health benefits of NEXs. Although this is an 
American analysis of factors affecting policy decisions, the external factors and 
meanings and the role of scientific evidence associated with NEXs are equally 
relevant for UK and Scottish policies. This reflects the context for the development 
and funding of any new intervention including syringe markers.  
 
1.11 Summary 
 
It is clear that there has been a change over time and that the protection of public 
health, through provision of NEXs and opiate substitute prescribing, has become the 
predominant public health imperative both locally and nationally for drug treatment 
services over the last 25 years. Stimson concluded that IDUs were able to change their 
behaviours resulting in reduced risks of HIV infection (1995:699). Based on the 
previous experiences with HIV and extensive evidence of changes in behaviour, it is 
possible to conclude that changes in behaviour that reduce the risk of HCV are also 
potentially achievable. This will be dependent on the existence of effective training 
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and information programmes for service users and professionals and on an effective 
means of reducing sharing of all injecting paraphernalia becoming more widely 
available. For any intervention to be completely effective there needs to be an 
understanding of the social context and meanings that surround all aspects of injecting 
drug use in addition to the  mechanics of drug preparation and injection.   
 
The initial aims of NEXs were to reduce the sharing of needles and syringes. There is 
evidence to support the effectiveness, across a range of factors, of sterile needle and 
syringe programmes. Wodak and Cooney’s review of the current international 
evidence of the effectiveness of sterile needle and syringe programmes demonstrated 
the existence of proven and substantial benefits (2005:31). In examining the 
perception of risk behaviour and risk reduction in the context of personal experiences 
and lifestyles it was highlighted that there is a need for interventions to incorporate 
experience as well as theory (Rhodes, Greenwood and Robertson, 2001:84). For this 
reason, although it may appear axiomatic that reducing sharing and reuse of injecting 
equipment will reduce the spread of HCV, it is essential that any new policy 
developments are informed directly by IDUs experiences. These authors outlined the 
benefits to be gained from linking interventions and evaluation (Rhodes et al, 2001, 
87).  
 
The intervention outlined in this syringe marker study evolved from the range of 
qualitative and quantitative research in the area of injecting drug use and risk 
behaviours. The aim of this intervention under evaluation is to implement the supply 
of syringe markers, to assess the acceptability to IDUs and to provide one possible aid 
to reduce re-use and sharing of injecting equipment and thereby offer a potential 
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means of reducing the transmission of HCV. Scotland’s Hepatitis C Action plan 
proposed a number of specific action points. This included asking NHS boards to:  
 
“Consider whether they have the full range of interventions in 
place to reduce re-using and sharing of needles, syringes and 
injecting paraphernalia to promote safer injecting. These 
interventions should include: more outreach and mobile 
exchange services; distributing a wide range of paraphernalia (in 
addition to needles and syringes) in needle exchanges and 
labelling or colour-coding of injecting equipment to help drug 
users identify their own” 
(Scottish Executive, 2006:10).  
 
In Scotland, an early review of the research concluded that strategies to prevent the 
spread of HCV should not be based on a single approach but should tackle the 
problem in different ways using a range of interventions (Morrison, Duff, Taylor et al, 
2002:12). The syringe marker supply is only one intervention that may potentially 
have a part to play in reducing the spread of HCV. The aim of the study described 
here is to contribute to the evidence base on the introduction and supply of colour-
coding of injecting equipment from NEXs by evaluating the syringe marker supply 
implementation. As the management of the NEX programme is the responsibility of 
the investigator, this work forms an integral and ongoing part of the investigator’s 
professional work role.  
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Chapter 2 
 
 
Methods and Methodology 
 
 
2.1 Background 
 
 
An examination of the injecting practices of injecting drug users in Scotland 
demonstrated that some users had difficulty identifying their own syringes when 
injecting in a group situation (Taylor et al, 2004:7). As outlined in the literature 
review, this is a recently identified problem with particular relevance being attributed 
to the role of shared items of injecting paraphernalia, in addition to needles and 
syringes, in the spread of infections, notably of HCV. This risk is irrespective of 
whether the sharing is deliberate or accidental.  
 
The growing body of work into transmission of HCV has shown that current 
prevention strategies are insufficient to adequately deal with the problem (Hutchison 
et al, 2006:8). Taylor et al highlighted the potential for transmission through other 
paraphernalia and made recommendations regarding the desirability of introducing a 
means of syringe identification (2004:4). Based on an examination of real life 
injecting practices, it was recommended that the current supplies of fixed 1ml needles 
and syringes should be produced in a range of different colours to enable IDUs who 
lived together to distinguish each other’s equipment (Taylor et al, 2004;38). 
 
Little previous work, however, has been done to either establish the practicalities of 
this type of intervention, to investigate service users’ views on the acceptability or of  
any potential problems of introducing syringe identifier supplies from existing 
services. In 2005, Exchange Supplies reacted to the emerging evidence on the risks 
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associated with sharing of injecting equipment and developed and marketed a new 
product range named syringe id plunger caps (Exchange Supplies). Although the 
rationale behind the introduction of these caps was strongly centred in the emerging 
evidence base, as previously noted, there was a lack of research evidence into the 
implementation and subsequent evaluation of the impact and applicability of markers 
or identifiers in real life situations. The syringe id plunger caps became the precursors 
to a further innovation from Exchange Supplies of the Nevershare® syringe. 
(Exchange Supplies, 2010). This is a coloured syringe that has a built in advantage 
over the previous id plunger caps as the IDU is not required to physically attach an 
additional part or alter the coloured syringe. The advantage is that it is ready for 
immediate use. 
  
As the author of this study manages the operational aspects of the Health Board NEX 
programme, the implications for services of the emerging research and the 
recommendations on syringe identification were identified as an appropriate subject 
for combined professional and educational investigation. Initially a decision was made 
to undertake a comparative study of the commercially produced syringe id plunger 
caps produced by Exchange Supplies and of sheets of coloured stickers (syringe 
markers) as a possible alternative means of syringe identification. The proposal to use 
sheets of coloured stickers as an alternative had emerged through informal discussions 
with staff and service user involvement groups as potentially being a cost effective 
alternative to the newly available id caps. As the community pharmacy based NEXs 
are the largest suppliers of sterile injecting equipment to IDUs it was decided to use 
this scheme to undertake a comparative study of the two potential options for syringe 
identification.  
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As part of the background preparatory work the local Health Board Risk Assessment 
Department was consulted for advice. They advised that, in their professional opinion, 
the syringe id plunger caps could potentially pose a choking hazard to children (Green 
J, 2006: personal communication). This was based on an examination of the design of 
the caps which are of a solid plastic material and are small enough to be attached onto 
the plunger end of a syringe. These are also produced in a wide range of attractive 
bright colours. Although it appears intrinsically obvious that a needle and syringe 
poses a hazard for a child, the view of the senior staff from the Risk Assessment 
Department of the health board was that supplies of separate plastic caps which are 
not attached to the syringe introduces another additional hazard if left in areas where 
children may be present. There are numerous health and safety messages available 
relating to safe storage and disposal of injecting equipment but it was advised that this 
material did not provide sufficient information on the risks associated with items other 
than the needle and syringe (Appendix 3). Based on this assessment the advice 
received was that there was an unacceptable extra risk and that these id caps could not 
be supplied through any health board funded NEXs. It was therefore not possible to 
continue with the initial planned comparative study.   
 
At this point the comparative study was reviewed and a decision taken to continue 
with an evaluation of the sheets of coloured stickers (referred to as syringe markers) 
as a means of syringe identification. As noted above the evidence had demonstrated 
the need for syringe identification; however the gap in the evidence base related to the 
practical applications of supply and acceptability of the different proposed options for 
syringe identification. The evaluation was designed to study the distribution of the 
markers from pharmacy NEXs, to identify whether this was acceptable to IDUs and to 
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determine if this offered a feasible method of reducing the accidental sharing of 
syringes by providing a potential means of identifying injecting equipment for 
personal use and therefore preventing the inadvertent accidental sharing of syringes 
within a group setting.    
 
The proposed study utilised the principles of evaluation research. This type of 
research is embedded in the social world and investigates “real-life interventions” 
(Bryman, 2004:539). This is distinct from basic or applied research designs in that it 
allows the assessment of “the outcomes of treatments applied to social problems” 
(Miller and Salkind, 2002:3). It does not involve seeking out new knowledge in 
relation to social phenomena or how this knowledge could be used to address a 
problem but is concerned with decisions relating to the “value or merit” of individual 
interventions or programmes (Miller and Salkind, 2002:3).  According to Rossi and 
Wright, evaluation research came to prominence as an applied social scientific 
activity in the mid 1960’s where they identified the distinctive feature as the 
recognition, amongst decision makers, that the principles of social science research 
could be applied to evaluations and that this was likely to yield more valid results than 
the previous “judgemental approaches” that had been employed (2002:79). This was 
re-enforced by Clark, who claims that the distinguishing factor for evaluation research 
is the ability to make recommendations for change based on an “action oriented” 
investigation into the outcomes of specific policies, programmes or service 
interventions (2005:vi). The essential features of evaluation research described above 
appeared to fit the requirements of this study where the objectives were to make 
judgements on the implementation of an intervention (syringe markers) within a 
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service setting (community pharmacy NEX) and to systematically examine the 
potential value of the intervention.  
 
This evaluation is distinct from a clinical audit of the intervention. Although audit and 
evaluation may both adhere to systematic procedures and have the same ultimate aim 
of quality improvement, there remains a clear distinction (Clarke, 2005:5). Clinical 
Audit has been defined as a:  
 
“Quality improvement process that seeks to improve patient care   
and outcomes through systematic review of care against explicit 
criteria and the implementation of change. Aspects of the 
structure, processes, and outcomes of care are selected and 
systematically evaluated against explicit criteria. Where 
indicated, changes are implemented at an individual, team or 
service level and further monitoring is used to confirm 
improvement in healthcare delivery”  
(National Institute for Clinical Excellence (NICE),2002:1) 
 
Essentially a clinical audit is a cyclical process whereby standards are set, practice is 
observed, comparison is made between standards and observed practice and change is 
then implemented. According to Clarke, for an evaluation, there is greater 
consideration of the underlying theory and the impact of a specific programme which 
enables evaluations to predict the direction of future developments (2005:5). Audit is 
described as being less ambitious than evaluation (Clarke, 2005:5). One of the main 
aims of the evaluation described here is to obtain information that will help to 
structure and expand future developments and for this reason a clinical audit would 
not have been sufficient as there is no predictive or transferable element to the audit 
process that would direct future developments. 
 51 
 
With the pilot study of syringe markers it would have been relatively straightforward 
to audit the practical operational aspects of the programme, including numbers 
supplied at each transaction, records of advice provided and requests for re-supplies, 
against a predetermined set of standards. However this would not have enabled an 
investigation of the feasibility of the markers as a method of reducing the accidental 
sharing of needles amongst IDU nor of their acceptability or of any practical problems 
associated with this method of supply. A basic clinical audit approach would not 
allow judgements to be made on the “value and merit” of the intervention as described 
previously (Miller and Salkind, 2002:3).     
 
2.2 Theoretical Perspectives 
 
The core of evaluation research is to investigate the effectiveness of social 
programmes or planned interventions. Claims are frequently made that the theory 
behind an evaluation is often ignored resulting in evaluation being portrayed as “an 
atheoretical, methods-oriented enterprise” (Clarke, 2005:30). However, although the 
role of theory may not be as immediately obvious or as relevant when compared with 
other forms of research methodology, it has an important role to play as it provides 
the evaluating researcher with the basis for the choice of specific research methods 
and methodological design (Clarke, 2005:30).  
 
According to McLaughlin there are four competing epistemologies that appear to have 
relevance to the theoretical basis of evaluation research. These are positivisim, 
constructionism, pragmatism and advocacy / participatory knowledge claims 
(2009:67). Positivism is associated with quantitative methods and refers to the use of 
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natural science methods to study social reality (Bryman, 2004:11). Constructionist 
knowledge claims are associated with a qualitative approach and are at the opposite 
end of the spectrum to positivism where meaning and human agency are the core 
elements (McLaughlin, 2009:70). Advocacy / participatory knowledge claims 
promote a social model perspective where the emphasis is on the disabling effect that 
society has on individuals (McLaughlin, 2009:72). According to the latter approach 
research cannot be justified solely by the search for new knowledge but can only be 
legitimised when it leads to change (Glasby and Beresford, 2006:268).  
 
These approaches all have elements that are relevant to the current study particularly 
as service users were involved as research participants. The syringe marker evaluation 
is set within a defined setting where the aim is to extrapolate findings to the wider 
population necessitating a positivist approach to design. Due to the setting and nature 
of the patient  group, other elements inevitably become involved in the design that 
require consideration from a constructionist position as the actions and interactions 
may be governed by potentially unknown meanings. The role of service users in 
research is discussed in Chapter 3 and considers the implications of using peer 
researchers in detail. However it is reasonable to assume that included in the benefits 
to service users participating in research is the opportunity to participate and advocate 
for change and thereby positively affect services they currently use or have used in the 
past (McLaughlin, 2009:34). However, despite the relevance of the three approaches 
mentioned above, the main theoretical perspective underpinning the syringe marker 
evaluation is one of pragmatism. The driving force behind modern pragmatism has 
been defined as the notion that “belief in the truth on one hand must have a close 
connection with success in action on the other” (Blackburn, 2008, Oxford Reference 
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Online). According to Misak one of the central claims of pragmatism is that 
“epistemological and moral theory should try to preserve our deeply held convictions 
and our ways of inquiring into various subject matters” (1999:6). The relationship of 
pragmatism to the syringe marker evaluation is that the study is conducted within the 
framework of a harm reduction model. The development of the harm reduction model 
was outlined in Chapter 1. Essentially this is a belief system where the compelling 
need to reduce harm is deemed to outweigh any other ethical or legal considerations. 
Harm reduction, in the form of providing clean injecting equipment, does not have 
universal acceptance, including within the pharmacy profession. However this study 
is set within a harm reduction setting and investigates a specific intervention in this 
context. The harm reduction model can be viewed as an ethical belief system where 
the value of the action is determined by the resulting beneficial consequences for 
individuals and the wider public. A constituent part of modern pragmatism is claimed 
to be “doxastic inertia” where any inquiry is carried out in a context where there is no 
need to justify the existing belief (Misak, 1999:179). This reflects the conduct of the 
evaluation within a harm reduction service setting. 
 
Although McLaughlin claimed that the four epistemologies mentioned above were 
“competing” it is clear that the syringe marker evaluation demonstrates elements of all 
four. Despite the evaluation demonstrating elements of different theoretical 
perspectives, it is primarily conducted within the paradigm of a harm reduction model 
where the core component of pragmatism is demonstrated by the belief in the efficacy 
and moral legitimacy of this model.   
 
 54 
 
In addition to the theory of the evaluation, it is relevant to examine the theoretical 
perspective aligned with IDU and NEX itself. Health and illness are now increasingly 
agreed to be the result of complex interplay of actions amongst biological, 
psychological and social factors (Alonso, 2004:239). According to Engel, sole 
reliance on the previously accepted biomedical model of disease which involved 
identifying and treating causative factors in illness, ultimately leads to inadequate 
patient care (1977:131). In 1977 he proposed a bio-psychosocial model of disease that 
incorporated human experiences and interactions. He proposed that, in addition to the 
biological factors, social, psychological and behavioural considerations are also 
essential for effective patient care in real life settings (1977:135). Although there may 
be legitimate debate about whether problematic drug use can be deemed as an illness 
or as a social construct there is no doubt that, for the majority, the health of an IDU is 
adversely affected. The role of NEXs can also be viewed from this perspective as its 
positive impact on the health of an IDU, and the wider community, is the result of a 
complex interplay of biological, psychological and social factors. This was 
demonstrated in Chapter 1 where the biological aspects of HIV and HCV transmission 
were discussed along with behavioural elements attached to injecting,  including 
sharing. Use of NEX services is associated with illegal behaviours and is set within 
communities and for these reasons is affected by numerous social factors including 
adverse public perceptions and attitudes along with the perceived barriers that often 
makes access difficult for IDUs. Taking these factors into account the bio 
psychosocial model appears to be the most apt theoretical perspective for complex 
public health interventions, like NEXs, that aim to promote health through 
behavioural change. 
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The term pragmatism is used in everyday language to convey a range of different 
meanings. According to Webb the term can be used in ways that can be vague and 
confusing (2007:1064). Care needs to be taken to distinguish between pragmatism, as 
a theoretical basis discussed above, and a pragmatic approach to the choice of 
methods employed in the evaluation. The key feature of the pragmatic approach is to 
focus primarily on the problem rather than the methods used. According to 
McLaughlin it is legitimate for the researcher to use whatever methods are required to 
address specific issues (2009). Creswell has identified the key features of a pragmatic 
approach as the “freedom to choose the methods, techniques and procedures” that best 
fit the aims of a particular study (2003:12). McLaughlin (2009) sums up the 
pragmatist methodological approach to research by claiming that no one method is 
inherently better than another as the choice is dependent on the question being asked. 
Irrespective of the theoretical basis, a pragmatic approach offers the option of using a 
variety of different methods at different times. This is relevant to evaluation research 
where the main aim is to evaluate the effects of interventions where the researcher 
requires methodological flexibility as they may have little or no control over some 
elements but still needs to strive to maintain an objective scientific rigour in the 
design, despite any practical contextual constraints.     
 
A pragmatic methodological approach to the syringe marker evaluation with 
pragmatism as the theoretical underpinning is the approach that best describes the 
evaluation set within community pharmacy NEXs. The service is best described with 
reference to the bio-psychosocial model which incorporates the various theoretical 
elements that constitute the totality of the NEX settings, professional participants, 
service users and wider community involvement. In addition to establishing the 
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underlying theoretical perspectives there were also a number of inherent practical 
difficulties involved in designing and implementing an evaluation of the syringe 
markers. These, along with the identified solutions, are considered below. 
 
2.3 Evaluation Design  
 
The study aimed to evaluate the distribution of syringe markers and to survey those 
who were supplied with markers to obtain feedback about their use. The final design 
and methods used in the evaluation were constrained by a number of factors including 
the limited funding available to conduct the study (Appendix 4). Due to the volume of 
supplies made and the extended opening hours of community pharmacy based NEXs 
a decision was made to use these outlets as the evaluation sites. This was based on 
information routinely recorded on the NEX database. The database contains recorded 
details of all individual transactions from 2003 onwards and is used to monitor 
activity and identify emerging trends. Although individuals using a NEX remain 
anonymous, a limited amount of basic transactional, drug and demographic 
information is collected to enable effective monitoring of the scheme and to identify 
new and emerging trends and patterns in injecting drug use. The centrally held 
comprehensive database records details of all individual transactions, supplies, returns 
of used equipment, information on drugs injected and other basic demographic 
information. Data monitoring has been described as a “process of keeping track of 
what is happening; watching what is happening and documenting this in some way” 
(Everitt and Hardiker, 1996:20). The data that is created through this monitoring 
process can be used to help to design practice evaluations (Everitt and Hardiker, 
1996). However as Clarke observed, any routine process involving auditing, 
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monitoring and inspection can generate data that may be useful in an evaluation, but 
these do not necessarily constitute evaluations in themselves (2005:7). Therefore the 
data that was generated from the NEX database was informative in assisting the 
design of the evaluation but was not an element of the evaluation itself.  This database 
was also a useful resource to assess the representative nature of the sample of people 
interviewed on the days when interviewers were present in each pharmacy. 
 
According to Clarke designing a “perfect evaluative study” does not follow set 
guidelines (2005:16). He further outlines the difficulties facing researchers that must 
be considered. These include all the practical, technical and methodological aspects 
that have to be considered and incorporated into the design before it is possible to 
implement an evaluation in an existing operational setting. This highlights that the   
researcher has to be prepared to deal with any of the multitude of practical challenges 
that will inevitably occur in real life settings (Clark, 2005:16). In designing this 
evaluation attempts were made, where possible, to identify and address in advance, 
any potential practical difficulties. This was largely based on background knowledge 
of the day to day operational aspects of community pharmacies and the delivery of a 
NEX service within this context. The anticipated and the actual practical difficulties 
encountered in the design and implementation of this evaluation are discussed below. 
 
The database information was used as the main source to select 3 sites in different 
geographic locations in Glasgow that were shown to be most likely to have the 
highest number of daily attendances and therefore offer the maximum opportunity for  
distribution of the markers. There were further practical considerations that restricted 
the choice of sites. These included identifying sites that had an internal area where 
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service users could complete the questionnaire in privacy and that this was an area 
that could be used throughout the day by the researchers without adversely impacting 
on the other pharmaceutical services being provided. In order to ensure consistency, 
only pharmacies with a permanent manager and not different temporary locums were 
used as sites to trial the markers. The reason for this was to ensure that, following the 
briefing session, the pharmacist was fully informed about the research and the 
background evidence and was therefore able to respond consistently to any questions 
that arose when supplying the markers during a NEX transaction. Using a pharmacy 
that was being managed by a series of locums would introduce additional 
uncontrolled variables that could potentially lead to unpredictable effects on the 
supply and inconsistent advice being given to those supplied with syringe markers 
when collecting their normal injecting equipment supplies.  
 
Pharmacy based NEX services operate with no appointment system over extended 
opening hours and it is therefore difficult to predict who will attend and at what times 
of the day. For this reason it was essential to explore, in advance, any potential 
problems that the subsequent onsite data collection could cause for pharmacy staff, 
service users, the researcher and other pharmacy customers and patients. The aim was 
to have procedures in place to minimise any potential difficulties when administering 
the questionnaire. This included adjusting the data collection process to the daily 
pattern of routine work within a busy community pharmacy by establishing 
relationships with regular staff, attempting to identify patterns of NEX attendance and 
making optimum use of consultation and private areas to administer the questionnaire 
confidentially with minimal disruption.  
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Based on the above criteria, 3 sites were selected that best met the identified 
requirements. These were situated in separate locations and were identified as 
Pharmacy 1, 2 and 3. Pharmacy 2 was part of a large multiple pharmacy chain and the 
other two were members of two smaller independent groups. All sites were 
established NEX pharmacies that had been assessed as fitting the inclusion criteria 
and were based in different geographical locations in the city. These pharmacies were 
then invited to take part in the pilot supply of syringe markers (Appendix 5).  
 
The fieldwork took place in 2 separate 4 week periods. In the first 4 week period the 
pharmacy staff were responsible for supplying syringe markers and giving directions 
on use to those attending the NEX. In the second 4 week period the peer researchers 
from the Scottish Drugs Forum (SDF), Service User Involvement Group (SUIG) * 
identified participants and administered the questionnaire in the 3 pharmacy sites. The 
type and brand of stickers to be used as markers were selected and a commercial 
source of supply was identified. Stocks were obtained and distributed. Specific 
tailored instructions for use were developed and produced (Appendix 6).  
 
Before the intervention could be implemented it was necessary to ensure that the 
pharmacists and relevant staff had received additional training to enable them to make 
the supply appropriately and to explain the purpose and use of markers to patients in  
 
--------------------------------------------------------------------------------------------------------
* The work of the SDF SUIG involves, identifying the views of service users, (peer research and service evaluation), representing 
the views of service users (planning forums, advisory groups, and media work) participation at conferences/seminars (participant 
or facilitator),training (peer education, drug worker training, emergency first aid) development and dissemination of drug 
awareness material (drug prevention and harm reduction material). http://www.sdf.org.uk/sdf/429.200.321.html#involving 
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a consistent manner across the 3 sites (Appendix 7). The training session was also 
attended by 6 members of the SUIG and their support co-ordinator. The SUIG 
members would be responsible for administering the questionnaire in the pharmacies. 
This allowed the pharmacy staff to meet with members of the SUIG in advance to 
help facilitate effective working relationships and establish clarity on the roles and 
responsibilities of all groups involved in the evaluation. The first 4 week period of 
syringe marker supply was initiated on the Monday following completion of the 
training sessions.   
 
The next identified step was to design a questionnaire to be administered at each site 
during the second 4 week period of the fieldwork. The questionnaire consisted mainly 
of closed questions with a number of fixed response answers. This was administered 
to respondents by the peer researchers responsible for conducting the structured 
interviews. The questionnaire was subdivided into 4 sections. These were Personal 
Information and Injecting pattern, Supply of Syringe Markers, Use of Syringe 
Markers and the Instruction Card. Details of the questionnaire are shown in Appendix 
8. The practicalities of administration of the questionnaire are described in detail 
below. This second period was the data collection phase of the evaluation.  
 
The time periods for marker distribution and questionnaire data collection were 
selected following interrogation of the daily log sheets and the database, as this 
showed evidence of a definite regular pattern of repeat attendances. This indicated 
that 4 weeks was an appropriate duration so that the first 4 week syringe marker 
supply period was likely to achieve maximum coverage of people attending the 
pharmacy for injecting equipment. Although, as mentioned above, the pre-existing 
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NEX data is collected anonymously, basic information including date of birth and 
initials are collected. Details of gender and ethnicity are also recorded. No 
confirmatory checks are made on the data supplied by individuals and it is not 
possible to identify individual patients on the system but it is possible to make 
estimates of numbers attending, repeat visits and new attendees. Examination of the 
database showed that extending past the 4 week period was likely to result in repeat 
attendances of the same people. The database information indicated that using the two 
separate 4 week periods (first period for syringe marker supply and second for data 
collection) was the most likely to achieve the maximum possible distribution to 
individuals from the pharmacy site and to maximise the likelihood that during the 
second stage of administration of the questionnaire that those attending the NEX 
would have previously been supplied with the markers. At this stage this was an 
important unknown factor. In order to have any meaningful results, it was essential 
that those interviewed had been exposed to the intervention and had had the 
opportunity to use the markers in practice. The information contained on the database 
combined with anecdotal information available from pharmacy staff and the SUIG 
were essential at this stage in the design of the evaluation. The choice and timing of 
the two 4 week periods was therefore based on a combination of information obtained 
from scrutiny of the database, background knowledge of the service provided by staff 
and knowledge of the patterns of behaviour of those attending a NEX provided by the 
SUIG.          
 
It has been noted that for this type of evaluation research the options for using 
particular data collection methods are strongly influenced by the practical constraints 
of the evaluation setting (Clarke, 2005:64). In this situation the anonymity of the 
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participants and the community pharmacy based operational conditions placed 
inevitable constraints on the data collection methods available. Interrogation of the 
NEX database indicated that the time scales chosen for the questionnaire 
administration were most likely to enable capture of information from a subgroup of 
the population attending the NEX that had previously been exposed to the 
intervention of syringe marker supply. This inevitably involved an element of 
judgement and was partly due to the essential feature of the NEX, which is the 
anonymity of those attending. Effectively this means that it is not possible to track 
specific individuals who have received the intervention. This problem had not been 
tackled before as previous evaluations conducted in the pharmacies and other NEX 
settings concerned the totality of the service and therefore anyone attending would 
have been eligible to complete a survey or questionnaire. One of the main issues to be 
solved in the evaluation design was that only a small subgroup of those attending 
would be eligible to complete the questionnaire as the original supply of markers took 
place over a restricted time period of 4 weeks. There were an unknown number of 
factors that may have influenced the data collection and the methods chosen needed to 
be sufficiently flexible to react to any emerging issues throughout the course of the 
trial.  
 
“Judgement sampling” was used as this allows existing information to be used to 
select a subgroup of the population that is presumed to be representative of the wider 
population (Miller and Salkind, 2002:55). There was no randomisation of the 
intervention at the pharmacies nor was there any non-intervention group as all 
attendees were offered the markers during the first 4 week (supply) period. This was 
due to the setting, as the intervention was carried out in an existing treatment service 
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and there were limitations on the number of variables that could be controlled in this 
type of research. To assist the design and to investigate whether these 3 sites were 
attended by a group with similar characteristics to other sites, the demographic data 
from the 3 pharmacy sites chosen was examined. This allowed a judgement to be 
made and indicated that for the three chosen sites there were no significant differences 
when compared with other sites in respect of gender, age, ethnicity or in recorded 
illicit drug use that would be likely to cause any idiosyncratic results.  The relevant 
details for the 3 chosen sites and the combined information for all sites in Greater 
Glasgow and Clyde are shown in Table 2.1. This indicated that the overall 
demographic pattern and the information collected on the types of drugs injected were 
consistent across the 3 research sites and were in line with the aggregated information 
from all sites in the health board area. The information contained on the main 
database allowed comparison to be made of the characteristics of the sample likely to 
be interviewed in each pharmacy and the wider NEX attending population. Data was 
collected by the SUIG interviewers on the number and reasons for refusal to 
participate.   
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Table 2.1.  
Recorded Information From Central Database on Characteristics of  NEX 
Attendees and Transactions 
 
%  based on 
transactions 
 
Pharmacy 
1 
Pharmacy 
2 
Pharmacy 
3 
All Health 
Board  
Sites 
Most 
common Age 
Range : 
35-39 ( % ) 
 
23.7 
 
26.7 
 
31 
 
24.8 
Female ( % ) 23.7 20.4 22.1 21.9 
Male ( % ) 76.3 79.6 77.9 78.1 
Ethnicity (% ) 
White British 
92.3 94.4 98.4 95.7 
Drugs 
Injected 
1. Heroin 
(Opiate) 
2. Cocaine 
(Stimulant) 
 
 
 
84.9 
 
6.9 
 
 
88.3 
 
8.9 
 
 
86.8 
 
10.1 
 
 
85.1 
 
9.4 
Source : NHS Greater Glasgow and Clyde Needle Exchange Database(2003-2007). 
 
Judgment sampling has a number of advantages for this type of evaluation as it 
reduces costs associated with identifying the sample and the subsequent fieldwork 
(Miller and Salkind, 2002:55). The main disadvantages are that it is difficult to control 
any bias and requires extensive knowledge of the population and subgroup identified 
(Miller and Salkind, 2002:55). It is recognised that there are inherent difficulties in 
attempting to exercise control over the range of factors that may potentially confound 
the final results. Based on knowledge and experience of the service and with the 
added experience of the peer researchers of the population under study, the evaluation 
was designed to overcome the practical difficulties that research in this type of service 
environment poses. The final design was mainly achieved through a process of 
continual refinement and consultation.    
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           2.4 Ethical Processes. 
 
Research and evaluation in a health care setting that has a direct effect on patients can 
take a number of forms. These include clinical audit, service evaluation and research. 
Normally only research that involves new treatments, random allocation to different 
groups and the direct involvement of patients requires ethical approval (National 
Patient Safety Agency (NPSA), 2006). Audit and evaluation are normally considered 
to be routine parts of service delivery that do not require ethical approval. However 
there were two main factors in this evaluation, discussed below, that prompted the 
decision to seek advice from the local research ethics committee (REC). 
 
 Firstly, the decision to involve the SUIG, and not existing staff members, to 
administer the questionnaire introduced an additional ethical dimension that needed to 
be considered. For example there are potential implications in allowing external 
groups access to patients as maintaining patient confidentiality is a key principle for 
any health care professional. For pharmacists there are seven governing principles in 
their code of ethics. These include “making care of patients your first concern” and 
“exercising your professional judgement in the interests of patients and the public” 
(Royal Pharmaceutical Society of Great Britain (RPSGB), 2010:4). Pharmacists are 
directed to “take all reasonable steps to prevent accidental disclosure or unauthorised 
access to confidential information and ensure that you do not disclose confidential 
information without consent” (RPSGB, 2010:8). This applies to all aspects of the 
NEX programme. Also the introduction of the SUIG members into the evaluation 
meant that there was an ethical responsibility on the principle researcher to ensure that 
their participation would have no adverse effects on the individual peer researcher. 
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Research has shown that when individuals are exposed to environmental triggers 
associated with their previous drug use there is a risk that this can precipitate relapse 
(Crombag, Bossert, Koya et al, 2008: 3233). In this evaluation the peer researchers 
were required to enter and spend time in the physical environment of the NEX 
resulting in exposure to both the physical environment and the injecting paraphernalia 
closely associated with their personal previous drug use. It was therefore essential to 
provide full support for the peer researchers to avoid involvement in the research 
resulting in relapse in their own personal recovery. The wider role of peer researchers 
is discussed separately in Chapter 3. 
 
Secondly, the National Patient Safety Agency (NPSA) has issued guidance on 
governance arrangements for service evaluations and has stated that: 
 
“If it is intended that the results of the service evaluation are to 
be used to influence practices or processes outside the immediate 
setting and the work was not managed within the Research 
Governance Framework, there would be a risk of the public 
being exposed to changes without a sound evidence base. Where 
it is intended to publish the results of an evaluation in a form that 
aims to generalise the results to others situations, the evaluation 
should therefore be managed within the Research Governance 
Framework” 
(NPSA 2006:2)  
 
If the results of the evaluation were positive there was a clear intention to extend the 
scope of the service intervention outside the immediate setting of the three research 
sites. Potentially this could affect thousands of individuals who access local NEXS on 
a regular basis. For these reasons this evaluation was submitted to the NHS Research 
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Ethics Committee for ethical approval. This had the added advantage that the REC 
provided independent scrutiny of the design of the evaluation as the practical 
difficulties associated with any evaluation research design have been outlined above. 
RECs are required to assess a number of factors for any application including the 
“scientific design, conduct of the study and the recruitment of research participants” 
(Department of Health (DoH), 2001:24). Before a favourable opinion is given to any 
application, the REC must be content that the study design is appropriate to the aims 
of the study (DoH, 2001). 
 
Following an informal approach for advice a formal submission of the evaluation was 
made to the NHS Research Ethics Committee. Ethical approval was granted subject to 
the following three minor amendments,  
 
“a) Researcher to ensure that there is a sufficient range of colours 
available for the syringes. Care should also be taken to ensure 
that people who could be colour blind cannot be misled. 
 b) Researcher requires to ensure that use of quotes is entirely 
anonymous and does not compromise confidentiality and  
c) The terminology of Q2 of the service user questionnaire 
should be altered to “street” terminology as the participant 
possibly might not understand the original phrases”  
(REC Reference Number 06/S0701/80).    
 
2.5  Data Collection  
 
 
According to Clarke (2005) evaluation studies routinely incorporate several different 
methods of data collection. Different strategies were involved in the design of this 
evaluation but the main method used to collect data was a questionnaire that generated 
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quantitative data. However qualitative data was also generated by the decision to use 
peers to administer the questionnaire. According to Patton researchers are described 
as the “instruments of data collection” which means there must be reflection and 
understanding of any resulting potential bias (2002:51). The research diary created 
during the fieldwork by the SUIG members assisted in the reflection process and 
generated relevant qualitative data. The reflexive observations from the SUIG and the 
researcher contributed to the final overall evaluation. At the end of the study the views 
of staff from the three participating pharmacies were sought and included in the 
overall reflection. The use of peer researchers and their involvement and impact on 
this work is considered separately in Chapter 3.   
 
The aim was for the 3 pharmacies to distribute the markers over a 4 week period to all 
patients receiving NEX packs. These were distributed along with an instruction card 
on the correct use of the markers (Appendix 6). This was accompanied by a brief 
consistent explanation from the staff on the nature of the supply and instructions on 
how to use the markers. It should be noted that this constituted a service development 
in an existing service and the evaluation was not discussed with service users at this 
point.  
 
Before ethical approval was sought a final version of the questionnaire was 
developed. This was devised in the planning stages by the researcher based on 
comments and advice from the SUIG. The main aim of the questionnaire was to 
assess the views of those who had been supplied with the markers. The SUIG were 
relatively inexperienced with this type of research work and this was a consideration 
in the design and length of the questionnaire. Members of the SUIG all had previous 
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personal experience of use of NEX services and piloting was undertaken by members 
of the SUIG amongst the group. With hindsight it would have been more informative 
to have piloted the questionnaire in one of the pharmacy based NEXs with current 
NEX attendees. This is explored further in Chapter 5 in discussion of the evaluation 
limitations. The questionnaire was divided into four sections and employed mainly 
closed questions. Closed questions have the advantage that they are easier and quicker 
for both interviewers and respondents to complete and help to reduce the variability in 
recording responses (Bryman, 2004:148). Further amendments were made following 
advice from the local REC. The final version employed is shown in Appendix 8. 
Members of the SUIG were responsible for introducing themselves to potential 
interviewees attending the NEX. This was followed by a brief introduction to the 
study. A copy of the patient information provided to respondents is shown in 
Appendix 9. The questionnaire forms were colour coded for the three pharmacy sites 
to aid the peer researchers’ recording procedures. This meant that the location did not 
have to be recorded each time as there was the possibility that the interviewers would 
relocate amongst the sites depending on the pharmacy operational requirements and 
the availability of those attending the NEX to interview. The questionnaire was 
administered in the second phase, four weeks after the initial marker distribution. 
 
Completion of a questionnaire can utilise different methods. When dealing with 
illegal behaviours such as injecting illicit drugs there are inevitably added difficulties 
in collecting the data through use of questionnaires. However, self completion 
questionnaires have the advantage that this method reduces adverse interviewer 
effects (Bryman, 2004:133).  These adverse interviewer effects have been identified 
as including characteristics such as ethnicity, gender, and the social background of 
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interviewers which may individually or in combination affect the responses that are 
given (Bryman, 2004:133). This is relevant to the syringe marker evaluation as 
Bryman reports that “social desirability bias”, where the respondent provides the 
answer that presents them in the most favourable way, is often exhibited when the 
interviewer assists with completion (2004:134). He demonstrates that this effect is 
particularly relevant when  investigating drug and alcohol issues as self completion 
results in higher reported rates of use than when the interviewer is present (2004:134).  
For the syringe marker study this highlights the possibility that answers to questions 
on whether syringes have been mixed up with some one else’s may be under-reported 
and the use and usefulness of the markers supplied could be over-reported. It is 
reasonable to assume that the combination of perceived interviewer effects and 
socially desirable responses are likely to be heightened when dealing with illegal, 
harmful and less socially acceptable types of behaviour. Previous work in Australia 
using peer workers in a participatory action research project had produced results that 
indicated that data quality was improved by involving peers in this way to offset 
biases experienced with other data collection methods (Coupland, Maher, Enriquez et 
al, 2005:191).  
 
In work investigating sharing behaviours, researchers claimed that this often relied on 
self reporting due to the difficulty of “ethically validating” alternative methods of data 
collection (White, Day and Mather, 2007:441). They observed that the behaviours 
which placed people at greatest risk were also the most likely to be considered 
stigmatised and therefore the most susceptible to effects of biased under reporting 
(White et al, 2007:441). This would suggest that the potential existed to over report 
use of the markers due to a desire to present any information on their implied injecting 
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behaviour in the most positive light. This was an issue for the syringe markers 
evaluation as the supply of markers to potentially promote safer injecting practices 
was the reason for the intervention. The study conducted by White and colleagues in 
Australia compared results obtained where the participants were needle and syringe 
programme (NSP) attendees with self completed questionnaires and those where an 
interviewer assisted with completion (2007:441). These results showed that when 
participants received assistance in the completion of the questionnaire they were less 
likely to report that they had shared or re-used a syringe previously known to have 
been used by someone else. As this evaluation related to questions on the use of 
syringe markers to identify individual syringes there may be potential challenges in 
addressing this type of sensitive topic and obtaining accurate responses.  
 
Despite the effects of interviewer bias described above and the findings of the 
Australian study, which recommended that questionnaires involving risk behaviours 
should be self completed rather than administered by the interviewer to improve the 
accuracy of the reports, a decision was taken to administer the questionnaire using an 
interviewer and not to offer it for self completion. Self completion may have initially 
appeared to be the most relevant method of investigating any sensitive and potentially 
stigmatising behaviour of those attending NEXs. However this was not considered to 
be appropriate for this particular evaluation due to the nature of the subject and the 
group. For example, initial contact with interviewees is essential to establish that the 
questions are being answered by those who have previously used the markers and are 
therefore eligible to complete the questionnaire. Facilities for self completion within 
the pharmacy environment would have been practically very difficult to arrange. The 
sensitivity of the subject matter and the influence of the interviewer on the accuracy 
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of responses were considered in the evaluation design. In this context, self completion 
was assessed and then dismissed as a workable option due to operational difficulties 
and the need to ensure that only those eligible completed the questionnaire. The use of 
peer researchers rather than staff to pose the questions is an attempt to address these 
potential sources of bias. Essentially the use of peer group interviewers was a 
practical compromise designed to reduce the impact of any potential interviewer bias 
effects and to improve the quality of data collected by minimising the need for 
respondents to provide socially acceptable responses.  
 
The SUIG were consulted and a decision was made for them to operate in pairs while 
attending each of the 3 pharmacy sites. This was due partly to the fact that although 
all of the members had received specific training they were all relatively 
inexperienced in this type of data collection. There were advantages to working in 
pairs in the initial stages as this provided their own peer support while they gained 
experience in an unfamiliar role. Following joint discussions between the researcher 
and the SUIG a decision was made to attempt to administer 150 questionnaires over 
the second 4 week (data collection) period. There were six members of the SUIG 
available to participate in the work and the figure of 150 was considered to be realistic 
within the timeframe available. This arrangement required to have flexibility due to 
the difficulties associated with the unpredictability of NEX attendances and the 
personal commitments and availability of the peer researchers. Planning was 
problematic as it was not possible to identify specified appointment times to interview 
respondents and the NEX service is available for extended periods during the full 
opening hours of the pharmacy. The SUIG members identified the perceived optimal 
time periods to attend each pharmacy and matched this with their own personal 
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circumstances that affected their availability. This was inevitably an evolving process 
and the SUIG members needed to be flexible to be able to react and alter their 
attendances to try and maximise contact with potential respondents.  
 
The SUIG field work diary was a contemporaneous record of their personal 
observations of the evaluation process during the time spent in each pharmacy. Along 
with personal observations, details were recorded of the pharmacy site, total length of 
time spent in the pharmacy, number of completed questionnaires and the number of 
refusals. The field work diary also recorded details of interactions with and comments 
made by pharmacy staff and respondents. This allowed the capture of a range of 
valuable qualitative information that was not recorded by the structured questionnaire 
or elsewhere. 
 
The methodological procedures described above illustrate a common feature of 
evaluation research where there are no set guidelines on methods to follow which 
means that the evaluator has to devise and have strategies in place that anticipate and 
deal with the inevitable practical challenges that will occur in this type of research 
(Clarke, 2005:16). It is impossible to separate any evaluation from its setting. In the 
early stages of evaluation theory and methodological development Patton had noted 
that due to the diverse nature of the settings where evaluations took place it was 
inevitable that “methodological flexibility and creativity” had become essential 
components (Patton, 1981:272). The social context influencing the design of the 
syringe marker evaluation has many elements and includes the requirement to 
respond, in a public place, to questions on normally hidden illegal and harmful 
behaviours. This inevitably introduced other social and political factors to the 
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evaluation, including public and staff perceptions of harm reduction and public health 
and the need to protect the rights and privacy of patients, staff and the wider public 
using the pharmacy premises. In practical terms the methods used in this evaluation 
research were designed to be feasible and also to maintain the integrity of the research 
methodology within a busy public healthcare and commercial environment. The 
phased steps in the design and implementation of the evaluation are summarised in 
Table 2.2. 
Table 2.2. Summary of Design and Implementation Steps. 
Phased Activity Comments 
1. Design comparative evaluation of id caps and 
markers. 
Advice from Risk Dept prevents 
distribution of id caps. 
2. Reconsider design and plan new evaluation. Obtain funding 
3. Markers and Advice card Design refined following wider 
consultation with staff and SUIG. 
4. Questionnaire design Consult and pilot final version with 
SUIG 
5. Questionnaire administration Agree method of administration and 
use of Field Diary with SUIG 
6. Interrogation of existing database. To identify pilot sites and any 
anomalies or sites with 
unrepresentative activity data, likely 
to affect results. Identify sample. 
7. Choose Sites                                 Contact 3 sites identified to agree 
participation. 
8. Ethical Approval  Approval granted with minor 
amendments suggested and 
incorporated. 
9. Brief staff and peer researchers Arrange training sessions and follow 
up for those unable to attend. 
10. Phase 1. Distribute supplies. Arrange distribution to 3 pilot sites. 
11. Phase 2. Administer Questionnaire 177 forms completed by SDF SUIG. 
12. Phase 3.  Analyse Results 
 
 
 
 
Included quantitative data from 
questionnaire and qualitative data 
from SUIG Field Diary. Analysis of 
questionnaire results and secondary 
thematic analysis of field work diary. 
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2.6 Reflections on Design and Methodology 
 
The author of this evaluation holds dual roles. These include the role of academic 
researcher and one of professional management responsibility for all aspects of the 
NEX programme in NHS Greater Glasgow and Clyde. This is an extensive 
programme that supplies in excess of one million sets of injecting equipment annually 
and is delivered by approximately 450 staff across a range of disciplines and agencies, 
to thousands of IDUs. It has been claimed that this is the largest provision, from a 
single organisation, of clean injecting equipment to IDUs in Europe (Roberts, 2007: 
personal communication). Prevalence data estimates that the number of IDUs in NHS 
Greater Glasgow and Clyde is in the range of 7,091 to 11,330 (Hay, Gannon, Casey et 
al, 2009:32). 
 
The role of a manager consists of a number of different component roles. These have 
been identified and listed as “communicator, leader, group leader and team builder, 
conflict handler and negotiator, communications manager, accountant, budget-holder, 
quality coordinator and evaluator” (Whitely, Ellis and Broomfield, 1996: vii). This 
placed the researcher in a position of power where the need to negotiate access for the 
service user research participants was removed as the role of management gatekeeper 
was an existing element of the researcher’s professional role. For any manager in the 
public sector the core of their service is governed by the “end benefit to the public” 
rather than with generating profit (Haynes, 2003:17). However they are required to 
manage within a defined budget and, according to Haynes, this can be as influential as 
the need to generate profits within the private sector (2003:17). Any resources 
allocated to the syringe marker evaluation had to viewed in the context of the budget 
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for the overall service and the potential wider benefits to be gained from the 
evaluation and associated expenditure. This was an additional reason why approval 
through the independent ethical processes outlined above was deemed to be essential 
to give an external objective opinion on the research proposals.  
 
The potential for conflict between the roles of manager and researcher is one that had 
to be considered and reflected upon throughout the design and implementation of this 
evaluation. According to Handy it is essential for anyone in a position of influence to 
“reflect upon the source of their power” (1993:125). He identified a variety of 
potential sources of power that affect the ability to influence others. These are listed 
as “physical, resource, position, expert and personal power” (Handy, 1993:125). For 
the researcher in this study, one of the additional sources of power not routinely 
available in the research setting was one of “resource power” where resources were 
available that could be re-directed to facilitate the research (Handy,1993:127). As the 
manager of the service there is also an element of “expert power” where this is 
defined as having specific relevant “acknowledged expertise” (Handy, 1993:130). In 
the management of the NEX programme, the researcher and other senior management 
colleagues routinely exercise “expert power” and act as sources of expert advice to a 
range of other professional health and social care colleagues on all practical and legal 
operational aspects of NEX provision. However, when examining the mechanics and 
the situational realities of the processes involved in the preparation and injection of 
illicit drugs, it was recognised that for the researcher, any knowledge in this area was 
purely theoretical. This gap was recognised and filled by the distinctive “expert by 
experience” knowledge that service user involvement contributed to the evaluation 
(McLaughlin, 2009:17).  
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A key component of this evaluation was to examine the acceptability of the syringe 
markers to IDUs and to ascertain if they would be useful as a means of identifying 
syringes. An audit of supplies made would not give any information on the use of 
these markers in real life situations and for this reason service users’ views and the 
assistance of the members of the SUIG in the design and analysis were essential to the 
validity of the evaluation. Irrespective of what the evidence base indicates, ultimately, 
any changes to types of injecting equipment or methods of supply will only result in 
improvements to health if the changes and the equipment supplied are acceptable to 
service users. According to Harris “Not only should health research be valid science, 
but also it should be deemed to be valuable by those who live with the medical 
condition or use the services of interest” (in Lowes and Hulatt, 2005:190). This is 
particularly relevant for those attending NEXs as, despite the increasing evidence on 
ranges of equipment and the types of behaviour that will prevent the transmission of 
BBVs and related infections, successful harm reduction will only be achieved if the 
equipment offered and the routes of supply are acceptable to those using the service. 
The design of the syringe marker evaluation aimed to employ methods that were 
scientifically valid to assess the syringe marker supply, despite the practical 
constraints of the setting and the limitations on the variables that could be 
manipulated. Despite the use of the questionnaire being more likely to provide 
relevant information on use than an audit of supplies there are still limitations to this 
approach. This relies on self reporting of behaviour and does not involve any direct 
observational evidence. This aspect is further explored in Chapter 5. 
 
Details of the questionnaire are shown in Appendix 8. According to Moser and Kalton 
it is presumed that the length of the questionnaire affects the morale of interviewer 
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and respondent, refusal rates and the quality of the data collected (1989:309). The 
design of the questionnaire had to take account of the setting, the relative inexperience 
of the interviewers and the nature of the group attending a NEX. Taking these factors 
into account it was essential to minimise the time taken to complete the questionnaire 
in order to reduce any practical difficulties and to attempt to increase the number of 
responses. The data in this evaluation was collected within the setting of an ongoing 
service delivery environment of a community pharmacy based NEX. This inevitably 
restricted the data collection methods and data available for analysis. 
  
There are obvious competing priorities and potential conflicts for the researcher who 
had different roles to undertake during the period of this evaluation. However the 
roles should not be viewed as incompatible as Cooper and Schindler noted that “good 
researchers and good managers alike, practice habits of thought that reflect sound 
reasoning” (2003:32). In this evaluation of the syringe marker supply it was not 
possible to separate the roles, leading to the final evaluation design and the methods 
employed being an inevitable amalgamation of management and research 
requirements.    
 
2.7 Analysis. 
 
The analysis of the data has two main components. This involves analysis of the 
quantitative data from the questionnaire and of the qualitative data provided by the 
peer researchers’ fieldwork diaries and recommendations. The views of the researcher 
and the participating pharmacy staff were incorporated in the final reflection on the 
evaluation.  
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According to Blaikie there are a number of different methods of data analysis that can 
be used to describe the characteristics of social phenomena and to investigate their 
interrelationships (2003:29). The data generated in the evaluation was investigated to 
uncover any underlying patterns of association. Statistical analysis of the 
questionnaire results involved identifying three variables to be used as potential 
independent variables (IV) to investigate relationships amongst a range of dependent 
variables (DV). The variables identified as potentially relevant independent variables 
were gender, length of time injecting and housing status. Cross tabulations of these 
three variables were undertaken with five identified potential dependent variables to 
look for differences between groups. These were, current syringe identification, 
mixing up of syringes, use of the markers, reported usefulness of the markers and 
reported usefulness of the instruction leaflet. SPSS version 12 and Excel were used.  
 
The characteristics of those attending the three pharmacy sites were compared with 
each other and with the characteristics of the aggregated data contained in the health 
board wide database and these were found to be broadly similar with no major 
apparent differences. Therefore, based on a combination of the questionnaire 
responses, knowledge of the service and the observations of the SUIG it may be 
possible to infer whether the characteristics of the information gathered can be 
extrapolated to the wider population who use NEXs. 
 
The qualitative element of the evaluation involved secondary analysis of the field 
work diaries completed by the peer researchers during the data collection phase of the 
evaluation. The categories and themes that emerged from thematic analysis of the 
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field work diaries are shown in Appendix 10. Feedback was also sought from staff in 
the participating pharmacy sites.  
 
Chapter 3 is devoted to the background and the role played by the peer researchers in 
the evaluation and includes findings from the secondary analysis. The results of the 
quantitative analysis, including descriptive statistics and cross tabulations are 
discussed in Chapter 4. The combined results and the implications for the syringe 
marker evaluation and the future implications and identified areas that require further 
investigation are discussed in Chapter 5. 
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Chapter 3 
 
 
Peer Research Involvement 
 
 
3.1 Background 
 
 
De Winter and Noom have defined peer research as a form of research where “people 
from a particular target group act as fellow researchers of problems that occur within 
the same target group” (2003:327). In this evaluation the peer researchers involved 
were volunteers drawn from members of the Scottish Drugs Forum (SDF), Service 
User Involvement Group (SUIG).  The peer researchers were responsible for the data 
collection using a structured questionnaire. The questionnaire used to collect data   
and the reasons for involving service users as peer researchers in this evaluation were 
described in Chapter 2. The ethical and practical issues for the research that the 
participation of peer researchers raised are explored in this chapter.  
 
According to McLaughlin in order to understand any involvement of service users in 
research there is a need to look at and understand “user involvement more generally” 
(2009:2). In 1969 Arnstein had identified a “ladder of citizen participation” that was 
used to describe user involvement in policy making (1969:216). Within this model the 
only means of assessing the level of involvement is to examine the extent of the 
individual’s “power to make decisions” and that a determination of the level of 
control is an accurate measure of the extent and the final aim of full engagement 
(Tritter and McCallum, 2006:157). The main problem identified with this model as a 
description of user involvement is that there is no differentiation amongst “method, 
category of user and outcome” (Tritter and McCallum, 2006:161). Within the health 
 82 
 
services recent developments have placed a greater emphasis on the relevance of 
“public and patient involvement” (Tritter and McCallum, 2006:156).  
 
The origins of any type of consumer or service user involvement in the development 
of health policy were contained in the “Griffith’s Report” of 1983 (Department of 
Health and Social Security, 1983).  This report had argued that the “NHS had to 
recognise and respond to the needs of its “customers” ” (Boote, Barber and Cooper, 
2002:218). The syringe marker evaluation involved peer researchers at various stages 
throughout the evaluation. The link between NHS “consumers”, those who attend a 
NEX and the use of peer researchers in a NEX setting are not immediately obvious 
and are examined in more detail below. This evaluation research involves an NHS 
commissioned service; however the population under investigation is one which is 
involved with illegal activities and where their anonymity is protected as a core 
component of the service provided. In the UK, in this context, “consumers” have been 
defined as “patients, potential patients, informal (unpaid) carers, people who use 
health and social services and members of the public who may be potential recipients 
of health promotion plans” (Boote et al, 2006:280). Despite the fact that attendance at 
a NEX service is on an anonymous basis, injecting drug users who access a pharmacy 
exchange can be legitimately be considered as “consumers” of a specific public health 
service. 
 
Despite the unique nature of a NEX service, its management follows the same 
principles as the management of any other type of organisation where a product or a 
service is provided. Total Quality Management (TQM) is a generic approach to 
management underpinned by a number of principles defined as “Customer 
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Orientation, Process Orientation and Continuous Improvement” (Wilkinson, Redman, 
Snape et al, 1998:12). According to Wilkinson et al within TQM, quality means being 
able to “meet customer requirements” (1988:12). Although the final product (injecting 
paraphernalia) is not purchased, but provided as a service, the principles of meeting 
the customer requirements remain the same. The final customer is the drug user and it 
can be argued that customer satisfaction with the provided product is particularly 
essential as the correct use of the product potentially results in reducing the pool of 
serious infections within communities. This therefore can provide potentially life 
saving health benefits for the individual user and for local populations. Ultimately any 
changes made in the equipment supplied will only result in positive improvements if 
the changes are acceptable and if drug users continue to access the service and to use 
the equipment supplied. For these reasons it was considered essential for the 
evaluation to use the peer researchers to attempt to reflect accurately the drug users’ 
responses and views on the supply and use of syringe markers. There is no doubt that 
there are difficulties and barriers associated with peer researcher involvement but for 
an evaluation of a service development associated with the illegal activities of illicit 
drug use, the potential benefits outweigh any perceived difficulties.     
 
This type of consumerist approach to service user involvement in research has been 
described by Hulatt and Lowes as essentially “a passive process by service users, who 
were consulted regarding services but saw no real place for their input in the process 
of shaping those services” and that this sense of “frustration about being consulted in 
a tokenistic manner extended further into the arena of research” (2005:1).  From this 
early involvement as consumers of services there has been a continuous progression 
from the 1990’s to incorporate a range of different strategies and innovative levels of 
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participation. Kemshall and Littlechild have described how this form of service user 
and peer research involvement has extended into areas of “health, social care and 
criminal justice” and they have drawn together and described the range of research 
and evaluation strategies that can promote user participation and involvement in 
research (2000:8).   
 
As discussed in Chapter 2, any research involving direct contact with injecting drug 
users has additional ethical and practical dimensions as, due to the nature of the 
activity, this is traditionally a marginalised and therefore a hard to reach group. In 
1996 the NHS Central Research and Development Committee established a group 
entitled “Consumers in NHS Research” which was designed to advise them on “how 
best to involve members of the public in the research and development process” 
(Caton and Hanley, 2001:195). In 2001 the Policy Research Programme of the 
Department of Health was given an expanded remit and in 2003 the programme group 
was renamed “INVOLVE” and was specifically re-designed to promote “public 
involvement in NHS, public health and social care research” (INVOLVE, 2003).    
 
In 2004 INVOLVE produced a consultation document entitled “Involving 
Marginalised and Vulnerable People in Research”. This document has relevance for 
the syringe marker evaluation as it gives examples of groups of people that can be 
viewed by themselves or by others as “vulnerable or marginalised”. These groups 
included “homeless people, people whose voices cannot be heard, drug addicts, 
people in poverty, people who need, but are not receiving health or social care 
services” (INVOLVE, 2004:2). It is clear that those attending a needle exchange are a 
multifaceted group who may fall into more than one of the categories of vulnerable 
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and marginalised groups listed above. In addition to their injecting drug use other 
complex factors can contribute to their marginalisation and social isolation. For these 
reasons the design and implementation of the syringe marker evaluation benefited 
from the contributions of the previous personal experiences of the SUIG members. 
For example, their experiences were utilised in ensuring that the content and language 
of the questionnaire was appropriate and understandable to the study participants and 
their networks of contacts could be used to disseminate results.   
 
Despite the difficulties and challenges associated with engaging marginalised and 
hard to reach groups in the research process there are many examples from a range of 
related disciplines where this has been conducted successfully. For example, in the 
field of mental health research, service user and peer involvement has been shown to 
have numerous benefits including:  
“increasing relevance of the research (for example, by enriching 
researcher’s understanding of the illness, ensuring the questions 
being asked are meaningful, improving the design of a study, 
choosing appropriate outcome measures, and generally 
preserving a focus on the meanings of the research for those 
with the illness); better recruitment to studies and better, more 
open responses from research participants who are more likely 
to feel their interests are being addressed, and with less 
likelihood of dropouts; fresh insights in interpreting results; 
service user support may assist dissemination and 
implementation of research findings;”  
(Szmukler, 2009:87).   
 
This has resonance with the main purpose of incorporating service user involvement 
into the syringe marker evaluation and identifies many of the anticipated benefits for 
the evaluation. 
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“Children in general, children in care and young carers” have also been identified as 
hard to reach, vulnerable and marginalised groups (INVOLVE, 2004:2).  Even with 
children, where the challenges of involving them in the research process may be 
considered even more problematic, it has still been possible to use children to make 
positive contributions to research and for them to participate as full research group 
members. In 2006 in Scotland, a mapping exercise was conducted to review literature 
around children carrying out research. This work included interviews with policy 
makers, researchers, research managers and young researchers (Brownlie, Anderson 
and Ormston, 2006:2). Many of the key issues identified in this review were similar to 
the issues that were explored in Chapter 2 when the justification for using peer 
researchers in the syringe marker evaluation was explored. These identified issues 
included “ethical issues around confidentiality, risk of harm, payments and power in 
research partnerships; and balancing young people's involvement with the need for 
high quality, reliable data” (Brownlie et al, 2006:3).  
 
In 2005 a study was initiated to examine the experiences of homeless people who 
were attempting to find and sustain employment whilst being homeless (Butcher, 
2005:30). The methodology of this project involved using peer interviewers to 
conduct the interviews. The benefits of using peer interviewers were found to be 
twofold. Firstly the peer researchers “provided important input into the methodology 
and development of the questions used in interviews, surveys and focus groups” and 
secondly for those interviewed some reported that they felt that the “the peer 
researchers were role models, inspiring them to get more involved in shaping 
homelessness services” (Butcher, 2005:31). This is an example of where peer 
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researchers from an identified marginalised group were successful participants in the 
research process.  
 
This indicates that the problems associated with the incorporation of members of the 
injecting drug using community as co-researchers are not unique to this group and that 
there are close parallels, particularly from research experiences with other hard to 
reach groups including those who use mental health services and with populations of 
children and the homeless.  
 
A project conducted in 2002 was designed to explore the views and experiences of 
one of the groups that would be considered as particularly hard to reach, namely, 
parents who use illegal drugs (Elliot, Watson and Harries, 2002:172). This was a 
qualitative study and the methodology involved the use of peer interviewers. This 
study concluded that “the involvement of peer interviewers in research can be a 
valuable means of enhancing our knowledge and understanding of a variety of 
population groups who tend to live beyond the gaze of more orthodox researchers” 
(Elliot et al, 2002:172). However, the authors did acknowledge that there were both 
positive and negative aspects to using peer interviewers as co researchers in this type 
of setting. They identified that this methodology posed a number of challenges related 
to the difficulties associated with the need to support interviewers who were not 
trained researchers, the inevitable tensions that arose due to the researcher being 
removed from the immediate interaction involved in data collection and the associated 
“difficulties of gaining from the skills and experiences of peer interviewers without 
exploiting their labour” (Elliot et al, 2002:172). This was reflected in the practical 
experiences of the syringe marker evaluation where on-going support for the peer 
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interviewers had been identified in the early stages as a crucial factor to ensure, as far 
as possible, full and safe participation by the group members. The ethical issues 
linked to the use of peer researchers are explored in more detail below in section 3.3. 
The possibility that the use of peer researchers may result in a sense of distance from 
the raw data was considered in Chapter 2 in the discussion on the reasons for the 
choice of specific methods. 
 
The UK Government has been described as “keen to promote service user and carer 
involvement” (McLaughlin, 2009:3). This is a very wide generic statement. The term 
user involvement can cover a wide spectrum and promoting service user and care 
involvement in service delivery may involve simple consultation, with minimal 
involvement, on various aspects of services but does not necessarily involve service 
users further in service and service delivery research. There are now statutory 
requirements set down in the National Health Service Reform (Scotland) Act where, 
for new policy developments, there is a “duty to encourage public involvement” 
(2004:6). More detail is outlined in the paper, “Patient Focus and Public Involvement” 
which states that services should be developed where “people are respected, treated as 
individuals and involved in their own care” (2001:2). It is claimed that this improves 
the “quality of service provided” for patients and for staff (2001:16). This establishes 
the principle of service user involvement in helping to develop quality services but 
gives little or no guidance on service user participation in research. For this reason, it 
is important to note that there is no clear indication as to the extent of the level of 
service user involvement or peer research that is necessary for improved service 
quality to be achieved. This document also identifies that patient and public 
involvement is often seen as a “low priority issue” (2001:10). It is possible to 
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speculate that involving hard to reach groups, including IDUs, is  likely to be even 
less of a priority for those developing services due to the many barriers associated 
with involving those involved with illegal activities. 
 
Service user involvement can incorporate a range of potential roles across the 
spectrum from consultation with no direct effect on service development to full 
service user controlled research. There needs to be recognition and acknowledgement 
of the different roles that service users are able to perform and that this may be 
extensive in some health and social care areas. In reviewing the impact of service user 
involvement in research and evaluation Beresford notes that there is “growing 
political and research interest in user involvement” which is specifically relevant to 
the public and social sphere particularly in the fields of health and social care 
(2002:95). Despite this, service user participation as peer researchers is far less 
common than other types of service user involvement in services. According to Hulatt 
and Lowes this can be viewed as a “continuum model” that incorporates varying 
levels of service user consultation, peer research participation, through to research that 
is designed and controlled by service user involvement groups that have been 
responsible for designing and undertaking the research (2005:2).  
 
For the syringe marker evaluation the views of service users were considered to be 
essential in helping to shape and develop the service. The reason for using peer 
researchers in this evaluation was to utilise their unique expertise, as previous users of 
the needle exchange service under study, to assist with the development of the 
original design of the syringe marker evaluation and in the data collection phase to 
facilitate contact with a recognised hard to reach group. It can be seen that this level 
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of involvement for the peer researchers incorporates elements of consultation, 
collaboration and participation in the research process whilst the ultimate control of 
the research remains with the principle researcher.  
  
As this type of service user involvement and interaction has evolved a number of 
terms have been used to describe the various layers of service user involvement. 
These include “patient, client, expert by experience and service user” (McLaughlin, 
2009:10). The most relevant descriptive term for the form of service user involvement 
in the syringe marker evaluation is “expert by experience”. This has been defined and 
includes “people who use services now or have done in the past; people who need 
services but haven’t been offered them; people who need services but haven’t been 
offered any that are appropriate” (McLaughlin, 2009:16). All of the six members of 
the SUIG had used NEX services in the past and had a range of both positive and 
negative experiences of various types of NEX service provision. Their major 
contribution to the evaluation was based on the premise that they had unique expertise 
from their previous experiences as intravenous drug users and that they were familiar 
with and had used the services offered by NEXs. The term “expert by experience” 
aptly describes their role. The main aim was to utilise this experience to support the 
researcher in the design and implementation of the evaluation to ensure that the 
intervention and any proposed expansion was of practical, not theoretical, relevance in 
promoting safer injecting practices.  
 
The field of service user involvement has moved from one of consultation to the 
position where service user led research is now possible. The area has not remained 
static and the focus is now on assessing the quality and the impact on research and 
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outcomes of incorporating service user researchers into research processes. There 
have been major advances and developments in the involvement of service users in all 
aspects of health orientated research, to the extent that Wright and colleagues have 
claimed that “involving service users is now seen as a core component of good 
research practice for all forms of health research” (2010:359). Wright and colleagues 
have developed critical appraisal guidelines for assessing the quality and impact of 
user involvement in research (2010:359). According to this appraisal the quality of 
any research involving service users should include an assessment of the following 
criteria, summarised below: 
1.  Is the rationale for involving users clearly demonstrated? 
2.  Is the level of user involvement appropriate? 
3.  Is the recruitment strategy appropriate? 
4.  Is the nature of the training provided appropriate? 
5. Has sufficient attention been given to the ethical 
considerations of user   involvement and how were these 
managed? 
6. Has sufficient attention been given to the methodological 
considerations of user involvement and how were these 
managed? 
7. Has there been any attempt to involve users in the 
dissemination of findings? 
8. Has the “added-value” of user involvement been 
demonstrated clearly? 
9. Have attempts been made to evaluate the user involvement 
component of the research? ” 
(Adapted from Wright et al, 2010:364-366).  
 
Although initially the use of the service user involvement group as peer researchers 
was aimed solely at assisting with targeting a hard to reach population there are many 
aspects of the criteria documented by Wright that became central to the assessment of 
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the role that the peer researchers played. The practical and ethical aspects are 
discussed below and user involvement component became a separate issue for 
discussion in the analysis of the findings where it became apparent that the peer 
researchers had “added-value” to the evaluation.  
 
The Wright criteria are in line with the work of Morrow et al who claim that for any 
level of service user involvement in research there is now a pressing need “for more 
critical and consistent assessment of what constitutes quality improvement” (Morrow, 
Ross, Grocott, 2010:532). The model and measure developed by Morrow and 
colleagues is aimed directly at research teams and is designed to assist with evaluating 
“dimensions of quality service user involvement in the contexts they are working 
within” (2010:538). This work proposes a model for a “Quality Involvement 
Framework” that would enable both researchers and service users to assess the quality 
element of service user involvement and to promote a more reflexive account of the 
process (2010:532). The main benefit of this type of formal framework model is that it 
allows consideration of the impact of “personal factors” to be considered along with 
the research context and setting. One of the personal factors identified by Morrow et 
al was the concept of payment for participation where for peer researchers this was 
shown to be associated with a “sense of empowerment” (2010;534). For the syringe 
marker evaluation the financing issue has two separate aspects, both of which have 
the potential to affect the quality of the evaluation. Firstly the SUIG members were 
not paid to conduct the research although full expenses were provided. The issue of 
financial and other types of benefit are explored further in section 3.3 on the ethical 
aspects of peer research. Secondly the participants who completed the questionnaire 
were a distinct group from the SUIG who acted as peer researchers. The participants 
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who responded were current service users of the pharmacy NEXs. There are 
conflicting views on the ethics of payment to current injecting drug users for 
participation in research and the potential this has to influence results. According to 
Ritter et al it is normal practice to pay any research participants as a reimbursement 
for their time and experience (Ritter, Fry and Swan, 2003:2). In Australia this extends 
to all research in the public health domain involving IDUs (Ritter et al, 2003:2). The 
difficulties arise when the payment can be deemed an inducement to participation, 
particularly in the field of illicit drug use. It has been claimed that payment to service 
users who are IDUs is ethical as long as value is not so great that it makes “informed 
consent questionable” (Ritter et al, 2003:4). These authors go further in that they 
claim it would be unethical to withhold any payment from this group as it would be 
“unfair and prejudicial” to a group that is already marginalised from society (2003:2). 
For the syringe marker evaluation no payments were made to the service user 
respondents. This was not an option for consideration as no funds were available for 
this purpose. However there was no element of discrimination or judgement involved 
as it is not routine practice to make payments to participants for any type of service 
evaluation in a community pharmacy. Reasons for refusal to participate are explored 
further in Chapter 4 however it should be noted that lack of a payment was never 
reported as a reason for non participation.              
 
 Elements of the service user involvement as peer researchers and their role in 
improving the quality of the syringe marker evaluation are discussed in Chapter 4. 
Involvement of service users in research is an area that is continuing to evolve, not 
only for the health services but in other public services. Minogue and Girdlestone 
have noted many examples of increasing public involvement in research in “NHS, 
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Higher Education Institutes (HEIs) and social care organisations across the UK” and 
they claim that there are numerous examples of work that “presents a very positive 
picture in terms of the level of interest, energy, and volume of work being 
undertaken” (2010:432). However they record a note of caution as they claim that 
despite this being an emerging area that is continually evolving fragmentation exists 
in developments that can be the result of lack of both direction and resources 
(2010:433). Despite this caution there remains the possibility of major potential 
benefits for services, research, researchers, policy development, evaluation and users 
of services from the continued more structured development of service user 
involvement that extends to include the involvement of peer researchers.  
 
The practical and ethical aspects of the peer research involvement in the syringe 
markers evaluation are detailed below and a further examination of the relevance of 
service user involvement in the evaluation analysis is discussed in Chapter 4. 
 
3.2 Practical Aspects 
 
Hanley and colleagues identified a number of points along a continuum to describe 
the extent of the involvement of external groups in health and social care research. 
These progress through “tokenism, consultation, and collaboration” and ultimately to 
research which is wholly “service user controlled” (Hanley, Bradburn, Barnes et al, 
2004:26). The extent of the involvement in the syringe markers evaluation was an 
evolving aspect of the research and had elements of both “consultation” and 
“collaboration”. Although the initial aim had been to use SUIG members to collect 
data to reduce interviewer bias, the role and the nature of their involvement changed 
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and increased throughout the various stages of the evaluation. The initial role involved 
consultation as the SUIG members were consulted on the design and the practical 
implementation of the questionnaire. However their role evolved during the course of 
the evaluation to take on a more collaborative aspect. According to McLaughlin, 
collaboration requires the lead researcher to be “more participative than is required for 
consultation as they are sharing their power to control the research as a means to 
ensure a more collaborative research process and a better quality product” (2009:28). 
Within the syringe marker evaluation the move from consultation to collaboration 
emerged as the researcher devolved control of the data collection to the SUIG. This 
aspect of the evaluation became controlled by the interviewers as, for example, they 
took responsibility for identifying those to be interviewed, ensuring that respondents 
were properly informed of the nature of the research and that informed consent was in 
place and in identifying and recording accurately any additional relevant information.    
 
This collaborative approach is in line with the views of Godfrey who, when 
examining the use of user interviewers in research in a social care setting, concluded 
that “asking users for their views is not enough” (2004:223). He argued that for any 
real change to take place the “balance of power has to be shifted, and it is only by 
agencies releasing some control that this will happen” (Godfrey 2004:223). Although 
the peer researchers in this evaluation did not have sole control over the evaluation 
their involvement was extensive and continually evolving. Godfrey noted that when 
undertaking research in evaluating services “user researchers bring a new and 
different perspective, which generates new ideas and constructs” (2004:229). For this 
evaluation the use of peer researchers supported the conclusions reached by Godfrey 
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that their involvement could help to improve the quality of the research process in 
unanticipated ways (2004:229).  
 
The peer researchers contributed during all stages in a number of ways to the overall 
evaluation including, for example, maintaining their own field work diaries. The 
diaries were initially intended to be used to record details of the numbers of people 
approached, refusals and reasons for refusal to participate and the time spent in each 
pharmacy. However the use of the diaries as a tool expanded as the research 
progressed. There were six peer researchers, however the diaries did not record who 
had made which comment or observation. As noted in Chapter 2 the peer researchers 
worked in pairs and completed the field work diary to reflect their agreed comments 
on the research experiences of the day. During the debriefing sessions and discussions 
with the six group members it was clear that the observations recorded had been 
discussed and agreed together before being recorded. From this it is reasonable to 
assume that the views expressed represented a consensus from the group. As the peer 
researchers experienced the practical difficulties of fieldwork, the diaries were used to 
record more subjective information on the process and their role and observations. In 
effect the use of the diaries developed over time and rather than being simply a record 
of contacts they increasingly functioned as field notes. Field notes have been defined 
as a “detailed chronicle by an ethnographer of events, conversations and behaviour, 
and the researcher’s initial reflections on them” (Bryman, 2004:539). This reflects the 
unanticipated evolvement of the peer researchers’ role from solely administering the 
questionnaire to one that incorporated elements of the participant observer role where 
they recorded observations and reflected on situations not directly related to 
questionnaire but relevant to the wider context of the research setting. Due to this 
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unexpected development with the field work diaries it appeared that it was possible 
these could be subjected to thematic analysis by the researcher and the results of this 
analysis are discussed in further detail in Chapter 4. The main theme that emerged 
centred on the role and identity of the peer researchers and how this changed over the 
course of the research. A number of related strands emerged around the main theme 
and these are illustrated by the following quotes:   
 
1) “Staff gave us a key for the store room which made us feel 
really trusted” 
2) “Staff were nice and came over to ask me how things were 
going and if I would like a cup of tea, felt included” 
3) “Really struggling hanging about the shop waiting for people 
to come in”  
4) “Chemist even quieter today, really disheartening” 
5) “I feel the methadone users are getting someone to come in for 
a pack then they are sharing it out as they don’t want to ask for it 
because they collect their methadone there. I have observed a few 
people getting their meth and then waiting about or coming back 
later with someone else who uses the needle exchange. They then 
leave and hang about outside for a few minutes before going in 
separate directions”   
 (Research Diary of Field Work 2006, SUIG) 
 
 
Quotes 1 and 2 relate to the identity of the SUIG members as individuals involved in 
the process as researchers. This is the result of a social interaction and interpretation. 
According to Morrow the term “service user” and by implication, service user or peer 
researcher is a “professionally generated concept” that is the subject of personal 
negotiations and allocation of power (2003:536).  This type of interaction can be 
“potentially sensitive” but according to Morrow et al it is essential to understand the 
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roles and identities of all involved to help to improve the relationships and 
interactions of service user involvement in any type of health research (2003:537). 
There are clear indications from the quotes above that the peer researchers’ 
interactions with pharmacy staff were positive and therefore likely to add to the 
quality of the evaluation as a whole. Quotes 3 and 4 are directly related to the peer 
researchers role and identity as researchers where they are directly responding and 
recording their reactions to the research setting and where they demonstrate that they 
are experiencing the realities of practical research field work which is often tedious 
and at times boring. Quotation 5 demonstrates a degree of initiative in that they have 
extended their researcher role into recording observations that are not directly related 
to the syringe marker evaluation but that are relevant to the wider area of injecting 
equipment distribution and sharing. It is possible to speculate that this extension into 
making observations on the wider aspects of the NEX and pharmacy functioning 
could be as a direct result of the reactions to the restrictions of the research setting and 
process shown in quotes 3 and 4. These three examples of Identity, Reaction to 
Research Setting and Observations can all be viewed as different strands in the change 
and development of the role and identity of the peer researchers during the conduct of 
the evaluation.  
 
At the end of the data collection period the SUIG collectively reflected on the process 
and produced a set of recommendations that had been agreed by the group, for 
consideration to inform future decisions on the extension of syringe markers supply to 
the other needle exchange sites. The positive contribution that this made to the final 
recommendations is discussed further in the analysis section in Chapter 4. The 
recommendations were based on a combination of their experience, observations and 
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reflections on the fieldwork phase and their previous “expert experiences”. This was 
not a requirement that had been originally sought by the researcher from the group but 
reflected the extent to which the peer researchers had become involved in the 
evaluation and the way the role and confidence of the peer researchers had evolved 
and expanded. This mirrors the experience of peer researchers in other addiction 
related settings where the role evolves and where it becomes necessary for the lead 
researcher to understand and to “appreciate the dynamics of role evolution” (Jason et 
al, 2006:9). At the start of this evaluation the identified role of the peer researchers 
was to collect data using the structured questionnaire. However this expanded into 
recording reflections on perceptions of their involvement in the research process and 
proposing and recording the group’s views on the usefulness of syringe markers. This 
extended to recording the group’s views on how the design of the markers and any 
proposed wider supply system could be improved.   
    
As this evaluation investigated the behaviours of individuals involved in illicit drug 
use there was an added extra dimension that is not normally a factor in mainstream 
health related research. The involvement of service user participants in the research 
therefore brought two distinct positive elements to the evaluation. The group provided 
service user expertise and also had the added benefit, described in Chapter 2, of 
helping to alleviate some of the problems associated with research on hard to reach 
groups.  
 
According to McLaughlin there are a number of benefits to be gained from engaging 
service users as participants in the research process. The service users provide unique 
insights into the working and organisation of hard to reach groups and this knowledge 
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assists the researcher in understanding the actions of the group under study and in the 
design of the questionnaire. Ultimately this makes a positive contribution to the 
design and implementation of the evaluation as it results in enhancing “range and 
quality of data” (McLaughlin, 2009:34). The use throughout the evaluation research 
of peer researchers therefore brought a number of benefits to the evaluation. These 
included the recommendations made by the group and their further involvement in 
disseminating the results of the work through the SUIG contact networks. When 
obtaining feedback from the participating pharmacists two commented without 
prompting that they and their staff had welcomed the opportunity to meet with the 
peer researchers before the evaluation started and that they considered this to have 
been one of the most useful aspects of the training session. It is possible to speculate 
that this early introduction of pharmacy staff and peer researchers in a neutral 
environment, outside the busy pharmacy, helped to break down any perceived barriers 
or misconceptions and contributed to the success of the peer researchers role and 
integration into the daily routine of the pharmacy.      
 
3.3 Ethical Aspects. 
 
In the UK, policy recommends that where service users are “involved as co 
researchers or active members of project teams there is a need to consider ethical 
issues both on the part of the service users and to protect other participants in the 
research” (Smith, Ross, Donovan et al, 2008:97). The authors of this review of the 
evidence and practice relating to service user involvement in health care research 
claim that the literature “ reveals little of the negative consequences of involvement, 
which means it can be difficult to foresee ethical implications for researchers and 
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service users” (Smith et al, 2008:97). The need to protect both the peer researchers 
and the participants raised several significant ethical considerations for the conduct of 
the syringe marker evaluation. 
 
There were a number of ethical dimensions associated with the use of members of the 
SUIG in the syringe marker evaluation that were outside the normal ethical 
considerations of data collection through use of a structured questionnaire. These 
were specific to the setting and the populations under investigation. The lead 
researcher operates with the benefit of clear guidance from their own professional 
governing body in relation to the participation of patients as research subjects. 
However, McLaughlin noted that merely following professional ethical codes “is no 
substitute for researchers exercising their own ethical integrity as morally active 
researchers” (2009:45). He further states that ethical codes can never fully anticipate 
every possible potential situation that a researcher may encounter (2009:45). For 
example, with the expansion of the role for members of the SUIG there is the need to 
ensure that the demands of the research did not destabilise their personal recovery or 
have any other potentially detrimental effects. As described in Chapter 2 in this 
evaluation the peer researchers were required to enter and spend time in the physical 
environment of the needle exchange resulting in exposure to both the physical 
environment and the injecting paraphernalia associated with their previous drug use. 
As previously discussed in Chapter 2  the setting for data collection in this evaluation 
is particularly relevant as research has shown that “in humans exposure to 
environmental contexts previously associated with drug intake often provokes relapse 
to drug use” (Crombag, Bossert, Koya et al, 2008:3233). An awareness of this 
background meant that it was possible to minimise the potential adverse effects of 
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these factors from the beginning by enabling potential problems to be identified at the 
earliest possible stage. Strategies employed included daily debriefing sessions for the 
peer researchers, working in pairs and not in isolation to ameliorate the effects of 
boredom, support from the permanent pharmacy staff and careful consideration when 
matching individual peer researchers to specific geographic locations. The latter 
consideration was deemed essential to minimise exposure to trigger factors that could 
potentially precipitate relapse or destabilisation. For this reason peer researchers were 
placed in pharmacies and locations that were unfamiliar to them. This had two main 
benefits, as not only were any contextual triggers minimised, but it also meant that the 
researchers were less likely to meet or interview individuals associated with their own 
previous personal drug use. A further benefit from placing members of the SUIG 
outside their local environment was that it helped to maintain aspects of patient 
confidentiality around both daily methadone supervision and the use of NEXs for 
those accessing the pharmacy services and for potential interviewees. This helped to 
reduce the impact of the demands of the research process on the routine operation of 
the community pharmacies involved. According to McLaughlin throughout the 
research period the ongoing interaction between service users and service user co-
researchers can lead to “both anticipated and unanticipated ethical issues” (2009:57). 
The measures described above were put in place in advance to attempt to pre-empt 
any ethical issues from arising. The requirement on each of the participants to 
maintain confidentiality and the ethical aspects of the evaluation had been outlined 
and discussed at the initial training session that had included the pharmacy staff and 
the peer researchers. The pharmacy staff were able to act as an immediate source of 
advice if any issues did arise and acted as a support for the peer researchers. One of 
the main reasons for having joint, rather than separate, training sessions was to 
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introduce the peer researchers to the permanent staff and to establish relationships in 
advance of the fieldwork. However as noted, it is impossible to anticipate all 
eventualities and for this reason it was essential for the lead researcher to continually 
review the situation to monitor and be able to react to any emerging ethical issues. 
 
One other major ethical dilemma for this evaluation involves the difficulties 
associated with what Elliot and colleagues outlined as “gaining from the skills and 
experiences of peer interviewers without exploiting their labour” (Elliott et al,  
2002:172). Despite the fact that the involvement of the SUIG was on a voluntary basis 
there is no doubt that the use of peer researchers contributed positively to the quality 
of the final evaluation. According to Elliot et al there is a fine line between “involving 
and empowering people on one hand, and exploiting their labour and expertise on the 
other” (2002:175). These observations were made following a project that had used 
peer interviewers in a study examining the views and experiences of parents who used 
illegal drugs (Elliot et al, 2002:172). During this project the peer interviewers had 
expressed frustration at feeling “used” by both the community drug team and the local 
drug reference group. They had formed the view, whether justified or not, that the 
research was benefiting from their access to the contacts, networks and the 
experiences of the volunteers but that there was no reciprocal benefit in terms of 
“recognition, remuneration or a sense of ownership of the work” (Elliott et al, 
2002:175). This was clearly a position that the researcher aimed to avoid in the 
syringe marker evaluation, as it would be unethical and also make it unlikely that 
there would be positive engagement by the SUIG members if a similar sense of 
exploitation was experienced by the peer researchers.   
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According to McLaughlin “reward and recognition covers both the reimbursement of 
expenses and payment for the skills, expertise and time that service user co-
researchers contribute to a research project” (2009:55). The funds available to conduct 
this evaluation research are shown in Appendix 4. Although expenses were paid it 
was not possible to offer any further remuneration to the SUIG members. However 
the definition of “reward” should not be viewed solely in monetary terms. The SUIG 
had already been trained and supported by the user involvement group co-ordinator to 
prepare the members to participate as active service user researchers. At this stage the 
SUIG were actively seeking opportunities to put their training into practice and the 
opportunity to be involved in the data collection part of the syringe identifier 
evaluation fitted their needs. For this reason the group were keen to participate despite 
no payments, apart from travel expenses, being offered. This evaluation gave them a 
framework to develop their theoretical skills through direct experience of a real life 
research environment and the resulting interaction and collaboration with researchers, 
pharmacy staff and interviewees. This was reported to have been a useful training 
experience for the group members and perceived as a reward in itself (Currie, 2007: 
personal communication).  It has been identified that other non monetary aspects of 
reward may be important where for some participants the rewards came from active 
participation (Tritter and McCallum, 2006:156). The researchers further claimed that 
“without clear evidence that involvement is linked to change, there is little chance that 
individual users or groups will remain engaged” (Tritter and McCallum, 2006:166). In 
the syringe marker evaluation it was established in the early stages that the results of 
the work would be used to implement changes in the NEX service. This led to two 
main benefits for the SUIG participation. These were firstly, effective participation in 
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the research process and secondly allowing the members to influence the decision 
making, and therefore the service delivery of the NEX scheme.  
 
3.4  User Involvement Group Field Work Diary and Reflections 
 
The original purpose of the field work diary was to record, on a daily basis, logistical 
information for the three pharmacies detailing the time spent in each site, the total 
number of completed questionnaires, number of refusals and any observations by the 
interviewers relevant to the research. The purpose of this was to monitor and direct 
the ongoing evaluation to ensure that the best use was made of the peer researchers 
time to try to maximise contact with those using the NEX who had been previously 
supplied with the syringe markers and to co-ordinate this into the practicalities of the 
day to day functioning of each community pharmacy site. Details are shown below in 
Table 3.1. Additional observations were also recorded by SUIG members.  
 
Table 3.1. 
Field Work Diary Data Collected During Second 4 Week (Data Collection) 
Period 
 Pharmacy 1 Pharmacy 2 Pharmacy 3 
Total Length of 
Time (Hours) in 
each Pharmacy. 
 
(Daily Range) 
 
40.5 
 
 
( 2 – 6.5 ) 
 
27.5 
 
 
( 2 – 6.5 ) 
 
29 
 
 
( 2 – 3.5 ) 
Total Number of 
Completed 
Questionnaires 
 
(Daily Range) 
 
86 
 
 
( 2 - 13 ) 
 
47 
 
 
( 0 – 9 ) 
 
44 
 
 
( 1 – 5 ) 
Total Number of 
Refusals 
 
(Daily Range) 
 
12 
 
( 0 – 6 ) 
 
25 
 
( 0 – 7 ) 
 
7 
 
( 0 – 2 ) 
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Although the initial aim was merely to use this as a practical recording tool the 
importance of the notes and observations recorded in the field word diaries increased 
over time. According to Gilbert “doing fieldwork has emotional costs, and one needs 
data on one’s own attitude to document one’s evolving relationship to others in the 
setting” (2003:153). This appears to describe accurately the type of situation that 
occurred with the peer researchers as the nature of the observations recorded reflected 
their emotional reactions to the research setting and their relationships and 
interactions with the pharmacy staff and participants. The effects of participation in 
the research for the peer researchers and the developing relationships with the 
permanent members of staff are illustrated in the quotes below. The quotes illustrate, 
firstly the peer researchers own reactions to the research setting that they were 
operating in: 
“Really struggling hanging about the shop waiting for people to 
come in. Was offered a chair by the staff but didn’t want to sit 
down as I think I would have felt more awkward”    
 
 “Needle exchange very quiet today. Found it really difficult to 
being in a room with another peer researcher for two and a half 
hours” 
 
 
Secondly the quotes below illustrate the peer researchers relationships and 
interactions with the regular staff. These indicated that positive working relationships 
were established and that the details and practicalities of the data collection and the 
peer researchers’ role were discussed. 
 
 
“All staff at the chemist were very friendly” 
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“Staff gave us a key for the store room which made us feel very 
trusted” 
 
“Pharmacist advised us that we were unlikely to get more 
clients attending at this time so we called it a day at 4.30 PM” 
 
During the analysis stage it became obvious to the principle researcher that these field 
notes contained relevant qualitative data that could contribute to the final evaluation. 
At this stage the peer researchers had completed their involvement and moved to other 
projects and activities and were no longer available as a group to discuss the 
fieldwork entries in further detail. However the unanticipated amount and quality of 
the information contained in the fieldwork diaries meant that this was potentially a 
useful data source that warranted further analysis. In essence this can be viewed as a 
form of secondary analysis. Secondary analysis of data is routinely carried out on 
studies using quantitative data where it has been defined as being conducted by 
“researchers who will probably not have been involved in the collection of those data 
for purposes in all likelihood were not envisaged by those responsible for the data 
collection” (Bryman, 2004:201).  There are additional difficulties in conducting 
secondary analysis on qualitative data and Hammersley has suggested that there may 
be problems associated with the “secondary analyst’s lack of an insider’s 
understanding of the social context within which the data were produced” (in Bryman, 
2004:415). This analysis of the field work diaries is essentially a hybrid form of 
secondary analysis. Although the data constituted part of the evaluation research it 
was not produced or collected by the principle researcher but was produced 
independently by the peer researchers. However although it was not possible to 
discuss the observations, meanings and subsequent interpretations with the members 
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of the SUIG the researcher had the advantage of a full understanding of the 
background and the context in which the diaries had been completed. 
 
An initial review of the field work diaries indicated that using “thematic analysis” 
would be the most appropriate method of analysing the recorded notes and 
observations. Thematic analysis has been defined as the “process of identifying 
themes or concepts that are in the data” (Strauss and Corbin, 1990:86). This is a useful 
tool to analyse data that is complete and over which the person conducting the 
secondary analysis has had no previous influence. Although the principle researcher 
had designed the evaluation and directed the work of the SUIG in administering the 
questionnaire they had no influence on the group’s recorded observations. It is these 
observations that were subjected to a thematic analysis.  Thematic analysis is related 
to “grounded theory”. However this term should only be used “to refer to studies in 
which data collection and data analysis are conducted concurrent alongside theoretical 
sampling and other techniques distinctive of grounded theory, such as constant 
comparative method” (Strauss and Corbin, 1990:86). With grounded theory the data 
collection and analysis are inextricably connected. Although grounded theory 
identifies themes and concepts that are present in the data, it is open to the researcher 
to direct the field work and data collection in response to emerging themes. For 
example it is possible to “check interpretations with participants” (Ezzy, 2002:68). An 
analysis of the recorded observations contained in the field work diaries was not part 
of the original evaluation design. For that reason it was not possible to confirm or 
refute any emerging themes with the participants or to test new concepts as the 
research was being undertaken. Thematic analysis is therefore a useful tool to analyse 
data that is complete and where it is not possible to redirect the research process to 
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test any emerging theories. An initial review of the field work diaries had indicated 
that they contained additional information that gave the researcher access to an 
unanticipated source of relevant data on the inclusion of peer researchers and their 
role in this type of evaluation. 
 
The analysis conducted on the field work diary contents has been inductive as with 
thematic analysis the “categories into which themes are sorted are not decided prior to 
coding data” (Strauss and Corbin, 1990:87). According to Robson, thematic analysis 
has the following structure. Initially descriptive codes are developed. This leads to 
axial coding when codes are integrated around the axes of central categories. This is 
followed by selective coding which can then identify the relationships between the 
emerging categories (Robson, 2002:495). The conclusions based on a thematic 
analysis of the field work diaries are discussed in the following section.  
 
3.5  Field Work Diary Analysis. 
 
Although the information on which this secondary analysis is based was limited to the 
written observations from the peer researchers, which were not a constituent part of 
the original design, it was possible to identify potentially significant and interesting 
areas for further investigation. Initial analysis of the field work diaries identified a 
number of themes, shown in detail in Appendix 10.  The main themes to emerge were: 
reaction to research setting, relationships and interactions, identity, practical 
difficulties, observations and communication. On further analysis it emerged that 
identity was a key concept that began to link the initial descriptive themes. The key 
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findings associated with each theme and illustrative quotes from the field work diaries 
are described and discussed below. 
 
Theme One: Reaction to the Research Setting. 
Unsurprisingly, as the questionnaire was being administered by members of the SUIG 
who were relatively inexperienced in this process the aspect of their reactions to their 
placement in the research setting emerged as an initial theme. 
 
“The set up was good and we got a room” 
 
“Felt a lot more isolated in this pharmacy as we couldn’t see 
from the consultation room what was happening” 
 
 
It can be seen from the illustrative quotes above that both positive and negative 
comments on the research setting and the peer researchers’ reactions to the setting 
were noted. 
 
Theme Two: Relationships and Interactions. 
This can be broken down into the peer researchers’ relationships and interactions with 
the regular pharmacy staff and with the participants that were approached to take part 
in the study. The success of this evaluation depended to a large extent on the peer 
researchers being able to engage those attending the NEX and to successfully 
facilitate completion of the questionnaire. This had to be done in an environment of a 
busy functioning community pharmacy. In order to do achieve this, peer researchers 
had to engage with staff and perform their research duties whilst causing minimum 
disruption to the daily routines. This inevitably required the employment of 
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negotiating skills and the establishment of effective working relationships. There was 
clear evidence of the establishment of these relationships and interactions with staff, 
illustrated by the quotes below that reflect the peer researchers’ views of staff and 
illustrate examples of interactive conversations related to the conduct of the research. 
 
 “Staff very friendly and helpful” 
 
“Informed by staff that sometimes people queue in the 
morning for the needle exchange to open” 
 
“Staff commented that people only appeared to use the 
needle exchange when we are not about” 
 
“Staff informed us that two people who had been given the 
stickers had asked for more stickers as they found them 
useful” 
 
 
The peer researchers were effective in achieving successful completion of more that 
the original estimated number of questionnaires in the allocated time frame. From the 
quotes below it became clear that their interactions with participants extended beyond 
completing the questionnaire. Many of the quotes were illustrative of extensive 
further discussion, including disclosure of potentially sensitive health information to 
the peer researchers. This resulted in recording additional relevant material that 
ultimately contributed positively to the final evaluation.   
 
“One interviewee said that they didn’t use the stickers, as 
they are Hep C positive” 
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“The two people interviewed thought that the stickers were a 
good idea but we had some discussion as to whether or not 
they stuck” 
 
“One interviewee said that he had been infected with Hep C 
after using his syringe in company and that he wished the 
syringes had been about years ago. He felt that the stickers 
should be available in multi coloured packs.” 
 
 
Theme Three: Identity 
This theme was multidimensional and contained a number of subcategories that 
centred on the researcher role that was being performed by the peer researchers. These 
subcategories included, trust, responsibility, role identity, view of self, unsolicited 
contributions to the research and perceptions. 
 
“I felt a lot of trust was given to us as we got to sit in the 
consultation room that had a lot of stock lying about in it. 
This trust shown to us made me feel really good about 
myself” 
 
“Staff were nice and came over to ask me how things were 
going and if I would like a cup of tea, felt like a member of 
the team” 
 
“Staff gave us a key for the store room which made us feel 
really trusted” 
 
 
In addition to the recorded observations and unsolicited comments, the production of 
a set of recommendations by the group can be considered within this theme as an 
example of how they perceived their identity and acted on this as researchers 
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throughout the evaluation. This view of themselves and the development of their 
extended role as researchers are examined further in the summary below. 
 
Theme Four: Practical Difficulties. 
With theme four there is a direct link to theme one, which deals with the physical 
aspects of the research setting where theme four is viewed in terms of the operational 
aspects of the peer researcher role and their reactions to the practical difficulties 
encountered during the daily conduct of the research. 
 
“Chemist even quieter today. Really disheartening” 
 
“We both felt a bit depressed. Nothing to report except no-one 
accessed the needle exchange in the time we were there.” 
 
“Much the same as previous days. A bit frustrated as the 
pharmacist said three people had accessed the exchange before I 
arrived”. 
 
Despite the difficulties that were recorded the entire group of six peer researchers 
completed their part in the evaluation and there were no absences during the data 
collection period. 
 
Theme Five: Observations. 
The peer researchers made a number of observations. These could be broken down 
into two sub sections. The first related directly to the research itself.  
 
“Questionnaires completed were straightforward although 
sensed that people weren’t overly impressed with the stickers 
as they all said that they used on their own always” 
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“Overall the day went without any problems and most people 
were very positive about the stickers” 
 
The second interesting strand that emerged from further study of the field work diaries 
was that the peer researchers also made observations and commented on areas beyond 
the immediate requirements of the evaluation questionnaire. These are illustrated by 
the quotes below and show that the observations related to other activities that were 
taking place in and around the pharmacy. 
 
“Felt that some people were conscious that other people could 
over hear them in the shop” 
 
“Noticed today that some people were going away with more 
than one pack”  
 
“I feel methadone users are getting someone to come in for a 
pack then they are sharing it out as they don’t want to ask for 
it because they collect their methadone there. I have observed 
a few people getting their meth and then waiting about or 
coming back later with someone else who uses the needle 
exchange. They then leave and hang about outside for a few 
minutes before going in separate directions”  
 
 
 
Theme Six: Communication.  
Communication is closely linked to Theme Two (Relationships and Interactions). 
There were numerous examples of ongoing communication between pharmacy staff 
and the peer researchers and between the peer researchers and the interviewees. 
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Examples of the types of communication between the peer researchers and the people 
they interviewed are shown below. 
“The two people interviewed thought that the stickers were a 
good idea but we had some discussion as to whether or not 
they stuck” 
 
“One drug user commented on why not just put the stickers in 
the pack instead of wasting money on the pilot study”  
 
“One client spoke after the interview about the reasons why 
he doesn’t have to mark his syringe. He says he always uses 
alone and that the stickers wouldn’t be any use to him” 
 
Effective communication is essential in the conduct of the research and in establishing 
effective working relationships. This was a prominent feature of this work as the 
evaluation was conducted in busy community pharmacies by a group who would not 
normally operate within this setting, making the need for effective communication of 
prime importance if the evaluation was to be completed successfully. There were 
numerous examples, shown below, of the communication between the regular staff 
and the peer researchers.   
 
“Spoke to a member of staff who said we missed 35 service 
users on the afternoon of the 27
th
. Informed us that the needle 
exchange is a bit of a hit and miss” 
 
“Pharmacist said that the previous day had been really busy 
at the needle exchange. She thought that maybe drug users 
had been paid the previous day” 
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All of the above themes are multidimensional as shown in Appendix 10. Further 
reviews of the diaries demonstrated the close relationships amongst the themes. The 
core concept that emerged linking the themes was one of identity. There is no clear 
universal concept of identity in modern sociology. However, the concept has been 
used “widely and loosely in reference to one’s sense of self and one’s feelings and 
ideas about oneself” (Scott and Marshall, 2009). For the analysis of the field work 
diaries the concept of identity relates to the role identity as researchers, particularly as 
participant observers in the research process, and the perceptions, reactions and 
interactions of the SUIG members that appeared to confirm their evolvement from 
basic data collectors into full participants in the researcher and observer roles. It also 
relates to their own perception and reflections on the role they performed and how this 
affected their self identity within the setting and how this was affected by interactions 
with the pharmacy staff.   
 
Although, as mentioned previously, it was not possible to confirm any theories that 
emerged from analysis of the field work diaries there are other pieces of evidence that 
support the conclusions. Informal feedback was sought from the pharmacists who 
participated in the evaluation. Despite the fact that no payments were made for their 
participation, all allowed the research to continue and accepted the involvement of the 
SUIG members on an equal basis as co-participants in the research. It is important to 
note that there were no reports from the pharmacists of any adverse impact that the 
peer researchers may potentially have had on the day to day operation of the 
pharmacy. If any problems had arisen it was possible for the pharmacists to 
immediately refuse continued access. This did not occur and the principle researcher 
received no negative reports on the peer researchers’ activities. This would appear to 
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support the view that the identity of the SUIG members was accepted and that they 
functioned effectively in the researcher role. It would also corroborate the positive 
comments that illustrated that the effective two way communication and 
establishment of good working relationships was a reality. It would not have been 
possible for the peer researchers to have completed the questionnaires if interactions 
and rapport with both staff and participants had not been successfully achieved. This 
indicates that the role performed by the peer researchers was identified and accepted 
as a research function. 
 
The group also produced a set of recommendations that “outlines the views of the 
peer researchers on lessons, which can be learned, from the pilot study before the 
scheme should be rolled out to other community pharmacy based needle exchanges” 
(Field Work Diary). As these recommendations were not a requirement of the original 
peer research role, this is another illustration of the extension of the role identity that 
developed during the course of the evaluation to the stage where the group had the 
confidence in their own experience and role within the process to offer these 
recommendations. The recommendations from the field work diary are produced in 
full and listed below.   
 
Recommendations  
The Glasgow Involvement Group have agreed on the following 
recommendations to be taken in to consideration before the stickers should be 
supplied on a routine basis in Glasgow. 
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 There is a need for staff to ensure that drug users are informed that stickers 
should be used to mark all paraphernalia and not just needles. This should be 
reinforced by information in the packs. 
 Information on the scheme should be made available in prisons before people 
are liberated so they are aware of the changes and purpose of the stickers. 
 Peer education should be used to ensure that people not directly accessing the 
needle exchange are clear to the purpose of the stickers. 
 Peer education would also benefit people who want to spend as little time as 
possible in the pharmacy to ensure that they are aware of the purpose of the 
stickers. 
 Information has to be included on safer injecting for people already Hep C 
positive 
 
These recommendations confirmed the results of the questionnaire and were 
consistent with many of the comments made by the respondents. It also reflected the 
group’s own analysis based on their personal experiences, expert knowledge, 
observations during the data collection period and on the results of their own 
interactions with the survey participants.  
 
3.6 Summary 
 
In summary there are a number of practical and ethical issues associated with the 
involvement of service users in any form of research. It has been demonstrated that 
“involving service users in research must be done both with integrity and due 
diligence or it can, and does, cause as much harm as good to all involved” 
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(McLaughlin 2009:40). For this evaluation the potential benefits of incorporating 
service users in the research were considered alongside any potential adverse effects 
both for the evaluation and for the service users themselves.   
 
Previous experiences of involving service user interviewers in the research process 
and the evaluation of services has shown that “user researchers bring a new and 
different perspective, which generates new ideas and constructs and enhances the 
quality of the whole research process” (Godfrey, 2004:229). In the syringe marker 
evaluation the incorporation of service users made a positive contribution and 
enhanced the work of the academic researcher by introducing additional new 
dimensions. The incorporation of SUIG members into the data collection role 
inevitably meant that the researcher was “distanced from the raw data they collected” 
coupled with the ethical implications due to concerns about “benefiting from their 
skills and experiences without exploiting their labour” (Elliot et al, 2002:173). 
Despite these concerns the decision to use members of the SUIG and their 
contribution appeared to have enhanced the final evaluation.  
 
In a related research study when peer researchers were asked for their perspectives 
about their involvement in the research effort the “findings indicated that these 
community members felt their participation was a positive experience” (Jason et al, 
2006:14). The SUIG members in the syringe marker evaluation reported similar 
positive experiences directly related to their participation as illustrated by the 
following quote from the fieldwork diary. 
 
“Staff very friendly and helpful. I felt a lot of trust was given to 
us as we got to sit in the consultation room that had a lot of 
 120 
 
stock lying about in it. This trust shown to us made me feel 
really good about myself”   
 
In 1993 Griffiths and colleagues had utilised the expertise of drug users as “privileged 
access interviewers” in a qualitative study to access heroin users not in contact with 
treatment services (1993:1617). The results of this early work incorporating peers as 
part of the research team had demonstrated the need to establish “supportive and non 
exploitative relationships with the interviewer team” (Griffiths, Gossop, Powis et al, 
1993:1617). Throughout the syringe marker evaluation there was an awareness, not 
only of the vulnerable nature of the participant group but also of the need to provide a 
supportive, non exploitative environment for the service users involved in the 
research. Only by providing this type of environment is it possible for peer 
researchers to function with maximum effectiveness.    
 
As outlined in the literature review in Chapter 1, NEX is a harm reduction 
intervention delivered within a health care setting. The aim of this evaluation was to 
critically evaluate the feasibility of extending a new initiative, syringe markers, 
supplied through community pharmacies. It is impossible to divorce this type of 
initiative from its “ethical, legal and social contexts” (Pauly, Goldstone, McCall et al, 
2007:19). Pauly and colleagues also highlighted that extensive evidence existed to 
support implementation of harm reduction strategies but cautioned that “scientific 
knowledge alone” was insufficient to ensure the introduction of harm reduction 
strategies across a range of health-care settings (Pauly et al, 2007:19). For this reason 
the views of the peer researchers on the use of syringe identifiers and their reflections 
on their participation in the evaluation had particular relevance and importance in the 
development of the service as part of their contribution was based on utilising their 
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personal experiences and expertise to augment the scientific dimensions of the 
research.    
 
The field work diary was originally intended merely to be a practical daily record by 
the SUIG members of the time spent in each pharmacy, number of completed 
questionnaires and the number of refusals. As discussed above, this gradually evolved 
into a document that recorded their views on the researcher role, their feelings and 
perceptions and also of their wider observations made during the time spent in the 
pharmacy. Effectively the interviewer role had extended to incorporate one of 
observer where it is “essential to record your personal impressions and feelings” 
(Gilbert, 2003:153). The interviewers recorded subjective details of the interviews, 
their perceptions and impressions of the process and the setting and observations 
relating to syringe markers in the wider context of the NEX and the pharmacy setting.    
 
In summary, for the syringe marker evaluation, the use of peer researchers to 
administer the structured questionnaire and their wider contribution helped to ensure 
that, in accordance with the recommendations made by Clark and colleagues, the “end 
product doesn’t merely reflect professional or academic considerations but is 
grounded in the reality of those who regularly navigate the health and social care 
system” (2005:34).  
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Chapter 4 
 
Findings 
 
4.1 Introduction 
 
This chapter will discuss and analyse the responses to the questionnaire and attempt to 
uncover any patterns of association. The findings, including feedback from 
participating pharmacists, are explored. The questionnaire and the syringe marker 
Instruction Card are shown in Appendix 8 and 6. In total, 177 questionnaires were 
completed during the second, data collection phase of the evaluation. Details of the 
number of completed questionnaires from each site are shown in Table 4.1. Pharmacy 
1 recorded the highest number of responses across the 3 sites with 48%, (n=86) of the 
total being completed in this pharmacy. Twenty seven percent, (n=47) attended 
Pharmacy 2 and 25% (n=44) of the responses were collected from Pharmacy 3. 
 
  Table 4.1.  
Completed Questionnaires 
 
 Completed 
Questionnaires 
Pharmacy 1 86 (48%) 
Pharmacy 2 47 (27%) 
Pharmacy 3 44 (25%) 
Total 177 (100%) 
         
 
The gender distribution of respondents is shown in Table 4.2. The male respondents 
ranged from 79% to 83% (average, 80%) and the female proportion was 17% to 21% 
(average, 20%). 
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Table 4.2.  
Gender Distribution 
 
 Male 
Respondents 
Female 
Respondents 
Totals 
Pharmacy 1 68  (79%) 18  (21%) 86 (100%) 
Pharmacy 2 39  (83%) 8   (17%) 47 (100%) 
Pharmacy 3 35  (80%) 9   (20%) 44 (100%) 
Totals (3 sites|) 142 (80%) 35 (20%) 177 (100%) 
 
As discussed in Chapter 2, the central database gives details of the characteristics of 
those routinely attending all sites including the 3 pharmacies in this study where the 
percentage of male attendees for the three evaluation sites (rounded to the nearest 
whole number) was 76%, 80% and 78 % respectively. Examination of the 
characteristics of all sites in the health board area show that the gender breakdown of 
those attending is 78% male and 22% female. From this data there is no indication 
that there is any major deviation in the ratio of the sample numbers of males and 
females interviewed in the three sites compared with the pattern of attendances that 
are routinely recorded at the three sites and at all other sites in the health board area. 
Although not conclusive, these are strong indications that the strategies employed in 
the design of the evaluation resulted in the sample interviewed being representative, in 
terms of gender, of the population from which it was drawn.    
 
Respondents were asked about their current housing status. This question was 
included to collect information on the relative stability of the home environment and 
to investigate if housing status affected syringe identification and use of the markers. 
The majority claimed to be in relatively stable accommodation with 60% (n=107) 
recorded as living in accommodation which was their “own tenancy” and a further 
23% (n=40) were resident in the “care of another”. The responses to less stable 
options were as follows; “temporary furnished flat” 7% (n=12), “hostel” 5% (n=9), 
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“supported accommodation” 3% (n=6), “roofless” 1% (n=2) and one respondent had 
no fixed abode. It should be noted that it is not possible from these responses to 
identify if others living in shared households were drug users. 
 
The main focus of the questionnaire was on information gathering, directly related to 
evaluation of the syringe marker supply. However it contains a number of variables 
that can be used to investigate potential associations. The results of this analysis may 
assist with planning service developments and refinements to the current intervention 
in the future.  
 
Three potentially relevant independent variables (IV) were identified. These were, 
gender, length of time injecting and housing status. For the latter two a further 
subdivision using gender was undertaken where possible. From the questionnaire the 
relevant dependent variables (DV) selected were: current syringe identification (Q3a), 
mixing up syringe with some one else’s in the past year (Q4), use of the markers 
(Q2.2), usefulness of the markers as a method of syringe marking (Q3.1) and 
usefulness of the instruction card (Q4.2). Additionally it was anticipated that there 
may possibly be a relationship with the group of IDUs who reported that they 
currently identified their syringe with those who reported use of the markers. A series 
of null hypotheses were developed using combinations of these variables.  
 
Chi squared tests were used to establish whether there was any significant relationship 
between the two variables. The chi squared test assumes that the expected value in 
each cell will be > 5 for 80% of the cells. If this condition was not met a Fisher’s 
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exact test was used as this can be utilised when > 20% of the cells have expected 
counts of less than 5 (Bruce, Pope and Stanistreet, 2008).    
 
When those who had been supplied with the markers were asked if they had used 
them, 49 of the 132 IDUs who had been supplied did not use them. This represents 
37% of the total 132 IDUs supplied with markers and is a significant minority. It is 
possible that the results obtained from utilising the use of markers as the DV with 
gender, length of time injecting and housing status as IVs will give an insight into any 
potential differences that may exist between those who were supplied with markers 
and used them and those who were supplied but did not use them. It is also important 
to compare the characteristics of this group (n=49) to attempt to uncover if there are 
any underlying differences that may be relevant when compared with the group 
(n=83) of IDUs who did report using the markers.  
 
4.2 Refusal Rates. 
 
 During the data collection phase, a total of 221 IDUs attending the needle exchange 
were approached to complete the questionnaire. One hundred and seventy seven 
participated and the breakdown of completed questionnaires and refusals for each 
individual site are shown below in Table 4.3.  
Table 4.3. 
 Refusal Rates by Pharmacy 
 
 Completed 
Questionnaires 
Refusals Total number of 
individuals 
approached. 
Pharmacy 1 86  (88%) 12  (12 %) 98 (100%) 
Pharmacy 2 47  (65 %) 25  (35 %) 72 (100%) 
Pharmacy 3 44  (86 %) 7   (14 %) 51 (100%) 
Total ( 3 sites) 177 (80%) 44 (20%) 221(100%) 
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The high refusal rate for pharmacy 2 is worth noting and investigating further. In 
Pharmacy 2 refusals represented 35% of those approached when compared with 12% 
and 14% in the other two sites. As shown in Chapter 2 the population characteristics of 
those attending each pharmacy are similar across the 3 sites and the characteristics of 
the evaluation sample are similar to the population of IDUs across the health board who 
attend needle exchanges. Similarly, the six interviewers remained the same and rotated 
across the three pharmacy sites over the 4 week period and this is therefore unlikely to 
have been a factor contributing to the higher refusal rate in Pharmacy 2. The reasons for 
refusals were recorded in the fieldwork diaries. Examination of the field work diaries 
showed that the reasons given for refusal were consistent across all three sites. The 
reasons given by those approached concerned lack of time or having previously 
completed the questionnaire as illustrated by the quotes below. 
 
“One drug user couldn’t take part as they had a taxi 
waiting” 
 
”Three refusals as one had already completed the study; 
one was in for a starter pack. The third refusal was in a 
hurry” 
 
“One person refused as they had to catch a bus” 
 
“Two people had already completed the survey and two 
people refused as they said they were in a hurry” 
 
On further investigation it was found that there were structural differences in the 
pharmacy premises and the NEX layout in Pharmacy 2 that may potentially have 
contributed to the higher refusal rate. In this pharmacy the SUIG members were based 
in a separate consultation room which was also used as the base to administer the 
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questionnaire. Because of the separation and distance from the NEX the SUIG 
members were dependent on the pharmacy staff to direct potential participants to 
them. Unlike the other two pharmacies this meant that the initial approach was from a 
member of the permanent staff and not from one of the peer researchers.  This was 
illustrated by the following quotes from the fieldwork diary of pharmacy 2. 
 
“Felt a lot more isolated in this pharmacy as we couldn’t see 
from the consultation room what was happening and were relying 
on staff to inform people using the needle exchanges of our 
presence” 
 
“Joe spoke to the people coming in and directed them to us” 
 
 
In the absence of any other identified explanatory factors it is possible to speculate 
that the reason for the higher refusal rate in pharmacy 2 is related to the fact that the 
initial approach was made by a member of the pharmacy staff and not by one of the 
peer interviewers. This situational problem had not been identified in the early stages 
as a potential issue but is an illustration of the problems associated with conducting 
any type of research or evaluation in a real life setting as discussed in Chapter 2. Any 
researcher in this type of scenario has to be flexible to adapt to the setting and to 
actively work to reduce any adverse effects their presence may cause whilst still 
maintaining the integrity of the research being undertaken. Despite the difficulties 
posed by the environment of Pharmacy 2, the peer interviewers were able to adapt and 
successfully completed 47 questionnaires, which constituted 27% of the total 
interviews conducted across the 3 pharmacies, in less favourable circumstances. The 
existence of the high refusal rate and the proposed explanation that it was due, at least 
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partly, to the initial approach being made by staff would seem to support the original 
decision to use peer researchers instead of permanent staff to increase the response 
rate by reducing any perceived interviewer bias. The respondents were all involved in 
illegal and potentially harmful behaviours and it was anticipated that the use of peer 
interviewers would be likely to increase their willingness to participate. It would also 
appear to confirm the findings from previous research where the experience of peer 
interviewers was used with drug using parents and which concluded that there needs 
to be a recognition that peer interviewers bring unique skills and also that acceptance 
and learning to work alongside individuals with this type of expertise is valuable 
despite the challenges this presents for traditional researchers (Elliott, Watson and 
Harries, 2002:177). It would appear that the skills of the peer researchers in this 
evaluation were effective, even in the pharmacy that posed the greatest practical 
challenge.   
 
4.3 Questionnaire Responses  
 
The Questionnaire was divided into four main sections and collected information 
under the following headings; personal information and injecting pattern, syringe 
markers, the use of the markers and the instruction card.  
 
            4.3.1  Personal Characteristics and Current Injecting Practices 
 
In response to questions on length of time injecting and on the types of drugs injected 
it was found that the majority of individuals injected opiates (80%, n=140, Figure 
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4.1(a) ) most often and that 36% of the total (n=64, Figure 4.1 (b) ) had been IDUs for 
11 years or more.  
  
  
Figure 4.1 (a): What do you inject (most often)? 
 
 
 
 
Figure 4.1 (b): How long have you been injecting? 
                                                               
 
These results would indicate that those interviewed were likely to be a representative 
sample of the injecting drug using population who routinely accessed needle exchange 
services. When asked to further elaborate, 11%, (n=19) of those who responded 
“other”, reported combinations of drugs injected which included opiates. The full list 
of “other” responses were “stimulant and opiates”, “steroids and opiates”, “stimulants, 
opiates and valium” and “valium and opiates”. When these additional 19 responses 
that involve opiate injecting are added to those who recorded single opiate injecting 
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this gives 89% of the total injecting opiates, (n=159).  This is in line with the reported 
drugs of injection recorded on the central database, shown Table 2.1 (p64), where the 
normal pattern for the three pharmacy sites for opiate injecting ranged from 85% to 
88% (average 86%). The central database records that for all health board sites, 85% 
of those attending report injecting opiates. The central data base records the whole 
population of IDUs who attend a NEX and not merely a sample of those attending. 
The figures for the population were taken from the 2003-2007 databases where only 
single drug use was recorded. Current database developments now record additional 
information including combinations of drug use, housing status and frequency of 
injecting in line with the recommendations of the Scottish National Injecting 
Equipment Providers (IEPs) Guidelines on Best Practice (Scottish Government, 
2010).     
 
Respondents were asked if they currently identified their syringe. The responses 
recorded that the majority of individuals (58%, n=102) did not currently identify their 
syringe. For those that did (42%, n=75), the most popular techniques of doing so were 
to “burn” it (39%, n=29), “scratch” it (24% n=18) or “mark” it (23%, n=17). It should 
be noted that this question was asked in the context of a NEX service where the safe 
injecting advice provided promotes the use of clean needles for each injecting episode 
and advises against the reuse or sharing of any injecting equipment. Despite this, a 
substantial number (42%, n=75) reported currently marking their syringes, giving an 
indication that they had recognised that they were likely to be exposed to practices 
and situations where there was an increased risk of BBVs and related infection 
transmission.  The response options to this question were limited to three following 
discussion and advice from the peer researchers. These response options were “burn”, 
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“scratch” and “mark”. This appears to have been successful in capturing the majority 
of the responses, as only (14%, n=9) recorded “other” as an option. The 9 “other” 
responses are shown below in Table 4.4 and demonstrate the range of different 
inventive means reportedly employed to identify personal syringes. They also 
illustrate that despite being recorded as “other”, with the exception of “carry it about”, 
all of the responses could have been captured in the three options given in the 
questionnaire.  
 
Table 4.4   
“Other” methods of current syringe identification. 
 
Burn Scratch Mark None of the 
three options 
offered. 
Both burn and 
scratch 
Both burn and 
scratch 
Bite top of 
plunger 
Carry it about 
Scrape the 
numbers off the 
syringe 
Bite  
 Chew end 
Clip the top of 
it 
Cracks the end 
of it 
Mark the 
number 
 
 
The responses to the questions about syringe identification validated the premise of 
the evaluation that this is a subject of practical relevance and one that is open to 
further research and investigation as it confirms that attempting to identify syringes is 
an existing practice. In 2004, Taylor and colleagues published a ground breaking 
study in the UK involving in-depth observational study of injecting practices of IDUs 
in Scotland (2004). The setting for this research was the IDU’s own environment and 
the injecting practices were observed and video recorded (Taylor et al, 2004). 
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Through the course of this observational work the researchers had noted that 11 of the 
48 observed injecting episodes demonstrated  a variety of different methods being 
used to identify injecting equipment. These observed methods were described as 
“burning the plunger end of the syringe, scraping the units on the side of the syringe 
and pulling the plunger down” (2004:18). The fact that the responses to questions on 
current methods of identification in the present study are in accordance with the 
previous Scottish observational study would tend to indicate that the reported 
responses are an accurate reflection of actual practice.  
 
The results of cross tabulation of current syringe identification with gender, length of 
time injecting and housing status are shown below in Tables 4.5 and 4.6 
 
                                                      Table 4.5  
                                Current Syringe Identification by Gender 
 
Do you currently 
identify your syringe? 
Male Female Total 
YES 59 (42%) 16(46%) 75(42%) 
NO 83(58%) 19(54%) 102(58%) 
Total 142(100%) 35(100%) 177(100%) 
N= 177, Chi squared = 0.199, 1 degree of freedom, p=0.66,  not significant. 
 
The difference between men and women in terms of whether or not they currently 
identified their syringe was not statistically significant. It cannot be established from 
these results whether men or women are more or less likely to be currently marking 
their syringes. This would tend to support the assertion that for this group of 
respondents, men and women were equally likely to make attempts to mark their 
syringes.   
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For the independent variable, length of time injecting, the original question offered 
five possible responses. These were: <1 year, 1-2 years, 3-5 years, 6-10 years and 11+ 
years. Inspection of the raw data showed that the numbers in some of the categories 
were small and these categories were therefore collapsed into 3, which were 0-5 years, 
6-10 years and 11+ years.  
 
Table 4.6   
Current Syringe Identification by Length of Time Injecting 
 
Do you 
currently 
identify your 
syringe? 
How long have you been injecting? Total 
0 - 5 years 6 - 10 years 11 years + 
Yes 37 (49%) 17 (46%) 21 (33%) 75  (42%) 
No 39 (51%) 20 (54%) 43 (67%) 102 (58%) 
Total 76 37 64 177 
 
N=177, Chi Squared 3.829, 2 degrees of freedom, p=0.15, not significant. 
 
The null hypothesis, stating that current syringe identification is not dependent on the 
length of time injecting, cannot be rejected. The results indicate that current syringe 
identification is not dependent on the length of time that an IDU has been injecting. 
However from the figures above it can be seen that for those injecting for a period of 
0-5 years, 49% currently identified their syringe, for the 6-10 year group 46% 
identified their syringe and for the 11 years plus group, this figure fell to 33%. 
Although not shown to be statistically significant, this may potentially indicate 
evidence of an emerging trend. To investigate further length of time injecting was 
collapsed into two categories, 0-10 years and 11+ years. This gave a Chi Squared 
value of 3.752 (1df), p=0.053 which just failed to reach the level of statistical 
significance. However this value is approaching the critical value for Chi Squared 
(1df) of 3.84 and at the 90% significance level it is significant. Although this does not 
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provide definitive evidence that the longer an IDU has been injecting the less likely 
they are to make attempts to identify their syringes, it does indicate an area that is 
worth further exploration. These results illustrate the view of Garner who claims that 
bivariate analysis of this type tends to pose further questions (2005). 
 
A further subdivision into male and female respondents was undertaken to investigate 
if gender and length of time injecting were associated with current syringe 
identification. This is shown in table 4.7 
 
                                                   Table 4.7. 
        Current Syringe Identification by Length of Time Injecting and Gender 
 
Do you currently 
identify your 
syringe? 
How long have you been injecting? Total 
0 - 5 
years 
6 - 10 years 11 years + 
        Male            Yes                 
 
                              No 
31(48%) 
 
12(40%) 16(34%) 59 
34(52%) 
 
18(60%) 31(66%) 83 
Total 65 30 47 142 
         Female        Yes                 
 
                               No 
6(54%) 
 
5(71%) 5(29%) 16 
5(46%) 
 
2(29%) 12(71%) 19 
Total 11 7 17 35 
Male, N=142, Chi Squared 2.130, 2 degrees of freedom, p=0.34, not significant.  
Female, N= 35, Chi Squared 4.031, 2 df, p=0.13, p ≥0.05 not significant, (p ≤0.10, 
significant), however, 2 cells (33.3%), have an expected count less than 5. 
 
This appeared to indicate that there was a possibility that a negative association 
existed between women who marked their syringe and length of time injecting i.e. the 
longer they had been injecting the less likely they were to identify their syringes. 
Collapsing the data for men and women further found that the only significant 
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association to emerge was for women grouped into the 0-10 years and the 11+ year 
groups shown below in Table 4.8 where a significant association at the 90% level was 
demonstrated. To account for the number of cells with an expected count of less than 
5 from Table 4.7 (female) a Fisher’s exact test was carried out where the length of 
time injecting was contracted from the original 5 responses to two categories. Length 
of time injecting was dichotomised in the two ways described above (0-5 years and 6+ 
years) and (0-10 years and 11+ years).  
 
                                                        Table 4.8  
       Current Syringe Identification by Length of Time Injecting (Female) 
  
FEMALE 
 
Do you currently identify your 
syringe? 
How long have you been injecting? 
0 - 10 years 11+ years Total 
Yes 11 (61%) 5 (29%) 16 (46%) 
No 7  (39%) 12 (71%) 19 (54%) 
Total 18 17 35 
N=35, Chi squared 3.540, 1 degree of freedom, p=0.06 not significant, (p≤ 0.10, 
significant). 
 
Although it is possible to speculate that evidence is emerging to indicate that current 
syringe identification is negatively associated with the length of time injecting and 
that this is more evident for women than men it is difficult to draw any meaningful 
conclusions from these results. A significance level of p≤0.10 accepts that as many as 
10 in 100 cases might demonstrate a relationship that does not exist in the population 
and increases the likelihood of Type 1 errors (Bryman, 2004: 238). Bearing this in 
mind the results shown in Tables 4.7 and 4.8 should be viewed with caution and 
considered as tentative early indications of a relationship. It is possible that stronger 
associations may have existed if, for example, more women had been recruited and 
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increased options, consisting of shorter time periods of length of time injecting, had 
been recorded to attempt to uncover subtle changes over time and between genders.   
 
Reviewing the responses to the five options on housing status showed that the 
majority responded either as living in their own tenancy or staying care of an 
individual. A decision was made to reduce this from five to three categories for 
analysis. These were own tenancy, staying care of an individual and a third category 
of “other” that incorporated the replies to the remaining five categories. This 
amalgamated together the smaller number of individual responses into categories that 
can be considered to reflect less stable accommodation.  
 
                                                      Table 4.9  
                             Current Syringe Identification and Housing Status 
 
 
 
Do you currently identify 
your syringe? 
What is your current housing status? 
 
Total 
Own 
tenancy 
Staying 
care of an 
individual 
Other(s) 
Yes 46 (43%) 17 (42.5%) 12 (40%) 75 (42.4%) 
No 61 (57%) 23 (57.5%) 18 (60%) 102 (57.6%) 
Total 107 (100%) 40 (100%) 30 (100%) 177 (100%) 
N=177, Chi squared 0.086, 2 df, p=0.96, not significant. 
 
From this analysis there is no indication that identification of syringes is influenced 
by, or associated with, housing status. However caution should be exercised in 
interpreting these results as the majority of IDUs (107 of the total 177 interviewed) 
reported living in their own tenancy. It is known that IDUs in unstable housing 
situations tend to participate in more risky injecting practices (Briggs, Rhodes, Marks 
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et al, 2009). Only 3 respondents of the 177 total reported that their housing status was 
roofless or of no fixed abode. It is therefore possible that there is an under-
representation of IDUs in less stable housing situations and that this may have 
influenced the result. 
 
Despite the finding that there is no association between current syringe identification 
and housing for the respondents as a whole it is possible that there may have been 
over or under representation of males or females in individual categories. For this 
reason a further subdivision by gender was undertaken to investigate if the 
relationship between housing status and syringe identification differed by gender. The 
results are shown below. 
 
                                                           Table 4.10  
               Current Syringe Identification and Housing Status by Gender. 
 
Do you currently 
identify your 
syringe? 
What is your current housing status? Total 
Own 
tenancy 
Staying care 
of an 
individual 
Other(s) 
        Male            Yes                 
 
                              No 
36 (41.4%) 
 
14 (45.2%) 9 (37.5%) 59 (41.5%) 
51 (58.6%) 
 
17 (54.8%) 15 (62.5%) 83 (58.5%) 
Total 87 (100%) 31 (100%) 24 (100%) 142 (100%) 
         Female        Yes                 
 
                               No 
10 (50%) 
 
3 (33.3%) 3 (50%) 16 (45.7%) 
10 (50%) 
 
6 (66.7%) 3 (50%) 19 (54.3%) 
Total 20 (100%) 9 (100%) 6 (100%) 34 (100%) 
Male, N=142, Chi Squared 0.330, 2 degrees of freedom, p=0.85, not significant. 
Female, N=35, Chi Squared 0.748, 2 degrees of freedom, p=0.69 not significant. (4 
cells (66.7%) have expected count less than 5). 
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The results shown in Table 4.10 show that when examined individually by gender  
syringe identification was not shown to be dependent on housing status for males or 
females.  
 
When asked whether they had mixed up their syringe with someone else’s in the past 
year, 78% (n=138) of respondents reported they had never done this, 13% (n=23) 
reported having done so rarely, 6% (n=11) said that they had done so occasionally, 
2% (n=4) said they had done so often and 1% (n=1) said very often. The responses to 
this question need to be interpreted with caution as the question does not record any 
information on mixing up of syringes that is unknown to the respondent. It should be 
noted that this does not refer to deliberate or planned sharing through other injecting 
practices which constitutes an additional hazard in the preparation and administration 
of illicit drugs.  The figures also need to be viewed in the context that the questions 
deal with sensitive subjects such as illegal drug use where there will be a high 
possibility that this can result in under reporting (Gilbert, 2003). Despite this the 
responses indicated that, 22% (n=39) of the total sample were aware of, and prepared 
to admit to having personal experience of, the known risk related behaviour of mixing 
up their syringe with another’s. It was reported in a study of those who had prepared 
drugs for injection in the previous month that 18% reported using someone else’s 
needle and syringe (White et al, 2007). The observational study carried out in 
Glasgow in 2004 showed that even when individuals claimed not to share injecting 
equipment, the complexity and chaos of the circumstances surrounding the actual 
preparation highlighted potential ways of inadvertent sharing and participants in the 
study reported that they could have unintentionally used a syringe that was not their 
own in error (Taylor et al, 2004). This study showed that these problems could occur 
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when IDUs were living together as this resulted in needles and syringes being stored 
in a communal space within the residential setting, leading to potential confusion over 
the ownership and usage of individual needles and syringes leading to difficulties in 
distinguishing their own syringe (Taylor et al, 2004).   
 
There is existing evidence to indicate that the social context of the drug preparation 
and injecting environment has an impact on and can affect the extent of inadvertent 
sharing. In a study conducted in Dublin, a city which has similar demographic 
characteristics to Glasgow, it was found that there was evidence to suggest that 
“accidental and unnoticed sharing” was a possible contributory factor that led to 
increased infection risks for IDUs (Smyth et al, 2005:166). Based on the evidence of 
previous research in Glasgow and Dublin it is therefore reasonable to assume that the 
22% (n=39) who responded in the evaluation that they had experience of mixing up 
their syringe with someone else’s in the last year is likely to be an underestimate of 
the true numbers at risk of infection due to the combined risks of known and unknown 
sharing. If it is assumed that the respondents in the evaluation are representative of the 
wider population of drug injectors where this is estimated to be between 7,091 and 
11,330 then the figure of 22% (n=39) can be extrapolated to suggest that in the region 
of 1560 to 2493 individuals are aware of mixing up their syringe with someone else in 
the last year (Hay et al, 2009:32). These extrapolated figures are speculative; however 
they do demonstrate that due to the size of the overall injecting population, even small 
percentages can represent significant numbers of IDUs who are likely to be affected 
by inadvertent sharing. If it is accepted that the factors outlined above demonstrate 
that there is an underestimation in the actual numbers sharing then it can be seen that 
the extrapolated figures potentially underestimate the true extent of the problem. It 
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should be noted that these figures relate solely to individual IDUs and not to the 
number of injecting episodes.  The evaluation responses indicated that, despite the 
likely underestimation discussed above, 22% reported mixing up their syringe with 
others and 42% currently used a range of methods to identify their own syringes. It 
appears logical to assume that the 42% who report marking their syringe have 
identified, and are responding to, perceived risks related to their own injecting 
practices and environment. It is therefore possible to speculate that the true incidence 
of sharing when both known and unknown sharing is combined will be greater than 
the numbers recorded. 
 
There are undoubted difficulties around quantification of the full extent of the 
problem. However the responses from the questionnaire do indicate that the 
intervention (syringe marker supply) is a relevant one for IDUs, as it is aimed at 
addressing what has been identified as an actual, and not merely a theoretical, aspect 
of illicit drug injecting practice. 
 
To respond to the question on whether respondents were aware of having mixed up 
their syringe with someone else’s in the past year, five response options were 
available. These were very often, often, occasionally, rarely and never. Investigation 
of the data showed that 161 of the 177 respondents (91%) answered never or rarely to 
this question. It was therefore not possible to establish any meaningful associations 
using mixing up of syringes as the DV and the IVs of length of time injecting and 
housing status. It would appear that this question is insufficiently sensitive to be used 
as the DV to uncover any patterns associated with previous mixing up of syringes. It 
should be noted that this question did not cover unknown mixing up of syringes and it 
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is possible to speculate that a number of those who responded never will include those 
who were unaware of any mixing up of their syringe with others.   
 
4.3.2  Use of the Markers 
 
One of the important unknown factors discussed in Chapter 2 was the design problem 
related to the timings of the supply of syringe markers and the length of the second 4 
week period of data collection to ensure that the potential respondents had been 
exposed to the intervention and had had the opportunity to use the markers in practice. 
In the second section of the questionnaire 75% (n=132) of the 177 respondents 
interviewed indicated that they had been supplied with the syringe markers to trial, 
with 63% (n=83) of the 132 individuals having used the markers. The 83 individuals 
who were recorded as using the markers constituted 47% of the original 177 
respondents. The relatively high percentage of individuals interviewed, 132 of the 177 
(75%), who had been supplied with the markers was a positive confirmation of the 
success of the strategy employed to address the time and interviewer availability 
factors. If there had been no staffing or funding restrictions then it would have been 
possible to continue with the supply of markers and the data collection for an 
indefinite period until the coverage was such that 100% of those approached for 
interview had been supplied with the syringe markers.  
 
A series of cross tabulations was undertaken with use of markers as the DV to 
investigate any potential associations with IVs from the questionnaire responses. The 
findings are shown below in Tables 4.11 to 4.18. 
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                                                    Table 4.11  
                                       Use of Markers and Gender 
 
Did you use the 
markers? 
Gender Total 
Male Female 
Yes 64 (62%) 19(68%) 83 (63%) 
No 40 (38%) 9 (32%) 49(37%) 
Total 104 (100%) 28 (100%) 132(100%) 
N=132, Chi Squared 0.377, 1 degree of freedom, p=0.54, not significant. 
 
From these findings there was no indication that the use of the markers supplied was 
associated with gender. 
 
                                                   Table 4.12  
                                 Use of Markers and Length of Time Injecting 
 
 
Did you use the 
markers? 
How long have you been injecting 
 
Total 
0-5years 6-10 years 11+years 
Yes 34 (57%) 19 (70%) 30 (67%) 83 (63%) 
No 26 (43%) 8 (30%) 15 (33%) 49 (37%) 
Total 60 (100%) 27 (100%) 45 (100%) 132 (100%) 
N=132, Chi Squared 1.918, 2 degrees of freedom, p=0.38, not significant. 
 
Similarly with length of time injecting as the IV it was not possible to reject the null 
hypothesis and no association was shown with use of the markers. This result, of no 
association between length of time injecting and use of markers, was replicated when 
the respondents were subdivided by gender.  
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Use of the markers was also shown not to be dependent on current housing status as 
there was no demonstrated association with these two variables as shown in table 
4.13. Examination of the male and female respondents separately yielded the same 
pattern of results. Housing status was collapsed further into two categories of own 
tenancy and a grouping all other types of housing into a second category representing 
less stable forms of accommodation. Conducting a Fisher exact test on this 2x2 table 
still revealed no statistically significant association. 
 
                                                   Table 4.13  
                            Use of markers and current housing status 
 
 
 
Did you use the 
markers? 
What is your current housing status? 
 
Total 
Own 
tenancy 
Staying 
care of an 
individual 
Other 
Yes 56 (68%) 16 (55%) 11 (52%) 83 (63%) 
No 26 (32%) 13 (45%) 10 (48%) 49 (37%) 
Total 82 (100%) 29 (100%) 21 (100%) 132 (100%) 
N=132, Chi Squared 2.759, 2 degrees of freedom, p=0.25, not significant 
 
Table 4.14 below appears to show an association between the use of the markers and 
whether respondents reported that they already marked their syringe. Examples of the 
reported range of strategies used to mark syringes were described previously and are 
shown in Table 4.4. 
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                                                 Table 4.14 
                         Use of markers and current syringe identification 
 
 
Did you use the 
markers? 
Do you currently identify 
your syringe? 
 
Total 
Yes No 
Yes 43 (73%) 40 (55%) 83 (63%) 
No 16 (27%) 33(45%) 49(37%) 
Total  59 (100%)  73 (100%) 132 (100%) 
          N=132, Chi Squared 4.573, 1 degree of freedom, p=0.03, significant 
 
These findings indicate that there is an association between previous identification of 
syringes and the use of the markers. Those who reported to already be identifying 
their syringes were more likely to report use of the markers supplied. Whilst it may 
initially appear disappointing that intervention is associated with those who are 
already attempting to identify their injecting equipment it should be noted that the 
syringe markers offer a more practical and safer alternative than the reported range of 
different strategies previously employed. Despite this finding it is important to note 
that 40 of the 83 respondents, who were supplied with the markers and used them, 
reported that they had not previously identified their syringes. This is a highly 
relevant finding which indicates that the intervention was potentially a feasible option 
to help promote safer injecting practices in a group who had not previously attempted 
to identify their syringes.  
 
Tables 4.15 and 4.16 demonstrate that when the relationship is broken down and 
examined by gender the association initially appears to remain for men but not for 
women.   
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                                                   Table 4.15   
            Use of markers and current syringe identification (male) 
 
 
Male 
Did you use the 
markers?  
Do you currently identify 
your syringe? 
 
Total 
Yes No 
Yes 33(73%) 31(52%) 64 (62%) 
No 12 (27%) 28(48%) 40(38%) 
Total  45 (100%) 59(100%) 104(100%) 
          N=104, Chi Squared 4.662, 1 degree of freedom, p=0.03, significant. 
 
                                                   Table 4.16   
            Use of markers and current syringe identification (female) 
 
 
Female 
Did you use the 
markers?  
Do you currently identify 
your syringe? 
 
Total 
Yes No 
Yes 10 (71%) 9 (64%) 19 (68%) 
No 4 (29%) 5 (36%) 9 (32%) 
Total 14 (100%) 14 (100%) 28 (100%) 
          N=28, Chi Squared 0.164, 1 degree of freedom, p=0.68, not significant. 
 
A Fisher’s exact test also showed that for women the relationship between current 
syringe identification and use of markers was not considered to be statistically 
significant. This finding should be viewed with caution as the number of women in 
this group is small. However Tables 4.17 and 4.18 show that when further examining 
the use of the markers and current syringe identification by gender, there appears to be 
no significant associations that would support any differences between the male and 
female groups. This indicates that the findings in Table 4.14, demonstrating that use 
 146 
 
of the markers is associated with current syringe identification, are unlikely to be 
solely dependent on gender and may be relevant for both male and female IDUs.  
 
                                                 Table 4.17 
                         Use of markers and current syringe identification by gender 
 
 
Did you use the 
markers? 
Current Syringe 
Identification 
 
Total 
Male Female 
Yes   33 (73%) 10 (71%) 43 (73%) 
No  12 (27%) 4 (29%) 16 (27%) 
Total    45 (100%)  14 (100%)    59 (100%) 
          N=59, Chi Squared 0.02, 1 degree of freedom, p=0.88, not significant 
 
                                                 Table 4.18 
                    Use of markers and No current syringe identification by gender 
 
 
Did you use the 
markers? 
Do Not Currently 
Identify  Syringe 
 
Total 
Male Female 
Yes 31 (52%) 9 (64%) 40 (55%) 
No 28 (48%) 5 (36%) 33 (45%) 
Total  59 (100%)  14 (100%)  73 (100%) 
          N=73, Chi Squared 0.63, 1 degree of freedom, p=0.47, not significant 
 
Those who had used the markers were asked their views about the instruction card 
that was developed for use and distribution with the supply of syringe markers 
(Appendix 6). Of the 83 individuals who had used the markers, 87% (n=72) reported 
that they had received a card with the markers. When these 72 respondents were asked 
how useful they found the card in providing supplementary information on using the 
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markers, the responses were as follows: 82% (n=59) of individuals said they found the 
card either “very” or “quite useful”, 15% (n=11) had “no opinion” and 3% (n=2) 
found it “not very useful” When asked if the card provided them with all the 
information needed to use the markers 80% (n=58) said “yes” and 7% (n=5) said that 
the card did not provide them with all the information needed to use the markers. No 
information was recorded on how the current card could be improved other than two 
individuals who reported that “more information could have been provided”. Table 
4.19 demonstrates that there appears to be an association between gender and the 
perceived usefulness of the instruction card as a guide to using the markers.  
 
                                                        Table 4.19.  
          Usefulness of the Instruction card as a guide to the markers and gender. 
 
Using the scale, indicate 
how useful you felt the 
instruction card was as a 
guide to using the markers 
Gender  
Total 
Male Female 
Quite useful / Very useful 
48 (89%) 11 (61%) 59 (82%) 
No opinion 
6 (11%) 5 (28%) 11 (15%) 
Not very useful / Not at all 
useful 
0 (0%) 2 (11%) 2 (3%) 
Total 54 (100%) 18 (100%) 72(100%) 
N=72, Chi Squared 9.726, 2 df, p=0.008, significant, (3 cells (50%) had expected 
values less than 5). 
 
This appeared to indicate that there was a statistically significant difference between 
men and women whereby men were more likely to find the instruction card useful 
than women. However due to the number of cells with expected values less than 5 it is 
not possible to accept this as a reliable result. Therefore the table was collapsed into a 
2x2 contingency table and a Fisher Exact test performed and shown in Table 4.20.   
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                                                    Table 4.20 
  Usefulness of the Instruction card as a guide to the markers and gender (2x2). 
 
Indicate how useful you felt 
the card was as a guide to 
using the markers 
Gender  
Total 
Male Female 
Useful 
48 (89%) 11 (61%) 59 (82%) 
Not Useful 
6 (11%) 7(39%) 13 (18%) 
Total 54 (100%) 18 (100%) 72 (100%) 
N=72, Chi Squared 7.04, 1df, p=0.01, significant. 
 
The “no opinion” responses were included in the “not useful” category. It is open to 
debate as to whether those who had no opinion on the usefulness of the instruction 
card should be allocated to the “useful” or “not useful” responses. The reason for 
allocation to the “not useful” category is that these responses did not make any 
positive statement on the usefulness of the instruction card. In order to check whether 
this re-allocation affected the apparent statistical relationship, the results were cross 
checked with the “no opinion” responses (6 male, 5 female) included in both 
categories and also with the responses excluded. For all of these permutations, the 
relationship indicating that men found the instruction card more useful as a guide to 
using the markers than women remained statistically significant. Possible reasons for 
the apparent discrepancy between the male and female responses are discussed below 
in section 4.5.   
 
No association was demonstrated between the reported usefulness of the instruction 
card as a guide to using the markers with either length of time injecting or housing 
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status. This lack of association was replicated when the latter two categories were 
subdivided by gender.  
 
When asked if they would use the markers again the response was overwhelmingly 
positive, where 99% (n=82) of the 83 individuals who had used the markers 
responded “yes” with only 1% (n=1) reporting that they would not use the markers 
again. This should be viewed in the context that within the group of 83 who used the 
markers, 40 (48%) of the 83 IDUs reported that they had not previously identified 
their syringes. Uncovering of this group is important when considering the potential 
usefulness of the marker supply as it provides an early indication that the markers 
were used by a group of IDUs, who had not previously identified their syringes. It 
appears that the intervention was acceptable to IDUs and was potentially able to 
promote safer injecting practices by providing an option that offered the possibility of 
helping to reduce inadvertent sharing.   
 
4.3.3 Attitudes Towards the Markers  
 
When asked how useful they felt the markers were as a method of marking their 
syringe, 94% of the 83, (n=78) were recorded as saying they were “very” or “quite 
useful”, with only 5% (n=4) reporting that they were “not very useful” and 1% (n=1) 
having “no opinion”. If the markers were to be made available on a routine basis from 
the pharmacy needle exchange, 90% (n=75) of individuals said they would be “more 
likely to mark their syringe”, 8% (n=7) said they would make “no difference” and 1% 
(n=1) said they would be “less likely to mark their syringe”.  
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When asked whether the markers could be improved in any way, 82% (n=68) of 
individuals said “no”. Of the 18% (n=15) who responded “yes” to this question, 13 
individuals gave constructive comments on practical ways the markers could be 
improved. The answers were grouped into the following categories and are listed 
below:  
38% (n=5) suggested that a variety of colours could be used. 
31% (n=4) said the markers could have been bigger so they 
could have been written on.  
23% (n=3) said that they came off easily and were not very 
sticky.  
8% (n=1) said they could have been smaller. 
 
Although the numbers are small, there are indications in these extended responses 
confirming that the markers were actually being used in practice as the comments 
appear to relate directly to practical problems that had been experienced, such as the 
degree of stickiness and the difficulties this caused.  
 
A series of cross tabulations with the responses to perceived usefulness of the markers 
as a method of identifying the syringe as the DV with the three IVs of gender, length 
of time injecting and housing status were performed. The results are shown in tables 
4.21, 4.22 and 4.23.  
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                                                     Table 4.21  
                                Usefulness of the Markers and Gender. 
 
Using the scale, indicate 
how useful you felt the 
markers were as a method 
of marking your syringe 
Gender  
Total 
Male Female 
Very Useful 
45 (73.3%) 9 (47.4%) 54 (65.1%) 
Quite Useful 
16 (25%) 8 (42.1%) 24 (28.9%) 
No Opinion 
1 (1.6%) 0 (0%) 1(1.2%) 
Not at All Useful 
2 (3.1%) 2 (10.5%) 4 (4.8%) 
Total 64 (100%) 19 (100%) 83 (100%) 
N=83, Chi Squared 4.630, 3 df, p=0.20, not significant. (4 cells (50%) have an 
expected count less than 5).   
 
                                                    Table 4.22  
                      Usefulness of the markers and length of time injecting. 
 
Using the scale, indicate 
how useful you felt the 
markers were as a 
method of marking your 
syringe 
How long have you been injecting? 
 
Total 
0 - 5 years 6 - 10 years 11 years + 
Very Useful 23 (67.6%) 15 (78.9%) 16 (53.3%) 54 (65.1%) 
Quite Useful 9 (26.5%) 4 (21.1%) 11 (36.7%) 24 (28.9%) 
No Opinion 0 (0%) 0 (0%) 1 (3.3%) 1 (1.2%) 
Not at all Useful 2 (5.9%) 0 (0%) 2 (6.7%) 4 (4.8%) 
Total 34 (100%) 19 (100%) 30 (100%) 83 (100%) 
N= 83, Chi Squared 5.307, 6 df, p=0.50, not significant. (6 cells (50%) have expected 
values less than 5). 
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                                                    Table 4.23  
                         Usefulness of the markers and housing status. 
 
 
Using the scale, indicate 
how useful you felt the 
markers were as a 
method of marking your 
syringe 
What is your current housing status? 
 
Total 
Own 
Tenancy 
Staying 
care of an 
individual 
Other 
Very Useful 33 (58.9%) 12 (75%) 9 (81.8%) 54 (65.1%) 
Quite Useful 20 (35.7%) 3 (18.8%) 1 (9.1%) 24 (28.9%) 
No Opinion 0 (0%) 0 (0%) 1 (9.1%) 1 (1.2%) 
Not at all Useful 3 (5.4%) 1 (6.3%) 0 (0%) 4 (4.8%) 
Total 56 (100%) 16 (100%) 11 (100%) 83 (100%) 
N= 83, Chi Squared 7.191, 4 df, p=0.13, not significant. (6 cells (50%) have expected 
values less than 5). 
 
In all three cases no differences in the perceived usefulness of the markers were found 
across the three IVs of gender, length of time injecting and housing status. As 94% of 
the 83, (n=78) who responded to the question on the usefulness of the markers 
recorded that the markers were “very” or “quite useful”, this means that for any cross 
tabulation the numbers who can populate the remaining cells are very small and this 
therefore limits the possibility of uncovering any statistically significant relationships 
with usefulness of the marker as the DV. In view of this, the responses to the question 
on usefulness of the markers were collapsed into two categories. The single “no 
opinion” response was excluded and the remaining responses allocated to a “useful” 
or “not useful” category. However this subsequent categorisation did not lead to any 
significant findings.   
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4.4 Feedback from Participating Community Pharmacists. 
 
As detailed in Chapter 2 (2.3), the evaluation was conducted in three community 
pharmacies with permanent pharmacist managers. The three pharmacists were 
contacted at the end of the study by the principle investigator (two by telephone and 
one by pharmacy visit) to ascertain their feedback on the whole process from the 
initial training session to completion. These were informal feedback sessions where 
their views and comments on the following topics were sought; the impact of the peer 
researchers on the pharmacy, payment structure, staff training and clarification on the 
discrepancy between the 83 who had been supplied with markers and the reduced 
number of 72 who reported that they had received the instruction card along with the 
marker supply.    
 
As reported in Chapter 3, during the data collection period, there were no reports of 
any problems or disruption to the routine functioning of the pharmacy caused by the 
presence and work of the peer researchers when administering the questionnaire. 
When questioned directly, the 3 pharmacists all reiterated that the peer researchers 
had at all times behaved professionally and their work had no adverse impact on the 
pharmacy staff, patients or members of the public. One pharmacist commented that 
this was “far better than having to do it yourself!” The 3 pharmacies had all 
participated in the evaluation voluntarily. Locum fees were paid for attendance at the 
joint training sessions. As part of the health board scheme, pharmacists are paid a fee 
per individual NEX transaction which is negotiated annually. No additional fee was 
offered for the supply of markers alongside supplies of packs of injecting equipment. 
All noted that if the marker supply was to be extended, in the current format, where a 
separate supply and explanation to patients was required that this should attract an 
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additional fee. However all agreed that if incorporated into existing packs, claims for 
additional fees would not be justified.  When asked if the joint training session had 
been useful and covered the relevant material for staff, there was unanimous 
agreement and no-one identified any gaps in the training that had appeared as the 
implementation progressed. All reported that they had been well supported throughout 
the evaluation.  
   
Of the 83 clients who received supplies of the markers, 13% (n=11) reported that they 
did not receive an instruction leaflet with the markers. This conflicted with the replies 
of the participating pharmacists who claimed that the markers and instruction leaflet 
were always supplied together along with verbal instructions during the supply phase. 
As the markers were packaged and supplied together with the instruction cards this is 
an indication that for the 13%, the card had no impact as information about or 
contained on the card was not retained.  There is evidence to demonstrate that when 
health care professionals provide medical information 40-80% can be forgotten by 
patients (Kessels, 2003:219).  This work showed that patients’ recall of medical 
information is affected by a number of factors including age, anxiety and distress, the 
perceived importance of the information being relayed and whether it is presented in a 
written, spoken or non-verbal form (Kessels, 2003:221). He concluded that any 
spoken information should be reinforced by written or visual materials. Whilst these 
results are not completely transferable from the traditional health care professional 
and patient interaction, information provided in a NEX setting is likely to be affected 
to some extent by these factors plus other site and situation specific factors including, 
desire to maintain anonymity and confidentiality due to the illegal nature of drug use 
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and potentially being in a state of withdrawal.  When viewed in this context it is not 
unexpected that 13% (n=11) claimed not to have received the instruction card.  
 
In summary, from the pharmacists’ perspective, the supply of syringe markers was an 
acceptable and straightforward intervention to implement and the presence of the peer 
researchers in the pharmacy for extended periods was managed successfully with no 
adverse impacts.  
 
4.5   Discussion of Findings.  
 
In summary, the design of the evaluation enabled a total of 177 questionnaires to be 
completed during the data collection period. All three pharmacies completed the 
supply and data collection phases with no reported problems. A majority of the 177 
respondents, 75% (n=132), had been supplied with the syringe markers during the 
initial phase and 63% (n=83) of the 132 reported using the markers. When asked how 
useful the markers were as a method of marking their syringe an overwhelming 
majority of the 83 who had used the markers, 94% (n=78), responded that they were 
very or quite useful and 99% (n=82) reported that they would use the markers again if 
they were to be made freely available. This indicated that the marker supply did 
constitute a feasible method of supply that was acceptable to both the staff involved in 
the supply and to the IDUs. As there was no direct observational data of injecting 
practices collected during this evaluation it is therefore only possible to report that the 
results indicate that this provides a potential means of preventing the inadvertent 
accidental sharing of syringes within a group setting.    
 156 
 
For the original group of 177 respondents interviewed, 80% (n=142) were men and 
20% women (n=35). This resulted from opportunistic sampling which was based on 
the interplay of timings of the peer researchers’ attendance in the pharmacy and those 
attending the exchange who agreed to be interviewed. Chi squared tests showed that 
there was no significant difference between this gender distribution and the health 
board database figures of 78% male, and 22% female, for the population who attend 
NEXs.  
 
Cross-tabulations demonstrated that current methods of syringe marking or 
identification were not shown to be associated with gender, length of time someone 
had been injecting or current housing status. It should be noted that although there 
may be a lack of evidence to demonstrate an association this does not automatically 
infer that evidence exists to support the null hypothesis of no association (Bruce, Pope 
and Stanistreet, 2008). It indicates that the available evidence is insufficient to reject 
the null hypothesis. There was an indication that some evidence was beginning to 
emerge that women who had been injecting for longer periods of time were less likely 
to mark their syringes and, by implication, were more likely to be involved in unsafe 
injecting practices. Alternative, although less plausible, explanations could also be 
proposed. For example, it could be suggested that women were less likely to mark 
their syringes as they injected alone or always used new equipment and therefore had 
no need to prevent inadvertent sharing. Although this relationship was not 
immediately obvious it serves to highlight an area that is worthy of further study to 
attempt to uncover the extent and nature of any potential relationship. The apparent 
differences between men and women IDUs that emerged from the evaluation and the 
wider implications are discussed below in more detail. 
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Use of the markers was shown not to be associated with gender, length of time 
injecting or housing status. It is worth noting that the converse is also true, where non-
use of the markers was also not associated with gender, length of time injecting or 
housing status. This is relevant as it provides confirmation that there were no apparent 
differences, in these recorded characteristics, between the group who used the markers 
(n=83) and the group (n=49) who were supplied with markers but did not use them. 
This can be interpreted that the use of the markers was not associated with any 
specific demographic group or characteristic. This therefore makes it difficult to target 
the intervention as there was no indication of the characteristics of the individuals 
who would utilise this intervention and equally it gave no indication of the 
characteristics of the IDUs for whom this intervention had no relevance. The one 
positive association that was demonstrated was between those who reported that they 
currently identified their syringes and those who had used the markers supplied to 
them. Although this may initially appear that the intervention was only of relevance to 
IDUs who were already making attempts to minimise risks, it should be noted that the 
marker supply offers an easier and safer option than the existing strategies used of 
burning, scratching or marking that were described in section 4.3.1. Despite the 
apparent statistical association between use of the markers and those already 
identifying their syringes, Table 4.14 also highlights that 48% (n=40) of the total of 
83 who used the markers had not previously identified their syringes. This indicates 
that the intervention appeared to be successful in reaching an important group who 
previously reported not making any attempts to identify their syringes. However 
caution should be exercised in interpreting the results as the responses are based on 
reported rather than observed behaviours. As discussed in Chapter 3 the use of peer 
researchers helps to militate against some of the factors that lead to biased responses. 
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Therefore it is reasonable to assume that the responses from those who used the 
markers, but had not previously identified their syringes, indicates a reaction to 
perceived risks related to their own injecting practices and situations.  
 
Despite the inability to identify any specific characteristics associated with marker 
use, other than pre existing syringe identification, 94% of the 83 who used the 
markers (n=78) responded that the markers were very or quite useful and 99% (n=82) 
responded that they would use the markers again. Although these overwhelmingly 
positive responses on the reported usefulness of the markers and indications that their 
availability would make IDUs more likely to mark their syringe, there needs to be an 
element of caution in interpreting and extrapolating these results as these responses 
are reported and not observed. It is therefore difficult to make any definitive claims 
about the use of the markers in real life settings.  
 
The responses in this evaluation to a question on whether syringes had been mixed up 
with another’s in the past year yielded little useful information. Seventy eight percent, 
(n=138) of the total 177 claim that this has never happened. It is possible that this 
form of questioning may not be the best method to elicit accurate responses on risky 
and unsafe injecting practices and that alternative methods should be explored. Recent 
work comparing responses from IDUs to questions on HCV risk behaviours using 
visual and written cues demonstrated that using written questions only, led to an 
underestimation of unsafe injection sharing practices (Beynon, Taylor, Allen et al, 
2010). It is possible that use of different media and incorporation of pictorial 
representations of risk related practices within the questionnaire may give a more 
accurate estimation of the extent of risky injecting practices.    
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The most significant factor to emerge from analysis of the findings was the individual 
differences that became apparent between male and female respondents. These should 
not be considered in isolation but serve to prompt further reflection on the possible 
reasons why there should be differences in the responses of male and female IDUs. 
The findings gave some preliminary indication that the longer women had been 
injecting the less likely they were to mark their syringes and men found the 
instruction card more useful than women. Tables 4.15 to 4.18 indicated that further 
investigation of female IDUs would be useful to allow definitive conclusions to be 
reached on the use of markers and association with current syringe identification. As 
the characteristics of the sample interviewed were similar to the usual pattern of 
attendees at each NEX and of the population as a whole across all sites, it is unlikely 
that these differences were due to an artefact of the group interviewed. This appears to 
provide some preliminary evidence that warrants further investigation as it indicates 
that there may be underlying differences in the injecting practices of male and female 
IDUs leading to speculation that female IDUs may engage in higher risk related 
injecting behaviours. There is existing evidence to suggest that women IDUs 
experience more physical problems with the injecting process than men including 
difficulty accessing veins and the resultant greater number of injecting sites and 
associated increased risks of blood spillage, contamination, and of infection and BBV 
transmission (Darke, Ross and Kaye, 2001). A previous exploration of the injecting 
practices of women IDUs reported on the differences and the underlying social 
complexity that affected women’s decision making in relation to their injecting 
behaviours (Sheard and Tompkins, 2008). This work noted that women IDUs are 
more likely to have a sexual partner who is also using drugs and that within this type 
of relationship; women were more likely to inject or to be injected using equipment 
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that they did not directly source themselves but had obtained from their partner 
(Sheard and Tompkins, 2008). This is further confounded by the interplay of trust and 
sharing of injecting equipment within a sexual relationship as outlined by McKeganey 
and Barnard in the early 1990’s and discussed in Chapter 1. Sheard and Tompkins 
highlighted that women may have different priorities that can adversely affect 
attempts to minimise injecting risks (2008). These were reported to include avoiding 
physical exposure of the visible signs of injecting and violence that is often inherent 
in dependent relationships. As part of this qualitative study the authors reported that 
the women described a range of different techniques that they used to identify their 
own used needles to prepare for situations where new supplies were not available. 
One of the recommendations from this work was that any health promotion and 
injecting advice to women in a relationship with a drug using partner should be 
specifically tailored to “reflect the dynamics” of these relationships (Sheard and 
Tompkins, 2008:1545). 
 
According to Clarke achieving success with any type of interview is dependent on the 
skills of the interviewer and how effective they are as an “active listener” and their 
ability to quickly establish a rapport with those being interviewed (2005:75).  Despite 
the relative inexperience of the SUIG members it would appear that they were able to 
successfully manage the interview process with minimal direct supervision in all three 
sites. This was demonstrated by the initial estimate of 150 being exceeded and 177 
questionnaires being successfully completed during the second data collection period. 
In follow up discussions with the pharmacy staff there was no identified adverse 
problems caused for staff or disruptions to the delivery of routine pharmacy services 
by the research or the presence of the peer researchers in the pharmacies. This 
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provided further evidence that the group had managed the process effectively. The 
absence of any problems is an important factor as not only did the peer researchers 
have to implement the survey, they had to do this within a busy community pharmacy 
where the situations they may have to deal with are unpredictable and often out of the 
direct control of staff. As discussed in Chapter 2 the pharmacies had been previously 
identified as sites that dealt with large numbers of people attending their NEX and 
were chosen to maximise potential contact with respondents. This therefore meant 
that due to the busy and public nature of the pharmacies chosen, there existed the 
likelihood that the practical aspects of administering the questionnaire could be 
adversely affected by any number of unexpected problems that were impossible to 
anticipate and plan for in advance.  
 
Feedback from the participating pharmacists indicated that the supply of markers 
could be successfully implemented in this setting. The intervention and the content of 
the associated training session held prior to the pilot were acceptable to the pharmacy 
staff. It is relevant to note that no site or staff related problems emerged during the 
duration of the pilot.  The recorded observations and recommendations contained in 
the field work diaries completed by the peer researchers provided the researcher with 
additional relevant data for inclusion in the evaluation. The recommendations, arrived 
at independently by the peer researchers, appear to support the results of the 
questionnaire in confirming that the supply and use of syringe markers provides IDUs 
with a useable practical means of reducing the accidental sharing of syringes. 
Discussion of the wider implications of these findings and areas of work proposed for 
further exploration that have emerged from the evaluation are explored in detail in 
Chapter 5. 
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Chapter 5 
 
Conclusions 
 
“Evaluation is important for determining the extent to which a policy has met or is 
meeting its objectives and that those intended to benefit have done so” (Booth, 
2009:257).  
 
5.1 Summary  
 
This study involved the development, implementation and evaluation of syringe 
markers as a pilot study within three community pharmacy NEX sites in Glasgow. 
The aims have been to evaluate the supply of markers which are designed to identify 
syringes and to determine if this offers a practical solution as a potential means of 
reducing accidental and unintentional sharing of injecting equipment and thereby 
contributing to minimising some of the health harms associated with injecting drug 
use. The study also aimed to identify whether the supply of syringe markers from 
community pharmacy needle exchanges was acceptable to IDUs and staff.  
 
The ACMD report into the primary prevention of HCV among IDUs reported on a 
number of innovative practices, including the provision of additional injecting 
paraphernalia and coloured syringes, designed to prevent this transmission however it 
was reported that despite the level of innovation there was a lack of supporting 
evidence of effectiveness. The report concluded that continued support should be 
provided for new initiatives but also stated that “more attention needs to be given to 
evaluation” (ACMD, 2009:29). This emerging evidence, discussed in Chapter 1, on 
the possible routes of transmission of HCV, including through accidental or 
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inadvertent sharing of injecting equipment, formed the basis for the design of the 
syringe markers supply pilot. The implementation of this new intervention within an 
existing service has been coupled with an evaluation of its acceptability for staff and 
service users. The design of the evaluation incorporated the active participation of 
peer researchers both in the preparatory work and in the administration of the 
questionnaire. 
 
Although this evaluation contributes to the emerging knowledge base on syringe 
identification, caution needs to be exercised in drawing final conclusions. It is 
possible to conclude from the results that the intervention can be successfully 
implemented and, due to the fact that the groups of IDUs attending the three 
pharmacy NEX sites chosen exhibited similar characteristics to those in all other sites 
in the area, that it would be possible to successfully extend the supply to other sites. 
However, although the implementation and the product can be considered successful 
and acceptable in practice to IDUs, this does not provide any definitive indication of 
its effectiveness in reducing the transmission of BBVs and other related infections. 
Proposals on how effectiveness could potentially be measured are discussed further 
below.  
 
The emerging differences between the male and female groups merit further 
investigation. This should not be confined only to future syringe marker supply but 
should be extended to the totality of the NEX service as it is possible to speculate that 
the current structure of generic NEX services may not be fully meeting the needs of 
female IDUs. This is important as previous work, across an extended time period, has 
shown that women injectors have greater risks of exposure to BBVs and other health 
 164 
 
risks and women, particularly drug using mothers, often experience increased 
stigmatisation and rejection from society (Taylor 1993, Hankins 2008, Olszewski, 
Giraudon, Hedrich et al, 2009). This contributes to the desire to reduce the visibility 
of drug use often resulting in participation in increasingly unsafe and higher risk 
injecting practices (Sheard and Tompkins, 2008).     
 
The findings  of the cross tabulations in Chapter 4 indicated no associations between 
the use of markers and attitudes towards them and other variables such as gender, 
length of time injecting and housing status. The identification of any relationships 
amongst groups with specific characteristics and different injecting practices may 
yield information to assist in the design and development of any intervention aimed at 
reducing injecting related risks. However, ideally, the utility of any syringe markers 
should have a universal appeal that is not strongly influenced by or associated with 
any limited defined groups. Therefore any lack of association is not necessarily a 
negative factor. The most significant association noted was between those who 
currently identify their syringes and use of the markers. The results shown in Table 
4.14 demonstrated that 73% of IDUs who previously reported identifying their 
syringes claimed to have used the markers. However use of the markers was not 
solely confined to this group as 55% of those who reported that they did not 
previously attempt to identify their syringes also reported use of the syringe markers 
supplied. These results provide some indication that the usefulness of the markers 
extended beyond the group already marking their syringes and included a proportion 
of those who are potentially engaged in more risky injecting practices and therefore 
more at risk.    
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The incorporation of peer researchers was a successful part of the evaluation. The 
field work diary that they collectively produced made a positive contribution to the 
final evaluation and opened up avenues for further work and collaboration. The 
relatively low number of refusals when compared to the rates in other Glasgow based 
NEX evaluations, and the number of responses exceeding the original estimate, is a 
testament to their commitment and successful participation. Based on this it is 
important that ways are found to further expand the unique contribution and insights 
that peer researchers can bring to assist, not only with the syringe marker supply, but 
also with other innovative work and the wider development of NEX services. This is 
an area where the views of the service users are paramount as even when NEX 
services and equipment are designed based on current academic theory and evidence, 
for any positive health benefits to be achieved both the service and the equipment 
supplied has to be acceptable to and used by IDUs. As was seen from the literature 
review and the evaluation this is affected by a complex and changing interplay of 
various internal and external factors. 
 
5.2 Potential Options to Monitor Effectiveness of Syringe Marker Supply. 
  
If the distribution of markers is to be expanded on a wider scale and incorporated into 
all of the NEXs in the area then it is possible to propose a number of proxy measures 
that could be used to identify if wider distribution has positive effects leading to 
reduced sharing behaviours and producing a subsequent reduction in the transmission 
of HCV. For example, the Health Protection Scotland (HPS) agency produces the 
Hepatitis C Diagnosis Database. This database provides anonymised epidemiological 
information from Scotland since 1991 on individuals who have had positive HCV 
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and/or Polymerase Chain Reaction (PCR) results (HPS, 2011). One of the main aims 
of this database is to provide a monitoring tool to identify trends in diagnosed HCV 
infection in the population in Scotland. Recent advances in avidity testing have been 
introduced (S Hutchison, 2010: personal communication). The avidity test enables an 
estimate of the length of time an individual has been infected with HCV to be made. 
For the purposes of using the Hepatitis C Diagnosis Database information as a proxy 
indicator of success of the extended distribution of syringe markers, the introduction 
of new avidity testing means that it is possible to distinguish newly acquired 
infections from those of much longer existence. To be deemed as successful, any 
programme, including the supply of syringe markers, aimed at reducing sharing and 
thereby reducing the transmission of HCV should be able to demonstrate a correlation 
with a reduction in newly acquired infections even if the total number of diagnoses 
increases with increased levels of testing. If the expanded supply programme was to 
be effective, the number of newly acquired HCV infections should decrease with a 
concurrent increase in the levels of markers supplied.  
 
Further examples of existing data that can be used to corroborate the effectiveness of 
a programme aimed at reducing sharing of injecting equipment include the 
information contained in the Scottish Drug Misuse Database (SDMD) and from the 
National Needle Exchange Surveillance Initiative (NESI). The SDMD is published 
annually and is the major source of statistical information on the misuse of drugs in 
Scotland. The dataset is based on the information provided by new clients attending 
medical and specialist drug services. It contains information on a wide range of 
behavioural and demographic characteristics of the clients and this includes details of  
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injection practices and sharing behaviours. The NESI study also provides information 
on injecting equipment sharing behaviours. However as the NESI study was 
conducted amongst those attending NEXs it is likely to have included relevant 
information from IDUs who are not in contact with treatment services, unlike the 
SDMD population which is drawn exclusively from new attendees at treatment 
services. If an extended syringe marker programme was to be deemed as effective 
then there would be an expectation that co-inciding with this, reduced equipment 
sharing behaviour trends would begin to be reported through these two separate 
monitoring mechanisms described above.  
 
As discussed in Chapter 1, injecting drug use is influenced by the interplay of 
combinations of practical, community, personal and physical health factors. Due to 
this multifactorial aspect, in practice it is difficult to devise a means of isolating any 
single causative effect associated with a specific intervention like the introduction of 
syringe markers. Although it appears intuitive that achieving a reduction in sharing of 
injecting equipment will lead to reduced BBV transmission this correlation does not 
necessarily imply a causal effect. This is due to the need to recognise the complexity 
and interplay of health, social, legal and other factors and means that attributing a 
beneficial response to one specific intervention is impossible in the absence of a 
randomised controlled trial (RCT). It is not possible to conduct a RCT with this type 
of intervention as all of the potential relevant variables cannot be controlled in a real 
life setting. This was recognised in Scotland’s Hepatitis C Action Plan. In discussing 
the prevention recommendations it was noted that if any reductions in virus 
transmission were to be found, attributing this conclusively to any single intervention 
would not be possible (Scottish Government, 2008). Despite this, the syringe marker 
 168 
 
evaluation has shown that, even within an ongoing service setting, it is still possible to 
devise studies that help to provide useful data to contribute to the emerging evidence 
base. 
 
A combination of the information available from the three data sources mentioned 
above (the Hepatitis C Diagnosis Dataset, SDMD and the NESI study) offers a viable 
means of monitoring the effectiveness of the wider introduction of syringe markers. It 
is possible to speculate that if reduced sharing could be demonstrated (for groups both 
in and out of treatment) and if a reduction in new cases of HCV infection could also 
be identified that these reductions would then potentially be positively correlated with 
an extended supply of syringe markers. The same principles can be applied to other 
areas including, for example, investigation of trends in Accident and Emergency 
admissions of IDUs with infected injecting wounds and any patterns of association 
with supplies of clean injecting equipment and specific products designed to reduce 
sharing and also reuse of equipment.  
 
5.3 Discussion of Findings and Proposed Areas for Further Work. 
  
Despite the apparent success of the pilot in offering a simple and easy to use means of 
identifying an individual IDU’s syringe, this gives no guarantee that it will actually be 
used in practice. A further range of observational and other studies would have to be 
undertaken to confirm the results from the evaluation, where 94% of those who had 
used the markers reported to have found them “very” or “quite useful”. It would be 
possible to design an observational study to test the accuracy of these results and to 
identify if the reported practices were replicated in real life settings. Despite these 
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cautions and the lack of published materials on effectiveness and feasibility of use, the 
distribution and use of the markers by the IDU community has been noted and acted 
upon by a commercial company who have produced their own version of syringe and 
paraphernalia markers for wider distribution (Appendix 11). This would indicate that 
there is already an existing demand for this type of product that has been identified 
and acted upon. 
 
Research in the USA into the risk related behaviours associated with the transmission 
of BBVs and related infections amongst the injecting drug using population used self 
completion daily diaries to investigate the correlation of behaviour and HIV risk 
(Stopka et al, 2004:73). The researchers claimed that this method had a number of 
advantages and that it was a useful corroborative method for a range of other 
qualitative and ethnographic designs. It was also a feasible method to employ with a 
hard to reach drug using group. They concluded that the diaries allowed a 
contextualised record to be built up that provided a deeper understanding, not only of 
injecting and risk behaviours but also of their “interrelatedness” (Stopka et al, 
2004:74). This work allowed the researchers to track risk related behaviours, related 
emotional states and high risk use associated with injecting by tracking what they 
termed the “life cycle” of an individual syringe (Stopka et al, 2004:78). The results 
from these diaries gave valuable information over a number of areas, including 
changing patterns of drug use related to unexpected risk related events, BBV risks and 
how this related to the life cycle of the syringe and the IDU’s emotional state. It is 
clear that the use of diaries is a potential method that could be used and adapted to 
expand the evidence base on the relevance of syringe markers in practice. 
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The findings have identified tentative differences in the male and female use of the 
markers. This is an area that requires work to further investigate the complex inter- 
relationships and co-existing factors that affect women’s injecting practices, sharing 
behaviour and their sources of injecting equipment. Previous evidence has 
demonstrated the different experiences of men and women IDUs and calls have 
frequently been made for services to be tailored to meet the needs of women (Becker 
and Duffy 2002, Ettore 2004). In Glasgow and across Scotland NEX services remain, 
almost exclusively, generic with minimal consideration being given to strategies to 
address this gap. This is despite previous identification of the relatively low uptake of 
injecting equipment by women from pharmacy NEXs and previous recommendations 
that women only exchanges should be established (Roberts, Gilchrist, Cameron et al, 
2002, Cameron, Gilchrist and Roberts, 2004). The findings of this evaluation indicate 
that this is an area that should be addressed particularly as there is evidence to show 
that female injectors are more likely to share injecting equipment than men (Eaves, 
2004). Consideration should be given to developing a women only service along the 
lines of the enhanced and specific NEX service provided on a once weekly basis for 
users of performance and image enhancing drugs (PIEDs). It is interesting to note that 
offering a bespoke service for this group has been successful in attracting a large 
number of individuals who are injecting PIEDs and who were not previously known 
to, or attending generic NEX services (John Campbell, 2012, personal 
communication). Although the challenges and the barriers facing women accessing 
NEX are different it is possible that a tailored women only service would help to 
address some of the barriers and gaps that are inevitable with a generic service. In 
research that utilised a social mapping tool with women involved in street sex work in 
Vancouver it was discovered through mapping the geographic relationships, that 
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access to health and harm reduction services, including NEXs, for these women was 
adversely affected by violence and policing activity (Shannon, Rusch, Shoveller et al, 
2008). It is difficult to make any cross cultural comparisons but this serves to illustrate 
the range of unknown and unexpected factors that could affect access, not only to 
syringe markers, but to the service as a whole. Recent examination of the electronic 
data collection system in Glasgow has highlighted distinct reductions in NEX 
transactions that appear to co-incide with the timings of local enhanced police stop 
and search activities in the immediate vicinity of NEXs (John Campbell, 2011: 
personal communication). Previous work has demonstrated that women IDUs are 
more likely to be involved in sex work than men (Hankins, 2008:95).             
Therefore it is possible to speculate that this type of policing activity may have more 
relevance for women resulting in greater impact in preventing women IDUs accessing 
harm reduction services. This is an area that should be considered in any further work 
aimed at developing and promoting syringe markers to women IDUs as access to the 
NEX and time spent there to engage with healthcare professionals on safer injecting 
and harm reduction issues could be affected by external factors.  
 
The findings of the evaluation indicate that further work in this area should explore 
the needs of men and women as two separate populations. Farris and Fenaughty 
described women who are using drugs as a population which is “dually 
disadvantaged” (2002:348). They examined the association of social isolation and 
domestic violence among female drug users and claimed that this affects the women’s 
ability to access health and support services. They recommended that treatment 
providers should design services to take account of these factors. It is reasonable to 
propose that NEX services should also be aware of, and respond to, the specific needs 
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of IDU women.  From the findings of the evaluation and the previous evidence on the 
physical and social factors affecting women IDUs it is essential that future work on 
the syringe marker supply should consider the specific needs of women IDUs. This 
applies equally to the future design of all harm reduction information and 
interventions which should be responsive to the specific needs and incorporate a 
strategy to target women IDUs 
 
The SUIG consisted of 4 men and 2 women who acted as peer researchers. There is 
no information on whether this affected the number or the responses. Based on the 
findings it is worthwhile pursuing the involvement of peer researchers to interview 
respondents of the same sex in future work.   
  
In a review of qualitative research into injecting drug use and risk related behaviours 
associated with the transmission of HIV, Rhodes and colleagues concluded that if any 
intervention was to be successful in promoting a reduction in needle and syringe 
sharing then there was an imperative to relate how attempts at reducing risk are 
affected by the social situation and other contexts that impact on injecting practices 
(Rhodes et al, 2001:58). It is reasonable to assume that relevance of the social context 
of injecting is equally applicable to HCV transmission and to the totality of the health 
risks associated with sharing and re-use of used injecting equipment. This reinforces 
the need for further observational studies to build on the findings of the syringe 
marker evaluation and to investigate the use of markers within the relevant social 
context, interactions and conditions of injecting drug use.  Early qualitative studies 
into risk behaviour by Rhodes had shown that for public health interventions to be 
successful in achieving a reduction in risk related behaviours that it was necessary to 
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employ “social action theories” to understand the how perceptions of risk are 
influenced by a complex interaction of a range of social factors (Rhodes, 1997:208). 
This qualitative study was supported by later quantitative work in Dublin that 
demonstrated how accidental and unnoticed sharing of injecting equipment was only 
one factor responsible for increasing the risks of infection transmission but that 
having a positive HCV status was statistically associated with the social context of 
injecting  (Smyth et al, 2004 ). 
 
An understanding of the social context of injecting and the effects that this has on 
harm reduction initiatives is a relevant factor that has to be considered when 
discussing the implications of the findings of the syringe marker evaluation. It 
demonstrated that the evaluation has only addressed specific aspects of injecting 
practices and that there is an interplay of other factors out with the scope of this 
evaluation that need to be considered when discussing the findings. Providing simple 
and easy to use tools to enable IDUs to identify their own equipment and to prevent 
inadvertent sharing or mixing of equipment in a group setting  may only be partly 
successful in promoting safer injecting behaviour amongst the IDUs community due 
to the interplay of various social factors outlined above. An additional factor was 
identified by Millar who showed that there was limited evidence to support the 
effectiveness of “safe using messages” in relation to overdose prevention and BBV 
transmission (2009:18). He undertook a combined quantitative and qualitative study 
in Australia to investigate IDUs experiences of overdose and prevention, and BBV 
experience and risk behaviours. Although there are limitations to the study that affect 
its generalisability, he concluded that harm reduction and health promotion messages 
were regularly disregarded or ignored. For the group interviewed, experiences of the 
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death of members of the group were common and, despite this and the adverse 
consequences to their own health, they continued to engage in hazardous and risky 
behaviour to an extent where the authors concluded that death was viewed with 
“indifference or resignation” (Miller, 2009:18). Despite the recognised difficulties in 
promoting behaviour change in this group there is still a need to provide the tools, 
equipment and advice to maximise the opportunities available to reduce the health 
harms associated with injecting drug use. The ultimate aim is to enable individuals to 
enter treatment services and to engage in a recovery process having sustained minimal 
permanent physical health problems as a result of their injecting drug use. It would 
appear from the results of the evaluation, that the provision of syringe markers has a 
part to play in potentially contributing to reducing these health harms. 
 
The Health Belief model is of relevance when discussing the different factors and 
influences that can affect an individual’s actions and behaviours. This is directly 
linked to the evidence from the Miller study with IDUs discussed above. This model 
has been defined as “a model of the relationship between attitudinal and cognitive 
variables and the likelihood of an individual engaging in some desirable health-
promoting behaviour” (Dyson and Brown, 2006:161). These authors concluded in a 
critical review of the health belief model that it was difficult to predict health related 
behaviour with any level of certainty as this type of behaviour can be viewed not only 
in health but also in social terms due to the concurrent existence of numerous social 
factors in people’s lives that become linked with any health behaviours (Dyson and 
Brown, 2006). There is a direct link here to the use of syringe markers as these 
markers are inevitably introduced into a social setting that is further complicated by 
numerous health, legal and social factors that constitute the often chaotic nature of the 
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routine daily life of an IDU. It is clear that further work involving direct observational 
studies in the real life setting would be required to enable a full picture of the benefits 
and difficulties associated with the use of syringe markers in practice to be 
determined. It is possible to speculate that this type of research would provide 
confirmatory evidence to support the initial findings of the syringe marker evaluation. 
 
Despite the cautions outlined above about the lack of direct observational evidence in 
the evaluation, it is clear that the syringe markers were viewed positively by those 
interviewed and supported by the research setting observations and independent 
recommendations of the peer researchers. The evaluation demonstrated that the 
markers reportedly offered an easy to use, simple solution to the problem of 
inadvertent and accidental sharing in a group situation that has been identified by 
previous research. Although the work described in this evaluation was carried out in 
2006 / 07, minimal progress has been made in extending the use of any means of 
syringe identification. In 2010, the Scottish Government guidelines on best practice 
for all types of injecting equipment providers, including community pharmacies, 
made a number of recommendations. Recommendation 8 stated that all suppliers 
should “Provide methods for syringe identification” (Scottish Government, 2010:19). 
This recommendation goes on to elaborate that “a method of equipment identification 
should be made available to clients who inject in the company of other injectors in 
order that they can identify their own equipment and avoid accidental sharing” 
(2010:19). It is clear from the results of the syringe marker evaluation that these 
markers can offer a potentially viable means of identifying needles, syringes and other 
items of paraphernalia.  
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It is possible to draw cautious conclusions from the evaluation. It appears from the 
results that the practice under study of syringe marker supply does offer a useable 
method of marking syringes which potentially can help to prevent inadvertent sharing 
of equipment. There is a need, however, to fully recognise the role of the individual in 
taking responsibility for protecting their own health and the health of others in their 
community. Whilst acknowledging the results of Miller’s research in Australia which 
demonstrated the association of indifference to individual health and the problems 
inherent in promoting positive health behaviours in this group there is some emerging 
evidence to show that IDUs do make some attempts to protect both themselves and 
others from the transmission of BBVs. Previous research has shown that HCV can be 
transmitted between IDUs through sharing of other pieces of injecting paraphernalia 
apart from needles and syringes (Thorpe, Quellet, Hershaw et al, 2002). This was 
confirmed by an in-depth observational study in Glasgow into IDU’s injecting 
practices in their own environment (Taylor et al, 2004). This study recorded a high 
level of awareness of the risks that were associated with needle and syringe sharing 
but highlighted many of the social and practical difficulties that made safe injecting 
practices difficult to achieve.  The same study also concluded that “indirect sharing” 
of all injecting paraphernalia was a common occurrence despite some observational 
evidence to show that attempts were sometimes made to mark individual syringes 
(2004:36). The responses from the syringe marker evaluation questionnaire support 
these findings where 42% of the respondents claimed to identify their syringe using a 
range of methods including burning and scratching. One of the findings with policy 
implications from the observational study was the recommendation that when IDUs 
were injecting in group situations a solution should be found so that IDUs could 
effectively identify and distinguish their own injecting equipment (Taylor et al, 2004). 
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The syringe marker intervention described in this evaluation would appear to offer a 
practical solution to the problem highlighted in the observational study by providing 
IDUs with the opportunity to mark and to easily identify all of their own 
paraphernalia and therefore to prevent inadvertent sharing. It would also appear to 
support the observational evidence that within the group under study, some basic 
attempts are made at safer and less risky injecting practices despite the adverse and 
unhygienic circumstances where this occurs. 
 
This evaluation was of a pilot study conducted in 3 community pharmacy sites. The 
rationale for the choice of the sites was discussed in Chapter 2. The characteristics of 
those who attended and the exchange transactions at the pilot sites were shown to be 
consistent with the wider NEXs and attendees (Table 2.1). Similarly those who 
responded to the questionnaire had broadly similar characteristics to the IDUs who 
used these 3 NEXs and to the board wide population of attendees. It is therefore likely 
that the conclusions drawn from the evaluation can be applied to other pharmacy 
NEXs. On this basis it would be legitimate to extend the supply of syringe markers to 
other sites across the health board. The implications and the role that the central 
database could play in the ongoing monitoring and evaluation of an extended syringe 
marker supply and it’s potential to contribute to future research are discussed below.   
 
If the intervention was extended and made available from all community pharmacy 
NEXs it would be possible to use the data contained in the central database for 
extended statistical manipulation to monitor and investigate the relationship of syringe 
marker supplies with data on a number of other collected variables. This would enable 
further exploration of the male and female differences that appeared to emerge from 
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the evaluation. This central database contains extensive information on transactions 
and individual characteristics and offers a range of opportunities for further detailed 
statistical exploration. This is an area of potential future work that would contribute to 
the evidence on syringe identification and can provide quantitative information that 
would complement the proposed qualitative observational work to measure the impact 
of this or any other intervention. The database records relevant information on all 
individual NEX transactions that occur in the health board area. The variables include 
gender, age, ethnicity, type of drug use, frequency of injecting, quantity of returns, 
location and type and amount of equipment issued. It is possible to add syringe 
markers to the type and amount of equipment issued. The database is therefore not a 
sampling frame of injecting equipment supplied from the NEXs but reflects the full 
population who attend NEXs. To date this is an extensive database that has been 
underutilised in terms of any statistical analysis. Along with qualitative research into 
their use in practice, this combination can potentially enable interventions and safer 
injecting messages to be more specifically targeted at particular groups or areas. There 
is an obvious link with the information contained in the national databases on sharing 
of equipment and on the incidence of new HCV infections, discussed above,  that can 
be included in future research into the effectiveness of syringe markers. For example, 
this combination could be used to examine any potential links between the 
geographical location of new cases of HCV infection and the location and 
characteristics of the population supplied with syringe markers, injecting frequency 
and the quantities supplied.    
 
The incorporation of peer researchers in the evaluation was considered to be 
successful and this is a role that should be actively developed and extended in future 
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work. The background and reasons for using peer researchers in this role were 
discussed in detail in Chapter 3. Initially there was some uncertainty and hesitancy 
from the principle researcher about the capacity of the peer researchers to undertake 
this work within the setting and if they would be able to complete the task 
successfully. However any fears proved groundless and despite some of the practical 
difficulties associated with the work, outlined in the field work diary, their 
participation in the pilot was successful. Any development of the syringe markers and 
other related research or evaluation in NEX settings should incorporate, develop and 
extend the role of peer researchers.   
 
5.4 Evaluation Limitations. 
 
As noted in Chapter 4, of the 177 respondents, 132 had been supplied with markers 
during the supply phase of the pilot and 83 reported that they had used them. The 
questionnaire focussed on this group of 83. The questionnaire was originally designed 
in collaboration with the members of the SUIG who would be administering this in 
the pharmacy NEXs. The initial priorities included targeting those who had used the 
markers in the limited time frame available, minimising the length and complexity of 
the questionnaire partly based on the inexperience of the SUIG members and to 
minimise any potential disruption within the pharmacy. The piloting of the 
questionnaire was undertaken with members of the group. On reflection, it would 
have been more productive to have piloted the questionnaire by the peer researchers in 
one of the pilot sites at the end of the supply phase. This would have indicated at an 
earlier stage that the peer researchers could cope with the practicalities of recruitment 
and questionnaire administration in this busy setting without adversely affecting the 
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routine activities. This may have given the opportunity to extend the questionnaire 
and to use visual cues in questions and on the instruction card as described in the 
recommendations from the field work diary discussed in Chapter 3.  
 
Further work needs to be undertaken with the 37%, (n=49)  of the 132 who were 
supplied with the syringe markers to trial but did not use them, as this may potentially 
indicate alternative interventions that may be more relevant for them and their 
injecting practices. However this does not invalidate the positive responses from those 
who did use the markers. Due to the large numbers of IDUs and the diverse range of 
injecting behaviours it is unlikely that one option for syringe identification would ever 
be sufficient as the sole means of identification. The majority of the 132 respondents 
who had been supplied with the markers did report that they used them (n=83, 63%) 
and 99% of the 83 (n=82) of those who used them indicated that they would use them 
again if they continued to be supplied. This would appear to support syringe marker 
supply as a useful and practical option that should be extended and made more widely 
available. This is particularly relevant where, due to the high estimated numbers of 
IDUs and sharing practices, any intervention that has the potential to be used by 63% 
of the population gives an opportunity to have a positive impact in promoting safer 
injecting practices for large numbers of IDUs covering multiple injecting episodes. 
Although information is not available from the 37% who were supplied with, but did 
not use the markers, this should not detract from the fact that this appears to be an 
intervention with potential positive benefits at minimal additional costs to the service. 
 
In this evaluation study there was no scope for direct observation of injecting episodes 
that would have confirmed or refuted the evidence from the questionnaire. Using this 
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form of method triangulation would assist in establishing more definitive conclusions 
on the use of syringe markers in real life injecting episodes. The evaluation results 
could have been corroborated if it had been possible to provide independent evidence 
of actual use. For example, confirmatory evidence may have been present if there had 
been residual evidence of syringe marker use on injecting equipment that was 
returned for safe disposal. To comply with good practice procedures and work place 
health and safety regulations, the returned individual disposal bins are sealed and the 
contents are not normally visible. This is an area that should be explored for ongoing 
monitoring and for any extension of this study.   
 
5.5 Role of the Practitioner-Researcher in the Syringe Marker Evaluation 
  
Dyson and Brown have shown that there are a number of issues for a health care 
researcher who has a dual role as a practitioner leading to the requirements of the  
research causing the practitioner to be placed from the beginning in what they 
describe as a “dilemmatic position” (2006:130). They highlight the expectations that 
are placed on healthcare workers to participate and to build evidence based research 
into routine professional practice and the associated problems that this causes. They 
highlight the fact that critical reflection is essential for the health care practitioner to 
help inform the structure of all phases of any research (Dyson and Brown, 2006). In 
this evaluation of the syringe markers there was a dual role for the researcher in 
managing the service and in designing the intervention and conducting the evaluation. 
The ethical dilemmas and the potential conflict between undertaking an academic 
research evaluation of a service that the researcher was responsible for managing were 
discussed in Chapter 2. The role of the researcher in this evaluation was one of 
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“Practitioner-Researcher”. This has been defined as some-one who “holds down a job 
in some particular area and is, at the same time, involved in carrying out systematic 
enquiry which is of relevance to the job” (Robson, 2002:534). Robson discussed the 
advantages and disadvantages associated with this type of dual role all of which were 
relevant to the syringe marker evaluation. Disadvantages were shown to include 
“time, lack of expertise, lack of confidence and “insider” problems” (Robson, 
2002:535). The research role for any practitioner is always the secondary role and this 
constitutes the main barrier to conducting any form of research. The advantages have 
been described as ““Insider” opportunities, “Practitioner” opportunities and 
“Practitioner-researcher” synergy” (Robson, 2002:535). This evaluation demonstrates 
the practical application of the advantages and disadvantages listed by Robson. In this 
evaluation the role advantages of the practitioner-researcher were in gaining access to 
the research sites, obtaining funding and in the inherent professional insights that 
assisted the design and conduct of the study as evaluation research. The disadvantages 
mentioned were countered by combining academic study and support with the 
professional practitioner role where the aim of the additional academic study was to 
develop the “ability to relate academic knowledge to professional interests” 
(University of Stirling, 2005:17). 
 
5.6  Concluding Observations. 
 
The primary purpose of any evaluation is to assess the impact of an intervention or 
social programme. According to Clark, evaluation is a type of applied research which 
should contribute relevant information to enable those people in decision making 
positions to take these future decisions with the benefit of the evidence from the 
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evaluation (Clark, 2009). Using peer researchers in the role described in this 
evaluation was successful and should be promoted and extended. For the syringe 
marker evaluation the initial aims were partly achieved. The results indicate that for 
IDUs this is an acceptable means of identifying individual injecting equipment and 
that in practice it was feasible to make this supply through the community pharmacy 
NEX network. Whether this then leads to a decrease in sharing of equipment and a 
subsequent decrease in HCV transmission is an area that needs further work before 
any definitive conclusions could be drawn. Discussion of the findings of the 
evaluation has indicated a number of areas of further work, including the use of proxy 
measures that could be used to investigate the impact of the markers on levels of 
sharing and of newly acquired HCV infections and the need to investigate further the 
group who did not use the markers with a view to design of alternative methods and 
strategies to help prevent inadvertent sharing.  
 
There are a number of difficult methodological challenges that exist when attempting 
to evaluate an intervention in an existing service setting. The NEX setting sets natural 
boundaries and limits the control and manipulation of the intervention and the 
participants that can be exercised by the researcher. The incorporation of peer 
researchers in the design was a factor that contributed positively to the overall 
evaluation and with hindsight the role of the peer researchers could have been 
extended and possibly incorporated at an earlier stage in the design. If the proposed 
areas of further work previously outlined were undertaken this would make it possible 
to enhance the validity of the initial results and the credibility of the conclusions that 
could be drawn. 
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For the widespread expansion of syringe markers or any other innovative 
interventions in NEXs it is essential that changes to policy and practices should be 
made on the basis of evidence. It is not always a straightforward process to embed 
evidence into practice as, for example, there may be competing priorities for limited 
funds. However the collection of evidence is a vital tool and it has been shown that it 
is essential that strategies are put in place to enable evidence to be integrated into any 
new practice developments or interventions (Nutley, Walter and Davies, 2003).  
 
The wider political, social and legal policies that are required to tackle drug use 
prevention, treatment and recovery are outside the scope of this study as it is restricted 
to the investigation of one specific health related harm reduction intervention. 
However there is a continuing pressing need to minimise the potential permanent 
health harms that injecting drug use can cause for individuals and for the wider 
community. There is an important role for practitioners and health care professionals 
to act within the scope of their professional responsibilities and boundaries to 
minimise the harms to individuals This evaluation has demonstrated that there is 
likely to be a useful role for the wider distribution of syringe markers in reducing 
some of the health harms associated with injecting drug use by providing a potential 
means of reducing the accidental sharing of injecting equipment.  Ideally the role of 
the health care professional in the context of syringe marker supply is summed up by 
the following quotation from Testa. 
 
“For many people with drug addictions, it is the development of a relationship with 
someone in the health care field who cares foremost about keeping them as safe as 
possible—no matter what type of behaviour they are engaging in – that ultimately 
leads to recovery” (2009:10). 
 185 
 
                                        References. 
 
 
Aceijas C and Rhodes T. 2007. Global Estimates of Prevalence of HCV Infection 
Among Injecting Drug Users. The International Journal of Drug Policy. 18, 352-358.  
 
Advisory Council on the Misuse of Drugs (ACMD). 1988. AIDS and Drug Misuse: 
Part One.  London. Department of Health and Social Security.  
 
Advisory Council on the Misuse of Drugs (ACMD). 1993. AIDS and Drug Misuse 
Update. London. Department of Health and Social Security.  
 
Advisory Council on the Misuse of Drugs (ACMD). 2009. The Primary Prevention of 
Hepatitis C Among Injecting Drug Users. London. Home Office.  
 
Alexander B. 2000. The Globalization of Addiction. Addiction Research. 8, 6, 501-
526. 
 
Alonso Y. 2004. The Biopsychosocial Model in Medical Research: The Evolution of 
the Health Concept over the Last Two Decades. Patient Education and Counselling. 
53, 239-244. 
 
Arnstein S. 1969. A Ladder of Citizen Participation. Journal of the American Institute 
of Planners. 35, 216-224. 
 
Ashton M. 2003. Hepatitis C and Needle Exchange. Drug and Alcohol Findings 8, 4-
7 
 
Battjes R J and Pickens R W (eds). 1988. Needle Sharing Among Intravenous Drug 
Abusers: National and International Perspectives. National Institute on Drug Abuse 
(NIDA) Research Monograph 80. United States. Department of Health and Human 
Services. 
 
Becker J and Duffy C. 2002. Women Drug Users and Drugs Service Provision: 
Service-level Responses to Engagement and Retention. DPAS Briefing Paper 17, 
London. Home Office.. 
 
Beresford P. 2002. User Involvement in Research and Evaluation: Liberation or 
Regulation ?. Social Policy and Society. 1, 95-105. 
 
Berridge V. 1999. Opium and the People. Opiate Use and Drug Control Policy in 
Nineteenth and Early Twentieth Century England. London. Free Association Books. 
 
Beynon C, Taylor A, Allen E and Bellis M, 2010. Visual Versus Written Cues: A 
Comparison of Drug Injectors’ Responses. Have Surveys Using the Written Word 
Underestimated Risk Behaviours for Hepatitis C ? Substance Use and Misuse. 45, 
1491-1508. 
 
 186 
 
Blackburn S. 2008. The Oxford Dictionary of Philosophy. Oxford Reference Online. 
Available at: 
http://www.oxfordreference.com/views/ENTRY.html?subview=Main&entry=t98.e24
66  (Accessed 31
st
 January 2012). 
 
Blaikie N. 2003. Analyzing Quantitative Data. London. Sage Publications. 
 
Boote J, Telford R and Cooper C.  2002. Consumer Involvement in Health Research: 
A Review and Research Agenda. Health Policy. 61, 2, 213-236.  
 
Boote J, Barber R and Cooper C. 2006. Principles and Indicators of Successful 
Consumer Involvement in NHS Research: Results of a Delphi Study and Sub-group 
Analysis. Health Policy. 75, 3, 280-297.  
 
Booth A. 2009. Research or Evaluation? Does it Matter? Health Information and 
Libraries Journal. 26, 3, 255-258. 
 
Briggs D, Rhodes T, Marks D, Kimber J, Holloway G and Jones S. 2009. Injecting 
Drug Use and Unstable Housing: Scope for Structural Interventions in Harm 
Reduction. Drugs: Education, Prevention and Policy. 16, 436-450. 
 
Brownlie J, Anderson S and Ormston R. 2006. Children as Researchers, Edinburgh. 
Scottish Executive Education Department. Available at: 
http://www.scotland.gov.uk/Publications/2006/06/SprChar/Q/Page/3.  
(Accessed 19
th
 July 2010) 
 
Bruce N, Pope D and Stanistreet D. 2008. Quantitative Methods for Health Research. 
A Practical Interactive Guide to Epidemiology and Statistics. England. J Wiley and 
sons Ltd. 
 
Bryman A. 2004. Social Research Methods, 2
nd
 Edition. Oxford. Oxford University 
Press. 
 
Buchanan D, Shaw S, Ford A and Singer M. 2003. Empirical Science Meets Moral 
Panic : An Analysis of the Politics of Needle Exchange. Journal of Public Health 
Policy. 24, 427-444.  
 
Bucknell P and Ghodse H. 1989. Misuse of Drugs and Drug Trafficking Offences Act. 
Supplement  Number 3. Waterlow Publishers. 
 
Bulmer M. 1986. Social Science and Social Policy. London. Allen and Unwin. 
 
Butcher L. 2005. No home, No job. Care and Health Magazine. 16, 30-31.  
 
Cameron, J, Gilchrist G and Roberts K. 2004. Needle Exchange Services: A Profile of 
Service Users in Community Pharmacies and other Settings. International Journal of 
Pharmacy Practice. 12, 211-215. 
 
Campbell J, 2011. Personal Communication. Development and Improvement 
Manager, Injecting Equipment Provision, NHS Greater Glasgow and Clyde. 
 187 
 
Cayton, H and Hanley B. 2001. Improving Research Through Consumer Involvement. 
In: Baker M and  Kirk S (eds) Research & Development for the NHS. Oxford. 
Radcliffe Medical Press. 
 
Clark A. 2005. Evaluation Research: An Introduction to Principles, Methods and 
Practice. London. Sage Publications.  
 
Cohen S. 1980. Folk Devils and Moral Panics: The Creation of the Mods and 
Rockers. Oxford. Martin Robertson.   
 
Commonwealth of Australia. 2002. Return on Investment in Needle and Syringe  
Programs in Australia. Summary Report. Publication Number 3123. Australia. 
Commonwealth Department of Health and Ageing. 
 
Cooper D and Schindler P (eds). 2003. Business Research Methods.8
th
 edition. 
International Edition. McGraw Hill. 
 
Coupland H, Maher L, Enriquez J, Le J, Pacheo V, Pham A, Carroll C, Cheguelman 
G, Freeman D, Robinson D and Smith K. 2005. Clients or Colleagues? Reflections of 
the Process of Participatory Action Research with Young Injecting Drug Users. 
International Journal of Drug Policy. 16, 3, 191-198. 
 
Creswell J. 2003. Research Design: Qualitative, Quantitative and Mixed Method 
Approaches. London. Sage.  
 
Crofts N, Aitken C K and Kalder J M. 1999. The Force of Numbers: Why Hepatitis C 
is Spreading Among Australian Injecting Drug Users while HIV is Not. The Medical 
Journal of Australia. 170, 5, 220-221. 
 
Crombag HS, Bossert JM, Koya E and Shaham Y. 2008. Context-induced Relapse to 
Drug Seeking: A Review. Philosophical Transactions Royal Society London 
Biological Sciences ( Philos Trans R Soc Lond B Biol Sci) 363, 1507, 3233-3243.  
 
Currie J. 2007. Personal Communication. Service User Group Co-ordinator.  Scottish 
Drugs Forum (SDF).  
 
Darke S, Ross J and Kaye S. 2001. Physical Injecting Sites Among Injecting Drug 
Users in Sydney, Australia. Drug and Alcohol Dependence, 62, 77-82. 
 
Department of Health. 1996. The Task Force to Review Services for Drug Misusers. 
Report of an Independent Review of Drug Treatment Services in England. London. 
Department of Health. HMSO.  
 
Department of Health. 2001. Governance Arrangements for NHS Research Ethics 
Committees. London. Department of Health. HMSO. Available at: 
http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/document
s/digitalasset/dh_4058609.pdf 
(Accessed 13
th
 March 2010) 
 
 188 
 
Department of Health and Social Security. 1983. NHS Management Inquiry (The 
Griffiths Report). London. Department of Health and Social Security. HMSO 
Derricott J, Preston A and Hunt N. 1999. The Safer Injecting Briefing. An Easy to use 
Comprehensive Reference Guide to Promoting Safer Injecting. Liverpool. HIT.   
 
Downie R S and Calman K (Eds).1994. Healthy Respect. Oxford: Oxford Medical 
Publications. 
 
Drug Misuse Statistics Scotland. 2009. Annual Report. Common Services Agency. 
Edinburgh. Information Services Division (ISD) Publications. Available at: 
www.drugmisuse.isdscotland.org 
(Accessed February 7
th
 2010) 
 
Drug Trafficking Offences Act 1986. Available at: 
http://www.opsi.gov.uk/acts/acts1986/pdf/ukpga_19860032_en.pdf 
(Accessed 11
th
 October 2009)  
 
Dyson S and Brown B. 2006. Social Theory and Applied Health Research. England. 
Open University Press. 
 
Eaves C. 2004. Heroin Use Among Female Adolescents: The Role of Partner 
Influence in Path Initiation and Route of Administration. American Journal of Drug 
and Alcohol Abuse. 30, 1, 21-38. 
 
Edwards R and Graber G (eds). 1988. Bio-Ethics. United States of America. Harcourt 
Brace Jovanovich, Inc. 
 
Elliott E, Watson AJ and Harries U. 2002. Harnessing Expertise: Involving Peer 
Interviewers in Qualitative Research with Hard to Reach Populations. Health 
Expectations. 5, 172-178.  
 
Engel GL. 1977. The Need for a New Medical Model: A Challenge for Biomedicine. 
Science. 196, 129-136.  
 
Ettore E. 2004. Revisioning Women and Drug Use: Gender Sensitivity, Embodiment 
and Reducing Harm. International Journal of Drug Policy. 15, 327-335.  
 
Everitt A and Hardiker P. 1996. Evaluating for Good Practice. London, MacMillan. 
 
Exchange Supplies: Tools for Harm Reduction. Available at : 
http://www.exchangesupplies.org/shopdisp_A903.php (Accessed 21
st
 June, 2010). 
 
Farid B. 1988. AIDS and Drug Addiction Needle Exchange Schemes: A Step in the 
Dark. Journal of the Royal Society of Medicine. 81, 375-376. 
 
Garden J, Roberts K, Taylor A and Robinson D. 2003. Evaluation of the Provision of 
Single Use Citric Acid Sachets to Injecting Drug Users, Effective Interventions Unit. 
Edinburgh, Scottish Executive. 
 
 189 
 
Garner R, 2005. The Joy of Stats. A Short Guide to Introductory Statistics in the 
Social Sciences. Canada, Broadview Press. 
 
Ghodse H, Treganza G and Li M. 1987. Effect of Fear of AIDS on Sharing of 
Injecting Equipment Among Drug Abusers. British Medical Journal. 295, 698-699.  
Gourlay Y, 2008. Personal Communication. Lead Anti Microbial Pharmacist, NHS 
Greater Glasgow and Clyde. 
  
Gilbert N. 2003. Researching Social Life. London. Sage Publications. 
 
Glasby J and Beresford P. 2006. Who Knows Best ? Evidence-based Practice and the 
Service User Contribution. Critical Social Policy. 26, 1, 268-284. 
 
Godfrey M. 2004. More  than “Involvement”. How Commissioning User Interviewers 
in the Research Process Begins to Change the Balance of Power. Practice. 16, 3, 223-
231.  
 
Goldberg D, Burns S, Taylor A, Cameron D, Hargreaves D and Hutchison S. 2001. 
Trends in HCV Prevalence Among Injecting Drug Users in Glasgow and Edinburgh 
During the Era of Needle/Syringe Exchange. Scandinavian Journal of Infectious 
Disease. 33, 457-461. 
 
Gossop M, Griffiths P, Powis B and Williamson S. 1997. Continuing Drug Risk 
Behaviour: Shared Use of Injecting Paraphernalia among London Heroin Injectors. 
Aids Care. 9, 6, 651-660. 
 
Greater Glasgow Health Board. 1996. Community Care in Glasgow: A Joint Planning 
Strategy for HIV and AIDs in the Greater Glasgow Health Board Area 1996-1999. 
Glasgow. Greater Glasgow Health Board.  
 
Green J. 2006. Personal Communication.  Senior Health and Safety Manager.Chair of 
National Waste Management Steering Group for the NHS. NHS Greater Glasgow and 
Clyde. 
 
Greene JC, Benjamin L and Goodyear L. 2001. The Merits of Mixing Methods in 
Evaluation. Evaluation. 7, 1, 25-44.   
 
Griesbach D, Abdulrahim D, Gordon D and Dowell K. 2006. Needle Exchange 
Provision in Scotland. A Report of the National Needle Exchange Survey. Edinburgh. 
Scottish Executive.  http://www.scotland.gov.uk/Publications/2006/06/16110001/0  
(Accessed 13
th
 Sept 2009) 
 
Griffiths P, Gossop M, Powis B and Strang J. 1993. Reaching Hidden Populations of 
Drug Users by Privileged Access Interviewers: Methodological and Practical Issues. 
Addiction. 88, 1617-1626. 
 
Gruer L. 2001. A Review of Needle Exchange in Greater Glasgow. Glasgow. Prepared 
by a Short Life Working Group for the City of Glasgow Addictions Planning and 
Implementation Group on behalf of the Greater Glasgow Drug Action Team.  
 
 190 
 
Grund J-P C, Friedman S R, Stern L S, Jose B, Neaigus A, Curtis R and Des Jarlais D 
C. 1996. Syringe-mediated Drug Sharing among Injecting Drug Users: Patterns, 
Social Context and Implications for Transmissions of Blood-Borne Pathogens. Social 
Science and Medicine, 42, 691-703.  
 
Grund J-P, Kaplan C, Adriaans N F P and Blanken P. 1991. Drug Sharing and HIV 
Transmission Risks: The Practice of “Front-loading” in the Dutch Injecting Drug User 
Polpulation. Journal of Psychoactive Drugs, 23, 1-10. 
 
Hall S, Critcher C, Jefferson T, Clarke J, and Roberts B. 1978.  Policing the Crisis: 
Mugging, The State and Law and Order. London, MacMillan. 
 
Handy C. 1993. Understanding Organisations. London. Penguin. 
 
Hankins C. 2008. Sex, Drugs, and Gender? High Time for Lived Experience to 
Inform Action. International Journal of Drug Policy, 19, 2, 95-96.  
 
Hanley B, Bradburn J, Barnes M, Evans C, Goodare H, Kelson M, Oliver S, Thomas 
S and Wallcraft J. 2004. Involving the Public in Health and Social Care Research: 
Briefing  Notes for Researchers. Eastleigh. Involve. Available at: www.invo.org.uk 
(Accessed 25
th
 April 2010) 
 
Hay G, Gannon M, Casey J and McKeganey N. 2009. Estimating the National and 
Local Prevalence of Problem Drug Use in Scotland. Edinburgh. ISD Scotland. 
 
Haynes P. 2003. Managing Complexity in the Public Services. Maidenhead. Open 
University Press. 
 
Health Protection Agency, Health Protection Scotland, National Public Health Service 
for Wales, CDSC Northern Ireland, CRDHB. 2009. Shooting Up: Infections Among 
Injecting Drug Users in the United Kingdom 2008.  London: Health Protection 
Agency.  
 
Health Protection Scotland website. Blood Borne Viruses and Sexually Transmitted 
Diseases. Available at: http://www.hps.scot.nhs.uk/bbvsti/hepatitisc.aspx (Accessed 
27th April 2010) 
 
Health Protection Scotland website.  Hepatitis C Diagnosis Database. Available at: 
http://www.hps.scot.nhs.uk/bbvsti/ssdetail.aspx?id=33  (Accessed 23
rd
 Feb 2011) 
 
Hedrich D, Pirona A and Wiessing L, 2008. From Margin to Mainstream: The 
Evolution of Harm Reduction Responses to Problem Drug Use in Europe. Drugs: 
Education, Prevention and Policy. 15, 6, 503-517.  
 
Hope V, Kimber J, Vickerman P, Hickman M and Ncube F.  2008. Frequency, 
Factors and Costs Associated with Injecting Site Infections: Findings From a National 
Multi-Site Survey of Injecting Drug Users in England. BMC Infectious Diseases. 8, 
120, 1-8. 
 
 191 
 
Hunter G, Stimson G, Jones S, Judd A and Hickman M.  1998. Survey of Prevalence 
of  Sharing by Injecting Drug Users not in Contact with Services. An Independent 
Study Carried out on Behalf of the Department of Health, The Centre for Research on 
Drugs and Health Behaviour, Imperial College, London.  
 
Hunter G, Stimson G, Judd A, Jones S and Hickman M. 2000. Measuring Injecting 
Risk Behaviour in the Second Decade of Harm Reduction: A Survey of Injecting 
Drug Users in England. Addiction. 95, 9, 1351-1361. 
 
Hutchison S, Bird S, Taylor A, and Goldberg D. 2006.. Modelling the Spread of 
Hepatitis C Virus Infection Among Injecting Drug Users in Glasgow: Implications for 
Prevention. International Journal of Drug Policy. 17, 211-221.    
 
Hutchison S, Roy K, Wadd S, Bird S, Taylor A, Anderson E, Shaw L, Codere G and 
Goldberg D. 2006. Hepatitis C Virus Infection in Scotland: Epidemiological Review 
and Public Health Challenges. Scottish Medical Journal. 51, 2, 8-15. 
 
Inciardi J and Harrison L. 2000. Harm Reduction: National and International 
Perspectives. London. Sage Publications.  
 
International Harm Reduction Association (IHRA). 2009. What is Harm Reduction ? 
A Position Statement from the International Harm Reduction Association. London. 
Available at: http://www.ihra.net/Whatisharmreduction  
(Accessed 21
st
 Nov 2010). 
 
INVOLVE. Available at: http://www.invo.org.uk/ 
 
INVOLVE (2003) Available at:  http://www.invo.org.uk/About_Us.asp (Accessed 
20th Dec 2010). 
 
INVOLVE (2004). Involving Marginalised and Vulnerable People in Research: A 
Consultation Document. Available at:  http://www.invo.org.uk/ 
(Accessed 20
th
 Dec 2010) 
 
Jason L A, Ferrari J R, Davis M I and Olson B D (eds). 2006. Creating Communities 
for Addiction Recovery. The Oxford House Model. London. Haworth Press.  
 
Johnson T. Dec 2008 / Jan 2009. Public Health Leaders Hope for Renewed Health 
Agenda Under New Administration:Health Outlook. The Nation’s Health, American 
Public Health Association. 38, 1-29. 
 
Jones L, Pickering L, Sumnall H, McVeigh J and Bellis M. 2008. A Review of the 
Effectiveness and Cost-effectiveness of Needle and Syringe Programmes for Injecting 
Drug Users. Centre for Public Health. Liverpool John Moores University. October 
2008. 
 
Kemshall H and Littlechild R (eds). 2000. User Involvement and Participation in 
Social Care. Research Informing Practice. London. Kingsley. 
 192 
 
Kessels R, 2003. Patients’ Memory for Medical Information. Journal of the Royal 
Society of Medicine. 96, 219-222. 
Koester S. 1996. The Process of Drug Injection: Applying Ethnography to the Study 
of HIV Risk among IDUs, in Rhodes T and Hartnoll (eds). AIDS, Drugs and 
Prevention. London. Routledge.  
 
Koester S, Booth R and Wiebel W. 1990. The Risk of HIV Transmission from 
Sharing Water, Drug Mixing Containers and Cotton Filters among Intravenous Drug 
Users. International Journal on Drug Policy, 1, 28-30.  
 
Last J M (Ed), 2007. Joint United Nations Programme on HIV/AIDS. A Dictionary of 
Public Health. Oxford University Press. Oxford Reference Online.. Available at 
http://www.oxfordreference.com/views/ENTRY.html?subview=Main&entry=t235.e2
434 (Accessed 16
th
 Jan 2011). 
 
Lowes L and Hulatt (eds). 2005. Involving Service Users in Health and Social Care 
Research. Oxfordshire. Routledge. 
 
Loxley W. 2000. Doing the Possible: Harm Reduction,Injecting Drug use and Blood 
Borne Viral Infections in Australia. International Journal of Drug Policy. 11, 407-
416.  
 
Lurie P and Drucker E. 1997. An Opportunity Lost: HIV Infections Associated with 
the Lack of a Needle-Exchange Programme in the United States. The Lancet. 349, 
604-608. 
 
McKeganey N and Barnard M, 1992. AIDS, Drugs and Sexual Risk. Lives in the 
Balance. Buckingham. Open University Press. 
 
McLaughlin H. 2009. Service User Research in Health and Social Care. London. 
Sage Publications. 
 
Miller D C and Salkind N J (eds). 2002. Handbook of Research Design and Social 
Measurement. 6
th
 Edition. London. Sage Publications.  
 
Miller P. 2009. Safe Using Messages May Not be Enough to Promote Behaviour 
Change Amongst Injecting Drug Users who are Ambivalent or Indifferent Towards 
Death. Harm Reduction Journal. 6.18. Available at:  
http://www.harmreductionjournal.com/content/6/1/18 (Accessed 8
th
 May 2011). 
 
Minogue V and Girdlestone J. 2010. Building Capacity for Service User and Carer 
Involvement in Research. The Implications and Impact of Best Research for Best 
Health. International Journal of Health Care Quality Assurance. 23, 4, 422-435. 
 
Misak C (ed). 1999. Pragmatism. Canada. University of Canada Press. 
 
Misuse of Drugs (Amendment) (No2) Regulations 2003. Statutory Instrument 1653. 
Available at : http://www.opsi.gov.uk/si/si2003/uksi_20031653_en.pdf 
(Accessed 29
th
 Nov 2009). 
 193 
 
Morrison A, Duff L, Taylor A, Sherval J, Ahmed S and Haw S. 2002. Hepatitis C: 
Risks and Prevention Strategies in Injecting Drug Users. Research Review. Effective 
Interventions Unit. Edinburgh. Scottish Executive. 
 
Morrow E, Ross F, Grocott P and Bennett J. 2010. A Model and Measure for Quality 
Service User Involvement in Health Research. International Journal of Consumer 
Studies. 34,532-539. 
 
Moser CA and Kalton G. 1989. Survey Methods in Social Investigation. England. 
Gower Publishing. 
 
National Health Service Reform (Scotland) Act. 2004. HMSO. Available at: 
http://www.opsi.gov/legislation/scotland/acts2004/pdf/asp_20040007_en.pdf 
(Accessed 28
th
 Feb 2010) 
 
National Institute for Health and Clinical Excellence (NICE). 2002. Principles for 
Best Practice in Clinical Audit. Abingdon. Radcliffe Medical Press. Available at: 
http://www.nice.org.uk/media/796/23/BestPracticeClinicalAudit.pdf 
(Accessed 26
th
 March 2010) 
 
National Institute for Health and Clinical Excellence (NICE). 2009. Needle and 
Syringe Programmes: Providing People who Inject Drugs with Injecting Equipment. 
Public Health Guidance 18. Available at: http://www.nice.org.uk/Guidance/PH18 
 
National Patient Safety Agency. 2006. Differentiating Audit, Service Evaluation and 
Research. London. Department of Health. Available at: 
http://www.nres.npsa.nhs.uk/applications/guidance/research-
guidance/?entryid62=66988 (Accessed 26
th
 March 2010) 
 
National Treatment Agency for Substance Misuse. 2007. The NTA’s 2005 Survey of 
Needle Exchanges in England. London. National Treatment Agency for Substance 
Misuse. 
 
Needle Exchange Surveillance Initiative (NESI). 2010. Prevalence of HCV and 
Injecting Risk Behaviours among Injecting Drug Users attending Needle Exchanges 
in Scotland, 2008/2009. University of the West of Scotland, Health Protection 
Scotland and West of Scotland Virology Centre. University of the West of Scotland. 
Available at:  http://www.hepcscotland.co.uk/media/50084/nesi-report-08-09.pdf 
(Accessed 24
th
 August 2011) 
 
Nutley S, Walter I and Davies HTO. 2003. From Knowing to Doing. A Framework 
for Understanding the Evidence-Into-Practice Agenda. Evaluation. 9, 2, 125-148.  
 
Olszewski D, Giraudon I, Hedrich D and Montanari L. 2009. Thematic Paper-
Women’s Voices. Experiences and Perceptions of Women Who Face Drug-related 
Problems in Europe. European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA). Luxembourg. 
 
 
 194 
 
Oxford Medical Dictionary. Oxford University Press. 2007. Oxford Reference Online.  
Available at:    
http://www.oxfordreference.com/views/ENTRY.html?subview=Main&entry=t60.e23
6 (Accessed 20 April 2010) 
 
Patient Focus and Public Involvement, 2001. Guidance. Edinburgh. Scottish 
Executive. Available at: 
 http://www.scotland.gov.uk/Resource/Doc/158744/0043087.pdf (Accessed 11
th
 Dec 
2010) 
 
Patton M Q. 1981. Creative Evaluation. London .Sage Publications. 
 
Pauly B, Goldstone I, McCall J, Gold F and Payne S. 2007. The Ethical, Legal and 
Social Context of Harm Reduction. Canadian Nurse, 103, 8, 19-23.  
 
Piot P and Cherney S. 2007. "AIDS: The Great Killers". The Oxford Companion to 
Medicine.  Stephen Lock, John M. Last, and George Dunea (eds). Oxford University 
Press . Oxford Reference Online. Available at: 
http://www.oxfordreference.com/views/ENTRY.html?subview=Main&entry=t185.e1
4> (Accessed 20
th
 April 2010) 
 
Rhodes T. 1997. Risk Theory in Epidemic Times: Sex, Drugs and the Social 
Organisation of “Risk Behaviour”. Sociology of Health and Illness. 19, 2, 208-227. 
 
Rhodes T, Greenwood G and Robertson K. (eds). 2001. Injecting Drug Use, Risk 
Behaviour and Qualitative Research in the Time of AIDS. European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA). 
 
Ritter A J, Fry C L and Swan A. 2003. The Ethics of Reimbursing Injecting Drug 
Users for Public Health Research Interviews: What Price are we Prepared to Pay? 
International Journal of Drug Policy. 14, 1, 1-3. 
 
Roberts K. 2009. The UKs Paraphernalia Laws and Impact on Cocaine and Crack 
Injectors. Pharmacy Misuse Advisory Group, PharMAGazine. 10, 1, 2-3.  
 
Roberts K. 2004. Personal Communication. Member of Advisory Council on the 
Misuse of Drugs (ACMD). Needle Exchange Coordinator NHS Greater Glasgow 
2003- 2005.  
 
Roberts K. 2007. Personal Communication. Member of Advisory Council on the 
Misuse of Drugs (ACMD). Needle Exchange Coordinator NHS Greater Glasgow 
2003- 2005.  
 
Roberts K, Gilchrist G, Cameron J and Ahmed S. 2002. Evaluation of the Greater 
Glasgow Pharmacy Needle Exchange Scheme, 1997-2002. Effective Interventions 
Unit. Edinburgh. Scottish Executive. 
 
Roberts K and Hunter C. 2004. A Comprehensive System of Pharmaceutical Care for 
Drug Misusers. Harm Reduction Journal. 1, 6. 
 
 195 
 
Robertson J R, Bucknall A B V, Welsby P D, Roberts J S K, Inglis J M, Peutherer J F 
and Brettle R P. 1986. Epidemic of AIDS-related Virus ( HTLV-111/LAV) Infection 
among Intravenous Drug Abusers. British Medical Journal. 292, 527-529. 
 
Robson C. 2002. Real World Research. Oxford. Blackwell. 
 
Rossi P H and Wright J D, 2002. Evaluation Research: An Assessment in Miller D C 
and Salkind N J (eds),. Handbook of Research Design and Social Measurement. 6
th
 
Edition. London. Sage Publications.  
 
Royal Pharmaceutical Society of Great Britain (RPSGB). 1982. Council Statement: 
Sale of Syringes. Pharmaceutical Journal. 228, 692.  
 
Royal Pharmaceutical Society of Great Britain (RPSGB). 1986. Council Statement: 
Sale of Hypodermic Syringes and Needles. Pharmaceutical Journal. 236, 205. 
 
Royal Pharmaceutical Society of Great Britain (RPSGB). 2005. Medicines Ethics and 
Practice. Guidelines for Pharmacists. London. Pharmaceutical Press.  
 
Royal Pharmaceutical Society of Great Britain (RPSGB), 2010. Code of Ethics for 
Pharmacists and Pharmacy Technicians. London. Pharmaceutical Press. 
 
Scott J, 2008. Safety, Risks and Outcomes from the use of Injecting Paraphernalia. 
Edinburgh. Scottish Government Social Research.  
 
Scott J and Marshall G. 2009. Identity. Oxford. Oxford University Press. Oxford 
Reference Online. Available at:   
http://www.oxfordreference.com/views/ENTRY.html?subview=Main&entry=t88.e10
61 (Accessed 14
th
 August 2010) 
 
Scottish Drug Misuse Database (SDMD). Available at: 
http://www.drugmisuse.isdscotland.org/sdmd/sdmd.htm 
 
Scottish Executive. 2002. Needle and Syringe Exchange Schemes. NHS Health 
Department Letter (HDL) (2002) 90. Available at: 
http://www.sehd.scot.nhs.uk/mels/hdl2002_90.pdf  (Accessed 2
nd
 Nov 2009) 
 
Scottish Executive. 2006. Hepatitis C Action Plan for Scotland Phase 1: September 
2006-August 2008. Edinburgh. Scottish Executive. 
 
Scottish Government. 2008. Hepatitis C Action Plan for Scotland Phase II: May 
2008-March 2011. Edinburgh. Scottish Government. 
Scottish Government. 2010. Guidelines for Services Providing Injecting Equipment: 
Best Practice Recommendations for Commissioners and Injecting Equipment 
Provision (IEP) Services in Scotland. Edinburgh. Health Department.  Available at: 
http://www.scotland.gov.uk/Publications/2010/03/29165055/2  
(Accessed 25
th
 September 2010)   
 196 
 
Scottish Home and Health Department. 1986. HIV Infection in Scotland. Report of 
the Scottish Committee on HIV Infection and Intravenous Drug Misuse. Edinburgh. 
SHHD  
 
Scottish Home and Health Department. 1988. AIDS and Drug Misuse: Sale of 
Injecting Equipment by Retail Pharmacies. NHS Circular No 1988(GEN) 19. 
Edinburgh. SHHD. 
 
Shannon K, Rusch M, Shoveller J, Alexson D, Gibson K and Tyndall M. 2008. 
Mapping Violence and Policing as an Environmental-structural Barrier to Health 
Service and Syringe Availability Among Substance-using Women in Street-level Sex 
Work. International Journal of Drug Policy. 19, 2, 140-147.  
 
Sheard L and Tompkins C. 2008. Contradictions and Misperceptions: An Exploration 
of Injecting Practice, Cleanliness, Risk, and Partnership in the Lives of Women Drug 
Users. Qualitative Health Research, 18, 1536-1547.  
 
Shepard C, Finelli L and Alter M. 2005. Global Epidemiology of Hepatitis C Virus 
Infection. The Lancet Infectious Diseases. 5, 9, 558-567. 
 
Sheridan J, Strang J, Barber N and Glanz A. 1996. Role of the Community 
Pharmacies in relation to HIV Prevention and Drug Misuse: Findings from the 1995 
National Survey in England and Wales. British Medical Journal . 313, 272-274. 
 
Shorrock T. 2003. The History and Operation of Pharmacy Needle Exchanges in 
Sheridan J and Strang J (eds). Drug Misuse and Community Pharmacy. London. 
Taylor and Francis. 
 
Smith E, Ross F, Donovan S, Manthorpe J, Brearley S, Sitzia J and Beresford P. 2008. 
Service User Involvement in Nursing, Midwifery and Health Visitor Research: A 
Review of Evidence and Practice. International Journal of Nursing Studies. 45, 2, 
298-315. 
 
Smyth B P, Barry J and Keenan E.  2005. Irish Injecting Drug Users and Hepatitis C: 
The Importance of the Social Context of Injecting. International Journal of 
Epidemiology.  34, 1, 166-172. 
 
Speed S. 1998. The Sharing of Injecting Paraphernalia Among 96 Regular Attenders 
at Needle-Exchange Schemes in the North West of England; Implications for Local 
Public Health Policy. International Journal of Drug Policy. 9,351-358.  
  
Stimson G. 1995. AIDs and Injecting Drug Use in the United Kingdom, 1987-1993: 
The Policy Response and the Prevention of the Epidemic. Social Science Medicine, 
41, 5, 699-716.  
 
Stimson G. 1988. Injecting Equipment Exchange Schemes in England and Scotland in 
Battjes R and Pickens R (eds). Needle Sharing Among Intravenous Drug Abusers: 
National and International Perspectives. National Institute on Drug Abuse (NIDA) 
Research Monograph 80. United States. Department of Health and Human Services. 
 
 197 
 
Stimson G, Allritt L, Dolan K and Donoghoe M. 1988. Syringe Schemes for Drug 
Users in England and Scotland. British Medical Journal, 296, 1717-1719.  
 
Stone D. 2001. Policy Paradox; The Art of Political Decision Making. New York. 
WW Norton and Co.  
 
Stopka T, Springer K W, Khoshnood K, Shaw S and Singer M.  2004. Writing about 
Risk: Use of Daily Diaries in Understanding Drug-User Risk Behaviours. AIDS and 
Behaviour. 8, 1, 73-85. 
 
Strang J and Gossop M (eds). 2005. Heroin Addiction and the British System. 
Treatment and Policy Responses. Volume 2. London, Routledge. 
Strauss and Corbin.  1990.  Basics of Qualitative Research. London. Sage.  
 
Szmukler G. 2009. Service Users in Research and a “Well Ordered Science”. Journal 
of Mental Health. 18, 2, 87-90.  
 
Taylor A. 1993. Women Drug Users. An Ethnography of a Female Injecting 
Community. Oxford. Clarendon Press. 
 
Taylor A, Fleming A, Rutherford J and Goldberg D. 2004. Examining the Injecting 
Practices of Injecting Drug Users in Scotland. Effective Interventions Unit. 
Edinburgh. Scottish Executive. 
 
Testa M. 2009. Effective Addictions Strategy is Often Overlooked. Psychiatric News, 
American Psychiatric Association. 44, 18, 10. 
 
Thompson K. 1998. Moral Panics. London, Routledge. 
 
Thorpe l, Quellet L, Hershaw R, Bailsy S, Williams I, Williamson J, Monterroso O 
and Garfein R. 2002. Risk of Hepatitis C Virus Infection Among Young Adult 
Injecting Drug Users who Share Injecting Equipment. American Journal of 
Epidemiology. 155, 645-653. 
 
Tritter J Q and McCallum A. 2006. The Snakes and Ladders of User Involvement: 
Moving Beyond Arnstein. Health Policy. 76, 156-168. 
 
University of Stirling, 2005. Doctor of Applied Social Research. Programme Guide 
2005-2006. Department of Applied Social Science. 
 
Van Haastrecht H. 1997. HIV Infection and Drug Use in the Netherlands: The Course 
of the Epidemic. Journal of Drug Issues. 27, 57-72. 
 
Vlahov D,Des Jarlais D,Goosby E,Hollinger P,Lurie P,Shriver M and Strathdee S. 
2001. Needle Exchange Programs for the Prevention of Human Immunodeficiency 
Virus Infection: Epidemiology and Policy. American Journal of Epidemiology. 154, 
12, Supplement S70-S77.  
 
Webb J. 2007. Pragmatisms (Plural) Part 1: Classical Pragmatism and Some 
Implications for Empirical Inquiry. Journal of Economic Issues. XLI, 4, 1063-1086. 
 198 
 
White B, Day C and Maher L. 2007. Self Reported Risk Behaviour Among Injecting 
Drug Users: Self Versus Assisted Questionnaire Completion. AIDS Care. 19, 3, 441-
447 
 
Whitely S, Ellis R and Broomfield S. 1996. Health and Social Care Management- A 
Guide to Self-Development. London. Arnold. 
 
Wilkinson A, Redman T, Snape E and Marchington M. 1998. Managing with Total 
Quality Management: Theory and Practice. London. MacMillan. 
Winter M de and Noom M.  2003. Someone Who Treats You as an Ordinary Human 
Being...Homeless Youth Examine the Quality of Professional Care. British Journal of 
Social Work. 33, 325-337.  
 
Wodak A and Cooney A. 2005. World Health Organisation Evidence for Action for 
HIV Prevention,Treatment and Care among Injecting Drug Users. Effectiveness of 
Sterile Needle and Syringe Programmes. International Journal of Drug Policy.16S, 1, 
31-44. 
 
Wright D, Foster C, Amir Z, Elliot J and Wilson R. 2010. Critical Appraisal 
Guidelines for Assessing the Quality and Impact of User Involvement in Research. 
Health Expectations. 13, 4, 359-368.  
 
Wright N, Millson C and Tompkins C. 2005. What is the Evidence for the 
Effectiveness of Interventions to Reduce Hepatitis C Infection and the Associated 
Morbidity? Copenhagen, WHO Regional Office for Europe (Health Evidence 
Network Report). Available at:  http:/www.euro.who.int/document/E86159.pdf   
(Accessed 8
th
 June 2010 ).  
 
Young J. 1971. The Drugtakers: The Social Meaning of Drug Use. London . Paladin.  
 
Yates R. 2002. A Brief History of British Drug Policy, 1950-2001. Drugs Education, 
Prevention and Policy.  9, 2, 113-124.  
 
 
 
 
 
 
 
 
 
 
 199 
 
Appendix One : Media examples illustrating “moral panic” type reporting. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Community opposition to ‘fixed site’ needle exchange November 1999 
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AppendixTwo: Discarded Needle Article. 
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Appendix Three: Safe Disposal Information 
 
  
 
 
 
 
 203 
 
 
Appendix Four: Costs 
 
 
 
ITEM COSTS 
Markers ( coloured stickers) £200 
Pharmacist Locum fees ( Training 
day) 
£600 
Lunch ( Training day) £100 
Expenses for Service User Group 
Members (£5 daily) 
£430 
Stationary / Printing £50 
  
TOTAL £1380 
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Appendix Five: Participation Letter 
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Appendix Six: Markers and Instruction Card 
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Appendix Seven: Training Presentation 
 
 
 
 
 
Glasgow Pharmacy Needle 
Exchange Syringe Marker Pilot
Carole Hunter
Lead pharmacist
Carole.hunter@glasgow.gov.uk
 
Background
• The need for a way of identifying syringes 
was flagged up by the Effective Interventions 
Unit study by Prof Avril Taylor
• It was also and action point in the Hep C 
Action Plan for Scotland that was produced 
by the Scottish Executive.
 
 
Not Endorsing Re-using!
• The most important part of the project is that 
we are not encouraging the clients to re-use 
their syringes
• This project is about stopping accidental
sharing of needles and syringes in a group 
situation
• Clients must be encouraged to use a new 
syringe for every injection
 
The Project so far….
• Exchange supplies produced a plastic identifier 
which we decided to pilot and compare with the 
more cost effective sticker option
• The SDF User Involvement Group were involved 
in the initial meetings and had expressed that 
they felt the stickers were more versatile and 
easier to use
• The UIG also stated that many clients were 
already marking their syringes in less 
conventional ways ie: scratching and burning
 
 
Risk Assessment!!!
• As we would be giving these out to clients we 
had to have them risk assessed and 
unfortunately the plastic identifiers did not 
pass as they were found to be a potential 
choking hazard
• We then had another plastic marker designed 
which was also felt to be unsafe
• So we are left with the stickers that the UIG 
suggested in the first place!
 
The Pilot
• Each pharmacy will supply a sheet of stickers 
to every needle exchange client who attends 
the pharmacy over the period of 4 weeks
• They will also supply a card which explains 
what the stickers are for
• The staff should explain to all clients verbally 
what they are for if it is the first time that they 
have been given them
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• Staff should mention that they can be used in 
a variety of ways
• - placing on the plunger
• - placing on the barrel
• - using more than one sticker on the barrel if 
two people have the same colour
• - if two people have the same colour then the 
initials of the users can also be written on the 
stickers
 
• The stickers have an advantage over the 
plastic markers due to the fact that they can 
be used on both 1ml and 2ml syringes.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluation
• The evaluation will start on the 5th week and 
will involve  2 members of the UIG spending 
time in each pharmacy
• The evaluation will run for 4 weeks 
• They will question NEX users about their use 
of the markers
• Clients are not obliged to take part and we 
have ethical approval to speak to anyone 
who is willing to participate.
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Appendix Eight: Questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
                 (*Note:            Pharmacy Name Recorded  
     Forms Colour Coded 
     Gender recorded on front page) 
 
 
 
 
 
 
Syringe Marker Pilot 
Community Pharmacy Needle 
Exchanges 
June 2006 
Patient Information 
 
This study has been complied in order to investigate the effectiveness of markers for 
the identification of syringes. This information will be used to inform planning and future 
service developments throughout Glasgow Addiction Services. 
 
This study is voluntary and completely anonymous. It should take no longer than 5-10 
minutes. If you do not wish to take part or want to stop at any time please indicate to 
the interviewer. All data will be used in accordance with the Data Protection Act 1998.  
 
If you have any queries in relation to this survey please contact Carole Hunter, Lead Pharmacist 
on 0141-276-6612 or Laureen McElroy, Senior Officer Monitoring, Performance & Evaluation 
0141-276-6626. 
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Service User Questionnaire 
IF ‘YES’ TO THIS, PLEASE PROCEED, IF ‘NO’ THEN END OF STUDY 
IF ‘YES’ TO THIS, PLEASE PROCEED, IF ‘NO’ THEN END OF STUDY 
 
Section One: Personal Information & Injecting Pattern  
 
1. How long have you been injecting? 
 
<1 year 1      1-2 yrs 2      3-5 yrs 3        6-10 yrs 4      11 yrs + 5 
 
2. Which of the following do you inject [most often]? 
 
Stimulant 1                             Steroid 2                           Opiate 3 
 E.g. cocaine, coke, crack,  E.g. roids, juice        E.g. heroin, smack, brown 
amphetamines, speed               
     
Other 4 Please specify ______________________________________ 
 
 3a. Do you currently identify your syringe? Yes 1  No 2    
 
 3b. If ‘yes’, how do you identify it? 
 
Burn 1                                Scratch 2                                      Mark 3        
                
Other 4Please specify ________________________________________ 
 
 4. In the past year, have you mixed up your syringe with someone else’s...
 
  
Very Often 1         Often 2        Occasionally 3          Rarely 4    
 
Never 5    
 
5. What is your current housing status? 
 
Own tenancy 1      Staying care of an individual 2     Hostel  3           
 
Temporary Furnished Flat 4          Supported Accommodation 5 
 
Roofless 6        Other 7 Please specify ________________________       
Section Two: Syringe Markers 
 
 1. Have you been given markers to trial? Yes 1  No 2    
          
 
        
  
 2.  Did you use the markers?   Yes 1 No 2   
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Section Three: The Markers  
 
1.   Using the scale below please indicate how useful you felt the  
markers were as a method of marking your syringe:                                             
 
       1           2   3         4              5 
Very Useful       Quite Useful        No opinion    Not very       Not at all 
         Useful        Useful      
             
 2.    If the markers were available to you, would you be:  
 
More likely to mark your syringe        1 
Less likely to mark your syringe         2 
No different      3 
 
 3. Would you use the markers again?   Yes 1 No 2    
 
 4.  Could they be improved in any way?  Yes 1 No 2    
  
 If ‘yes’ please explain how: 
_______________________________________________________________
_______________________________________________________________
_______________________________________________________________
___________________________________________ 
 
Section Four: The Card  
 
 1. Did you receive a card with your markers?  
 [Glasgow Pharmacy Needle Exchange Syringe Markers]  
        Yes 1 No 2    
 
2.       If you answered ‘yes’ to the above please answer the following questions, 
otherwise this is the end of the study.  
  
Using the scale of below please indicate how useful you felt the card was 
as a guide to using the markers: 
 
         1         2   3                   4                        5 
Very Useful Quite Useful              No opinion              Not very             Not at all 
       Useful         useful    
 
 3.  Did the card provide you with all the 
information needed to use the markers?  Yes 1 No 2    
 
What in your opinion would improve the current information card:  
_______________________________________________________________
_______________________________________________________________
_______________________________________________________________
___________________________________________                                  
       END OF STUDY           
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Appendix Nine: Patient Information 
 
 
Patient Information 
 
This study has been complied in order to investigate the effectiveness of 
markers for the identification of syringes. This information will be used to inform 
planning and future service developments throughout Glasgow Addiction 
Services. 
 
This study is voluntary and completely anonymous. It should take no longer 
than 5-10 minutes. If you do not wish to take part or want to stop at any time 
please indicate to the interviewer. All data will be used in accordance with 
the Data Protection Act 1998.  
 
If you have any queries in relation to this survey please contact Carole Hunter, Lead 
Pharmacist on 0141-276-6612 or Laureen McElroy, Senior Officer Monitoring, 
Performance & Evaluation 0141-276-6626. 
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Appendix Ten: Field Work Diary Themes 
 
 
Key Codes from Thematic Analysis of Field Work Diaries.  
 
1. Reactions to Research Setting 
 
i) Structural 
ii) Boredom 
iii) Frustration 
iv) Interactions with staff 
v) Communication with staff 
 
2. Relationships and Interactions 
 
i) Communication with staff. 
ii) Interaction/ communication with participants 
iii) Trust 
iv) Interactions with other peer researchers 
 
3. Identity 
 
i) Trust 
ii) Responsibility 
iii) Unsolicited contributions to research 
iv) Role identity 
v) View of self  
vi) Perceptions 
 
4. Practical Difficulties 
 
i) Isolation 
ii) Physical barriers 
iii) Boredom 
 
5. Observations 
 
i) Recording additional participant comments 
ii) Observing and recording interactions related to research 
iii) Observing and recording interactions external to research 
iv) Participant observation role 
 
6. Communication 
 
i) Pharmacy Staff 
ii) Research Participants 
iii) Field Work diary reflections 
iv) Recommendations produced 
v) Researcher 
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 Appendix Eleven: Commercially Produced Syringe and Paraphernalia Markers.  
 
 
 
 
 
 
